The Carlyle Group Inc. (CG) 10-Q8 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2022	Nov. 07, 2022
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-35538
Entity Registrant Name	Carlyle Group Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-2832612
Entity Address, Address Line One	1001 Pennsylvania Avenue, NW
Entity Address, City or Town	Washington
Entity Address, State or Province	DC
Entity Address, Postal Zip Code	20004-2505
City Area Code	202
Local Phone Number	729-5626
Entity Common Stock, Shares Outstanding		363,605,317
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001527166
Current Fiscal Year End Date	--12-31
Common Stock
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	CG
Security Exchange Name	NASDAQ
4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C.
Entity Listings [Line Items]
Title of 12(b) Security	4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C.
Trading Symbol	CGABL
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 1,361.9	$ 2,469.5
Cash and cash equivalents held at Consolidated Funds	177.2	147.8
Restricted cash	0.6	5.6
Corporate treasury investments	69.5	0
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively	10,998.2	10,832
Investments of Consolidated Funds	6,409.7	6,661
Due from affiliates and other receivables, net	486.4	379.6
Due from affiliates and other receivables of Consolidated Funds, net	108.6	138.8
Fixed assets, net	134.4	143.9
Lease right-of-use assets, net	333.5	361.1
Deposits and other	69.4	61.7
Intangible assets, net	925.1	34.9
Deferred tax assets	17.9	14.5
Total assets	21,092.4	21,250.4
Liabilities and equity
Debt obligations	2,235	2,071.6
Loans payable of Consolidated Funds	5,516.9	5,890
Accounts payable, accrued expenses and other liabilities	379.4	379.7
Accrued compensation and benefits	4,347.7	4,955
Due to affiliates	351.6	388.1
Deferred revenue	394.2	120.8
Deferred tax liabilities	449.9	487.1
Other liabilities of Consolidated Funds	222	683.9
Lease liabilities	499.9	537.8
Accrued giveback obligations	40.9	30.2
Total liabilities	14,437.5	15,544.2
Commitments and contingencies
Common stock, $0.01 par value, 100,000,000,000 shares authorized (363,372,564 and 355,367,876 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)	3.6	3.6
Additional paid-in-capital	3,123	2,717.6
Retained earnings	3,430.8	2,805.3
Accumulated other comprehensive loss	(439.7)	(247.5)
Non-controlling interests in consolidated entities	537.2	427.2
Total equity	6,654.9	5,706.2
Total liabilities and equity	$ 21,092.4	$ 21,250.4

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accrued performance allocations	$ 7,428.7	$ 8,133
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	100,000,000,000	100,000,000,000
Common stock, issued (in shares)	363,372,564	355,367,876
Common stock, outstanding (in shares)	363,372,564	355,367,876

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
Condensed Consolidated Statements of Operations - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Investment income	$ 422,300,000	$ 1,134,900,000	$ 1,846,700,000	$ 5,318,500,000
Interest and other income	35,500,000	21,900,000	92,500,000	63,300,000
Interest and other income of Consolidated Funds	79,700,000	62,100,000	204,600,000	185,300,000
Total revenues	1,088,500,000	1,639,500,000	3,719,300,000	6,783,000,000
Compensation and benefits
Cash-based compensation and benefits	251,400,000	224,900,000	779,700,000	685,200,000
Equity-based compensation	54,200,000	42,400,000	139,300,000	122,000,000
Performance allocations and incentive fee related compensation	163,500,000	495,200,000	741,200,000	2,355,800,000
Total compensation and benefits	469,100,000	762,500,000	1,660,200,000	3,163,000,000
General, administrative and other expenses	149,200,000	99,600,000	387,200,000	300,400,000
Interest	27,300,000	27,900,000	82,000,000	76,400,000
Interest and other expenses of Consolidated Funds	53,700,000	44,600,000	137,100,000	133,500,000
Other non-operating expenses	300,000	3,500,000	800,000	1,000,000
Total expenses	699,600,000	938,100,000	2,267,300,000	3,674,300,000
Other income
Net investment income (loss) of Consolidated Funds	(30,300,000)	(100,000)	(51,000,000)	9,600,000
Income before provision for income taxes	358,600,000	701,300,000	1,401,000,000	3,118,300,000
Provision for income taxes	76,200,000	153,900,000	274,900,000	733,500,000
Net income	282,400,000	547,400,000	1,126,100,000	2,384,800,000
Net income attributable to non-controlling interests in consolidated entities	1,600,000	14,600,000	28,300,000	57,700,000
Net income attributable to common shares	$ 280,800,000	$ 532,800,000	$ 1,097,800,000	$ 2,327,100,000
Net income attributable to The Carlyle Group Inc. per common share (see Note 14)
Basic (in dollars per share)	$ 0.77	$ 1.50	$ 3.04	$ 6.56
Diluted (in dollars per share)	$ 0.77	$ 1.46	$ 3	$ 6.42
Weighted-average common shares
Basic (in shares)	362,895,064	355,954,734	360,657,999	354,903,371
Diluted (in shares)	366,787,149	364,740,675	365,389,217	362,471,998
Fund management fees
Revenues
Fund management fees and incentive fees	$ 535,900,000	$ 407,500,000	$ 1,532,900,000	$ 1,182,900,000
Incentive fees
Revenues
Fund management fees and incentive fees	15,100,000	13,100,000	42,600,000	33,000,000
Performance allocations
Revenues
Investment income	298,100,000	974,500,000	1,346,200,000	4,841,300,000
Principal investment income
Revenues
Investment income	$ 124,200,000	$ 160,400,000	$ 500,500,000	$ 477,200,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 282.4	$ 547.4	$ 1,126.1	$ 2,384.8
Other comprehensive income (loss)
Foreign currency translation adjustments	(91.8)	(18)	(219.3)	(41.2)
Defined benefit plans
Unrealized gain (loss) for the period	(0.2)	0.4	(4.7)	2.3
Less: reclassification adjustment for gain during the period, included in cash-based compensation and benefits expense	0.2	0.5	0.7	1.6
Other comprehensive loss	(91.8)	(17.1)	(223.3)	(37.3)
Comprehensive income	190.6	530.3	902.8	2,347.5
Comprehensive income (loss) attributable to non-controlling interests in consolidated entities	(11.3)	9.4	(2.8)	51.9
Comprehensive income attributable to The Carlyle Group Inc.	$ 201.9	$ 520.9	$ 905.6	$ 2,295.6

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Equity - USD ($) $ in Millions	Total	Abingworth	Common Stock	Common Stock Abingworth	Additional Paid-in-Capital	Additional Paid-in-Capital Abingworth	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2020			353,500,000
Beginning balance at Dec. 31, 2020	$ 2,930.2		$ 3.5		$ 2,546.2		$ 348.2	$ (208.7)	$ 241
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)	(1,900,000)		(1,900,000)
Shares repurchased	$ (84.5)						(84.5)
Equity-based compensation	125.6		$ 0.1		125.5
Shares issued for equity-based awards (in shares)			4,900,000
Contributions	57.2								57.2
Distributions	(343)						(266.7)		(76.3)
Net income	2,384.8						2,327.1		57.7
Currency translation adjustments	(41.2)							(35.4)	(5.8)
Defined benefit plans, net	3.9							3.9
Ending balance (in shares) at Sep. 30, 2021			356,500,000
Ending balance at Sep. 30, 2021	5,033		$ 3.6		2,671.7		2,324.1	(240.2)	273.8
Beginning balance (in shares) at Jun. 30, 2021			354,500,000
Beginning balance at Jun. 30, 2021	4,622		$ 3.5		2,621.7		1,940.1	(228.3)	285
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)			(1,300,000)
Shares repurchased	(59.5)						(59.5)
Equity-based compensation	50.1		$ 0.1		50
Shares issued for equity-based awards (in shares)			3,300,000
Contributions	12.8								12.8
Distributions	(122.7)						(89.3)		(33.4)
Net income	547.4						532.8		14.6
Currency translation adjustments	(18)							(12.8)	(5.2)
Defined benefit plans, net	0.9							0.9
Ending balance (in shares) at Sep. 30, 2021			356,500,000
Ending balance at Sep. 30, 2021	$ 5,033		$ 3.6		2,671.7		2,324.1	(240.2)	273.8
Beginning balance (in shares) at Dec. 31, 2021	355,367,876		355,400,000
Beginning balance at Dec. 31, 2021	$ 5,706.2		$ 3.6		2,717.6		2,805.3	(247.5)	427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)	(3,600,000)		(3,600,000)
Shares repurchased	$ (146.9)						(146.9)
Equity-based compensation	147				147
Shares issued for equity-based awards (in shares)			5,900,000
Shares issued for performance allocations (in shares)			900,000
Shares issued for performance allocations	38.9				38.9
Shares issued related to the acquisition of CBAM (in shares)			4,200,000	600,000
Shares issued related to the acquisition of CBAM	194.5	$ 25			194.5	$ 25
Contributions	282.1								282.1
Distributions	(498.9)						(325.4)		(173.5)
Non-controlling interests related to the acquisition of Abingworth	4.2								4.2
Net income	1,126.1						1,097.8		28.3
Currency translation adjustments	(219.3)							(188.2)	(31.1)
Defined benefit plans, net	$ (4)							(4)
Ending balance (in shares) at Sep. 30, 2022	363,372,564		363,400,000
Ending balance at Sep. 30, 2022	$ 6,654.9		$ 3.6		3,123		3,430.8	(439.7)	537.2
Beginning balance (in shares) at Jun. 30, 2022			361,200,000
Beginning balance at Jun. 30, 2022	6,432.3		$ 3.6		3,033.6		3,309.9	(360.8)	446
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)			(1,200,000)
Shares repurchased	(41.6)						(41.6)
Equity-based compensation	62				62
Shares issued for equity-based awards (in shares)			2,600,000
Shares issued for performance allocations (in shares)			200,000
Shares issued for performance allocations	2.4				2.4
Shares issued related to the acquisition of CBAM (in shares)				600,000
Shares issued related to the acquisition of CBAM		$ 25				$ 25
Contributions	115.2								115.2
Distributions	(135.2)						(118.3)		(16.9)
Non-controlling interests related to the acquisition of Abingworth	4.2								4.2
Net income	282.4						280.8		1.6
Currency translation adjustments	(91.8)							(78.9)	(12.9)
Defined benefit plans, net	$ 0							0
Ending balance (in shares) at Sep. 30, 2022	363,372,564		363,400,000
Ending balance at Sep. 30, 2022	$ 6,654.9		$ 3.6		$ 3,123		$ 3,430.8	$ (439.7)	$ 537.2

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income	$ 1,126.1	$ 2,384.8
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	102.7	40.5
Right-of-use asset impairment, net of broker fees	0	24.8
Equity-based compensation	139.3	122
Non-cash performance allocations and incentive fees	184.1	(1,662.3)
Non-cash principal investment income	(483.8)	(458.3)
Other non-cash amounts	(27.4)	20.7
Consolidated Funds related:
Realized/unrealized (gain) loss on investments of Consolidated Funds	319.3	(100.3)
Realized/unrealized (gain) loss from loans payable of Consolidated Funds	(268.3)	90.7
Purchases of investments by Consolidated Funds	(3,090.1)	(3,864.4)
Proceeds from sale and settlements of investments by Consolidated Funds	2,418.4	3,631.7
Non-cash interest income, net	(7.6)	(9)
Change in cash and cash equivalents held at Consolidated Funds	(29.5)	43.5
Change in other receivables held at Consolidated Funds	15.8	(78.7)
Change in other liabilities held at Consolidated Funds	(380.1)	43.4
Purchases of investments	(559.6)	(178)
Proceeds from the sale of investments	388.3	533.8
Payments of contingent consideration	(5.7)	(50)
Changes in deferred taxes, net	(2.3)	449.1
Change in due from affiliates and other receivables	(62.6)	(21.4)
Change in deposits and other	(12.8)	(23.3)
Change in accounts payable, accrued expenses and other liabilities	(27.7)	90.9
Change in accrued compensation and benefits	(265.3)	17.3
Change in due to affiliates	2.4	1.4
Change in lease right-of-use assets and lease liabilities	(7)	5.9
Change in deferred revenue	274.9	247.6
Net cash provided by (used in) operating activities	(258.5)	1,302.4
Cash flows from investing activities
Purchases of corporate treasury investments, net	(69.6)	0
Purchases of fixed assets, net	(25)	(27)
Purchase of Abingworth, net of cash acquired	(150.2)	0
Purchase of CBAM intangibles and investments, net	(618.4)	0
Net cash used in investing activities	(863.2)	(17.8)
Cash flows from financing activities
Borrowings under credit facilities	0	70
Issuance of 4.625% subordinated notes due 2061, net of financing costs	0	484.1
Payments on CLO borrowings	(8.9)	(231.5)
Proceeds from CLO borrowings, net of financing costs	55.2	87.5
Net borrowings (payments) on loans payable of Consolidated Funds	449.4	165.2
Payments of contingent consideration	0	(0.1)
Dividends to common stockholders	(325.4)	(266.7)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	282.1	57.2
Distributions to non-controlling interest holders	(173.5)	(76.3)
Common shares issued for performance allocations	38.9	0
Common shares repurchased	(146.9)	(84.5)
Change in due to/from affiliates financing activities	(13.2)	21.8
Net cash provided by financing activities	88.9	157.9
Effect of foreign exchange rate changes	(79.8)	(26.2)
Increase (decrease) in cash, cash equivalents and restricted cash	(1,112.6)	1,416.3
Cash, cash equivalents and restricted cash, beginning of period	2,475.1	989.6
Cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9
Supplemental non-cash disclosures
Net asset impact of deconsolidation of Consolidated Funds	0	(34.4)
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,361.9	2,399
Restricted cash	0.6	6.9
Total cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9
Cash and cash equivalents held at Consolidated Funds	177.2	134.8
MRE
Cash flows from investing activities
Proceeds from sale, net of cash sold	0	5.9
Brazil management entity
Cash flows from investing activities
Proceeds from sale, net of cash sold	0	3.3
Consolidated Operating Entities
Cash flows from operating activities
Net income	1,112.1	2,383.9
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	102.7	40.5
Right-of-use asset impairment, net of broker fees	0	24.8
Equity-based compensation	139.3	122
Non-cash performance allocations and incentive fees	179.4	(1,662.3)
Non-cash principal investment income	(434.9)	(470.7)
Other non-cash amounts	(27.4)	20.7
Consolidated Funds related:
Purchases of investments	(582.4)	(250.9)
Proceeds from the sale of investments	410.2	559.1
Payments of contingent consideration	(5.7)	(50)
Changes in deferred taxes, net	(2.3)	449.1
Change in due from affiliates and other receivables	(62)	(21.1)
Change in deposits and other	(12.8)	(23.3)
Change in accounts payable, accrued expenses and other liabilities	(27.7)	90.9
Change in accrued compensation and benefits	(265.3)	17.3
Change in due to affiliates	2.4	1.4
Change in lease right-of-use assets and lease liabilities	(7)	5.9
Change in deferred revenue	274.9	247.6
Net cash provided by (used in) operating activities	793.5	1,484.9
Cash flows from investing activities
Purchases of corporate treasury investments, net	(69.6)	0
Purchases of fixed assets, net	(25)	(27)
Purchase of Abingworth, net of cash acquired	(150.2)	0
Purchase of CBAM intangibles and investments, net	(618.4)	0
Net cash used in investing activities	(863.2)	(17.8)
Cash flows from financing activities
Borrowings under credit facilities	0	70
Issuance of 4.625% subordinated notes due 2061, net of financing costs	0	484.1
Payments on CLO borrowings	(8.9)	(231.5)
Proceeds from CLO borrowings, net of financing costs	55.2	87.5
Payments of contingent consideration	0	(0.1)
Dividends to common stockholders	(325.4)	(266.7)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	7.2	13.1
Distributions to non-controlling interest holders	(52.5)	(56.3)
Common shares issued for performance allocations	38.9	0
Common shares repurchased	(146.9)	(84.5)
Change in due to/from affiliates financing activities	(471.6)	21.8
Net cash provided by financing activities	(972.8)	(31.4)
Effect of foreign exchange rate changes	(70.1)	(19.4)
Increase (decrease) in cash, cash equivalents and restricted cash	(1,112.6)	1,416.3
Cash, cash equivalents and restricted cash, beginning of period	2,475.1	989.6
Cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM and Abingworth	219.5	0
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,361.9	2,399
Restricted cash	0.6	6.9
Total cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9
Cash and cash equivalents held at Consolidated Funds	177.2	134.8
Consolidated Operating Entities \| MRE
Cash flows from investing activities
Proceeds from sale, net of cash sold	0	5.9
Consolidated Operating Entities \| Brazil management entity
Cash flows from investing activities
Proceeds from sale, net of cash sold	$ 0	$ 3.3

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Parenthetical)	Sep. 30, 2021
Subordinated Notes Due 2061 \| Consolidated Operating Entities
Interest rate (percent)	4.625%

Organization and Basis of Prese

Organization and Basis of Presentation	9 Months Ended
Organization and Basis of Presentation	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	1. Organization and Basis of Presentation Carlyle is one of the world’s largest global investment firms that deploys private capital across its business through three reportable segments: Global Private Equity, Global Credit and Global Investment Solutions (see Note 17). In the Global Private Equity segment, Carlyle advises buyout, growth, real estate, infrastructure and natural resources funds. The primary areas of focus for the Global Credit segment are liquid credit, illiquid credit, real assets credit, and other credit such as insurance solutions, and loan syndication and capital markets. The Global Investment Solutions segment provides investment opportunities and resources for investors and clients through fund of funds, secondary purchases of existing portfolios, and managed co-investment programs. Carlyle typically serves as the general partner, investment manager or collateral manager, making day-to-day investment decisions concerning the assets of these products. Basis of Presentation The accompanying financial statements include the accounts of the Company and its consolidated subsidiaries. In addition, certain Carlyle-affiliated funds, related co-investment entities and certain CLOs managed by the Company (collectively, the “Consolidated Funds”) have been consolidated in the accompanying financial statements pursuant to accounting principles generally accepted in the United States (“U.S. GAAP”), as described in Note 3. The consolidation of the Consolidated Funds generally has a gross-up effect on assets, liabilities and cash flows, and generally has no effect on the net income attributable to the Company. The economic ownership interests of the other investors in the Consolidated Funds are reflected as non-controlling interests in consolidated entities in the accompanying consolidated financial statements (see Note 3). The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information. These statements, including notes, have not been audited, exclude some of the disclosures required for annual financial statements, and should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the United States Securities and Exchange Commission (“SEC”). The operating results presented for interim periods are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the interim periods presented.

Recent Transactions

Recent Transactions	9 Months Ended
Recent Transactions	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Recent Transactions	2. Recent Transactions During the nine months ended September 30, 2022, the Company completed several transactions as outlined below. Acquisition of iStar Triple Net Lease Portfolio (See Note 6) In March 2022, Carlyle Net Leasing Income, L.P., a Carlyle-affiliated investment fund, acquired a diversified portfolio of triple net leases for an enterprise value of $3 billion, which was funded using $2 billion in debt and $1 billion in equity. The investment fund is not consolidated by the Company and the debt is non-recourse to the Company. Carlyle, as general partner of the investment fund, contributed $200 million as a minority interest balance sheet investment, which is included in the Company’s Global Credit principal equity method investments. Fortitude Capital Raise and Strategic Advisory Services Agreement (See Note 6) In March 2022, the Company raised $2.0 billion in third-party equity capital from certain investors in Carlyle FRL and T&D and committed $100 million from the Company to Carlyle FRL for additional equity capital in Fortitude. In May 2022, Fortitude called $1.1 billion of the capital raise, with the remaining capital expected to be called in 2023. In connection with the capital raise and subsequent funding, the Company’s indirect ownership of Fortitude decreased from 19.9% to 13.5% and is expected to further decrease to 10.5% upon funding the remainder of the capital raise. On April 1, 2022, the Company entered into a new strategic advisory services agreement with certain subsidiaries of Fortitude through a newly-formed investment advisor, Carlyle Insurance Solutions Management L.L.C. (“CISM”). Under the agreement, CISM provides Fortitude with certain services, including business development and growth, transaction origination and execution, and capital management services in exchange for a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability. Acquisition of CLO Management Contracts from CBAM Partners LLC (See Note 4) On March 21, 2022, the Company acquired the management contracts related to a portfolio of assets primarily comprised of U.S. and European CLOs as well as other assets across private credit from CBAM Partners LLC (“CBAM”) for a purchase price of $812.9 million. In connection with the acquisition of the CLO management contracts, the Company acquired CLO senior and subordinated notes of $175.9 million, a portion of which is financed through term loans and other financing arrangements. Acquisition of Abingworth LLP (See Note 4) On August 1, 2022, the Company acquired Abingworth LLP (“Abingworth”), a life sciences investment firm for a base purchase price of $185.6 million, of which $25.0 million was settled in newly-issued shares of the Company’s common stock. Consideration for Abingworth also includes up to $130 million in future incentive payments on the achievement of certain performance targets. The acquisition includes the rights to 15% of performance allocations generated by Abingworth’s two most recent active investment funds, Abingworth Bioventures 8 LP and Abingworth Clinical Co-Development Fund 2 LP.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	3. Summary of Significant Accounting Policies Principles of Consolidation The Company consolidates all entities that it controls either through a majority voting interest or as the primary beneficiary of variable interest entities (“VIEs”). The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3) whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company holds a variable interest, fees (including management fees, incentive fees and performance allocations) that are customary and commensurate with the level of services provided, and where the Company does not hold other economic interests in the entity that would absorb more than an insignificant amount of the expected losses or returns of the entity, are not considered variable interests. The Company considers all economic interests, including indirect interests, to determine if a fee is considered a variable interest. For those entities where the Company holds a variable interest, the Company determines whether each of these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly by the Company. As of September 30, 2022, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $6.7 billion and $5.8 billion, respectively. As of December 31, 2021, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $6.9 billion and $6.6 billion, respectively. Except to the extent of the consolidated assets of the VIEs, the holders of the consolidated VIEs’ liabilities generally do not have recourse to the Company. The Company’s Consolidated Funds includes CLOs, which are VIEs that issue loans payable that are backed by diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for managing the collateral for the CLOs, the Company earns investment management fees, including in some cases subordinated management fees and contingent incentive fees. In cases where the Company consolidates the CLOs (primarily because of a retained interest that is significant to the CLO), those management fees have been eliminated as intercompany transactions. As of September 30, 2022, the Company held $110.7 million of investments in these CLOs which represents its maximum risk of loss. The Company’s investments in these CLOs are generally subordinated to other interests in the entities and entitle the Company to receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs have no recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds also include investment funds that are consolidated as VIEs due to bridged investment activity during the fundraising process. Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest. All significant inter-entity transactions and balances of entities consolidated have been eliminated. Investments in Unconsolidated Variable Interest Entities The Company holds variable interests in certain VIEs that are not consolidated because the Company is not the primary beneficiary, including its investments in certain CLOs and certain AlpInvest vehicles, as well as its strategic investment in NGP Management Company, L.L.C. (“NGP Management” and, together with its affiliates, “NGP”). Refer to Note 6 for information on the strategic investment in NGP. The Company’s involvement with such entities is in the form of direct or indirect equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to its variable interests in these unconsolidated entities. The assets recognized in the Company’s consolidated balance sheets related to the Company’s variable interests in these non-consolidated VIEs were as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Investments $ 1,096.8 $ 901.9 Accrued performance revenues 391.1 368.7 Management fee receivables 44.3 27.2 Total $ 1,532.2 $ 1,297.8 These amounts represent the Company’s maximum exposure to loss related to the unconsolidated VIEs as of September 30, 2022 and December 31, 2021. Basis of Accounting The accompanying financial statements are prepared in accordance with U.S. GAAP. Management has determined that the Company’s Funds are investment companies under U.S. GAAP for the purposes of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and the unrealized gains and/or losses in an investment’s fair value are recognized on a current basis in the statements of operations. Accordingly, the Funds do not consolidate their majority-owned and controlled investments (the “Portfolio Companies”). In the preparation of these unaudited condensed consolidated financial statements, the Company has retained the specialized accounting for the Funds. All of the investments held and notes issued by the Consolidated Funds are presented at their estimated fair values in the Company’s condensed consolidated balance sheets. Interest and other income of the Consolidated Funds as well as interest expense and other expenses of the Consolidated Funds are included in the Company’s unaudited condensed consolidated statements of operations. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on performance allocations involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements and the resulting impact on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be material. Business Combinations The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price of the acquisition is allocated to the assets acquired and liabilities assumed using the fair values determined by management as of the acquisition date. Contingent consideration obligations that are elements of consideration transferred are recognized as of the acquisition date as part of the fair value transferred in exchange for the acquired business. Acquisition-related costs incurred in connection with a business combination are expensed as incurred. Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers . Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. ASC 606 includes a five-step framework that requires an entity to: (i) identify the contract(s) with a customer, which includes assessing the collectibility of the consideration to which it will be entitled in exchange for the goods or services transferred to the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when the entity satisfies a performance obligation. The Company accounts for performance allocations that represent a performance-based capital allocation from fund limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets within the scope of ASC 323, Investments - Equity Method and Joint Ventures , and therefore are not in the scope of ASC 606. In accordance with ASC 323, the Company records equity method income (losses) as a component of investment income based on the change in its proportionate claim on net assets of the investment fund, including performance allocations, assuming the investment fund was liquidated as of each reporting date pursuant to each fund’s governing agreements. See Note 6 for additional information on the components of investments and investment income. Performance fees that do not meet the definition of performance-based capital allocations are in the scope of ASC 606 and are included in incentive fees in the unaudited condensed consolidated statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the Company’s valuation group, as described in Note 5, Fair Value Measurement. While the determination of who is the customer in a contractual arrangement will be made on a contract-by-contract basis, the customer will generally be the investment fund for the Company’s significant management and advisory contracts. The customer determination impacts the Company’s analysis of the accounting for contract costs. Fund Management Fees The Company provides management services to funds in which it holds a general partner interest or to funds or certain portfolio companies with which it has an investment advisory or investment management agreement. The Company considers the performance obligations in its contracts with its funds to be the promise to provide (or to arrange for third parties to provide) investment management services related to the management, policies and operations of the funds. As it relates to the Company’s performance obligation to provide investment management services, the Company typically satisfies this performance obligation over time as the services are rendered, since the funds simultaneously receive and consume the benefits provided as the Company performs the service. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised services to the funds. Management fees earned from each investment management contract over the contract life represent variable consideration because the consideration the Company is entitled to varies based on fluctuations in the basis for the management fee, for example fund net asset value (“NAV”) or assets under management (“AUM”). Given that the management fee basis is susceptible to market factors outside of the Company’s influence, management fees are constrained and, therefore, estimates of future period management fees are generally not included in the transaction price. Revenue recognized for the investment management services provided is generally the amount determined at the end of the period because that is when the uncertainty for that period is resolved. For closed-end carry funds in the Global Private Equity and Global Credit segments, management fees generally range from 1.0% to 2.0% of commitments during the fund’s investment period based on limited partners’ capital commitments to the funds. Following the expiration or termination of the investment period, management fees generally are based on the lower of cost or fair value of invested capital and the rate charged may also be reduced. These terms may vary for certain separately managed accounts, longer-dated carry funds, and other closed-end funds. The Company will receive management fees during a specified period of time, which is generally ten years from the initial closing date, or, in some instances, from the final closing date, but such termination date may be earlier in certain limited circumstances or later if extended for successive one-year periods, typically up to a maximum of two years. Depending upon the contracted terms of investment advisory or investment management and related agreements, these fees are generally called semi-annually in advance and are recognized as earned over the subsequent six month period. For certain longer-dated carry funds and certain other closed-end funds, management fees are called quarterly over the life of the funds. Within the Global Credit segment, for CLOs and other structured products, management fees generally range from 0.4% to 0.5% based on the total par amount of assets or the aggregate principal amount of the notes in the CLO and are generally due quarterly in arrears based on the terms and recognized over the respective period. Management fees for the CLOs and other structured products are governed by indentures and collateral management agreements. The Company will receive management fees for the CLOs until redemption of the securities issued by the CLOs, which is generally five Under the strategic advisory services agreement with Fortitude, the Company earns a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability and which is due quarterly in arrears. Management fees for the Company’s carry fund vehicles in the Global Investment Solutions segment generally range from 0.25% to 1.0% of the vehicle’s capital commitments during the commitment fee period of the relevant fund. Following the expiration of the commitment fee period, the management fees generally range from 0.25% to 1.0% on (i) the net invested capital; (ii) the lower of cost or net asset value of the capital invested, or (iii) the net asset value for unrealized investments. Management fees for the Global Investment Solutions carry fund vehicles are generally due quarterly in advance and recognized over the related quarter. As of September 30, 2022 and December 31, 2021, management fee receivables, net of allowances for credit losses, were $217.9 million and $164.5 million, respectively, and are included in due from affiliates and other receivables, net, in the unaudited condensed consolidated balance sheets. The Company also provides transaction advisory and portfolio advisory services to the portfolio companies, and where covered by separate contractual agreements, recognizes fees for these services when the performance obligation has been satisfied and collection is reasonably assured. The Company also recognizes underwriting fees from the Company’s loan syndication and capital markets business, Carlyle Global Capital Markets. Fund management fees include transaction and portfolio advisory fees, as well as capital markets fees, of $34.5 million and $21.9 million for the three months ended September 30, 2022 and 2021, respectively, and $92.3 million and $54.3 million for the nine months ended September 30, 2022 and 2021, respectively, net of any offsets as defined in the respective partnership agreements. Fund management fees exclude the reimbursement of any partnership expenses paid by the Company on behalf of the Carlyle funds pursuant to the limited partnership agreements, including amounts related to the pursuit of actual, proposed, or unconsummated investments, professional fees, expenses associated with the acquisition, holding and disposition of investments, and other fund administrative expenses. For the professional fees that the Company arranges for the investment funds, the Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control the services provided by third parties before they are transferred to the customer. Therefore, the Company concluded it is acting in the capacity of an agent. Accordingly, the reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis in general, administrative and other expenses in the unaudited condensed consolidated statements of operations. The Company also incurs certain costs, primarily employee travel and entertainment costs, employee compensation and systems costs, for which it receives reimbursement from the investment funds in connection with its performance obligation to provide investment and management services. For reimbursable travel, compensation and systems costs, the Company concluded it controls the services provided by its employees and the resources used to develop applicable systems before they are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the Company to manage the fund limited partnerships are presented on a gross basis in interest and other income in the unaudited condensed consolidated statements of operations and the expense in general, administrative and other expenses or cash-based compensation and benefits expenses in the unaudited condensed consolidated statements of operations. Incentive Fees In connection with management contracts from certain of its Global Credit funds, the Company is also entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. In such arrangements, incentive fees are recognized when the performance benchmark has been achieved. Incentive fees are variable consideration because they are contingent upon the investment vehicle achieving stipulated investment return hurdles. Investment returns are highly susceptible to market factors outside of the Company’s influence. Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of future period incentive fees are generally not included in the transaction price because these estimates are constrained. The transaction price for incentive fees is generally the amount determined at the end of each accounting period to which they relate because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback. Investment Income (Loss), including Performance Allocations Investment income (loss) represents the unrealized and realized gains and losses resulting from the Company’s equity method investments, including any associated general partner performance allocations, and other principal investments, including CLOs. General partner performance allocations consist of the allocation of profits from certain of the funds to which the Company is entitled (commonly known as carried interest). For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally entitled to a 20% allocation (or approximately 2% to 12.5% for most of the Global Investment Solutions segment carry fund vehicles) of the net realized income or gain as a carried interest after returning the invested capital, the allocation of preferred returns of generally 7% to 9% and return of certain fund costs (generally subject to catch-up provisions as set forth in the fund limited partnership agreement). These terms may vary on longer-dated funds, certain credit funds, or external co-investment vehicles. Carried interest is recognized upon appreciation of the funds’ investment values above certain return hurdles set forth in each respective partnership agreement. The Company recognizes revenues attributable to performance allocations based upon the amount that would be due pursuant to the fund partnership agreement at each period end as if the funds were terminated at that date. Accordingly, the amount recognized as investment income for performance allocations reflects the Company’s share of the gains and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the fair values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is reasonably possible that the difference could be material. Carried interest is ultimately realized when: (i) an underlying investment is profitably disposed of, (ii) certain costs borne by the limited partner investors have been reimbursed, (iii) the fund’s cumulative returns are in excess of the preferred return and (iv) the Company has decided to collect carry rather than return additional capital to limited partner investors. Realized carried interest may be required to be returned by the Company in future periods if the fund’s investment values decline below certain levels. When the fair value of a fund’s investments remains constant or falls below certain return hurdles, previously recognized performance allocations are reversed. In all cases, each fund is considered separately in this regard, and for a given fund, performance allocations can never be negative over the life of a fund. If upon a hypothetical liquidation of a fund’s investments at their then-current fair values, previously recognized and distributed carried interest would be required to be returned, a liability is established for the potential giveback obligation. As of September 30, 2022 and December 31, 2021, the Company has accrued $40.9 million and $30.2 million, respectively, for giveback obligations. Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or when the Company receives or is due cash income, such as dividends or distributions. Unrealized principal investment income (loss) results from the Company’s proportionate share of the investee’s unrealized earnings, including changes in the fair value of the underlying investment, as well as the reversal of unrealized gain (loss) at the time an investment is realized. As it relates to the Company’s investments in NGP (see Note 6), principal investment income includes the related amortization of the basis difference between the Company’s carrying value of its investment and the Company’s share of underlying net assets of the investee, as well as the compensation expense associated with compensatory arrangements provided by the Company to employees of its equity method investee. Interest Income Interest income is recognized when earned. For debt securities representing non-investment grade beneficial interests in securitizations, the effective yield is determined based on the estimated cash flows of the security. Changes in the effective yield of these securities due to changes in estimated cash flows are recognized on a prospective basis as adjustments to interest income in future periods. Interest income earned by the Company is included in interest and other income in the accompanying unaudited condensed consolidated statements of operations. Interest income of the Consolidated Funds was $72.5 million and $56.9 million for the three months ended September 30, 2022 and 2021, respectively, and $188.2 million and $170.4 million for the nine months ended September 30, 2022 and 2021, respectively, and is included in interest and other income of Consolidated Funds in the accompanying unaudited condensed consolidated statements of operations. Credit Losses Under ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) , the Company is required to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The Company assesses the collection risk characteristics of the outstanding amounts in its due from affiliates balance into the following pools of receivables: • Reimbursable fund expenses receivables, • Management fee receivables, • Incentive fee receivables, • Transaction fee receivables, • Portfolio fee receivables, and • Notes receivable. The Company generally utilizes either historical credit loss information or discounted cash flows to calculate expected credit losses for each pool. The Company’s receivables are predominantly with its investment funds, which have low risk of credit loss based on the Company’s historical experience. Historical credit loss data may be adjusted for current conditions and reasonable and supportable forecasts, including the Company’s expectation of near-term realization based on the liquidity of the affiliated investment funds. Compensation and Benefits Cash-based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses (discretionary awards and guaranteed amounts), performance payment arrangements and benefits paid and payable to Carlyle employees. Bonuses are accrued over the service period to which they relate. Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is measured at fair value on the grant date. The compensation expense for awards that vest over a future service period is recognized over the relevant service period on a straight-line basis. The compensation expense for awards that do not require future service is recognized immediately. Cash settled equity-based awards are classified as liabilities and are re-measured at the end of each reporting period. The compensation expense for awards that contain performance conditions is recognized when it is probable that the performance conditions will be achieved; in certain instances, such compensation expense may be recognized prior to the grant date of the award. The compensation expense for awards that contain market conditions is based on a grant-date fair value that factors in the probability that the market conditions will be achieved and is recognized over the requisite service period on a straight-line basis. Equity-based awards issued to non-employees are generally recognized as general, administrative and other expenses, except to the extent they are recognized as part of the Company’s equity method earnings because they are issued to employees of equity method investees. The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously recognized compensation expense. The reduction in compensation expense is determined based on the specific awards forfeited during that period. Furthermore, the Company recognizes all excess tax benefits and deficiencies as income tax benefit or expense in the unaudited condensed consolidated statements of operations. Performance Allocations and Incentive Fee Related Compensation – A portion of the performance allocations and incentive fees earned is due to employees and advisors of the Company. These amounts are accounted for as compensation expense in conjunction with the recognition of the related performance allocations and incentive fee revenue and, until paid, are recognized as a component of the accrued compensation and benefits liability. Accordingly, upon a reversal of performance allocations or incentive fee revenue, the related compensation expense, if any, is also reversed. As of September 30, 2022 and December 31, 2021, the Company had recorded a liability of $3.8 billion and $4.1 billion, respectively, related to the portion of accrued performance allocations and incentive fees due to employees and advisors, respectively, which was included in accrued compensation and benefits in the accompanying unaudited condensed consolidated balance sheets. In October 2021, the Company commenced a program under which, at the Company’s discretion, up to 20% of the realized performance allocation related compensation over a threshold amount may be distributed in fully vested, newly issued shares of the Company’s common stock. Shares issued under the program are accounted for as performance allocations and incentive fee related compensation and do not result in incremental compensation expense. The Company has determined to pause the issuance of shares pursuant to this program. Income Taxes The Carlyle Group Inc. is a corporation for U.S. federal income tax purposes and thus is subject to U.S. federal, state and local corporate income taxes. Tax positions taken by the Company are subject to periodic audit by U.S. federal, state, local and foreign taxing authorities. The interim provision for income taxes is calculated using the discrete effective tax rate method as allowed by ASC 740, Accounting for Income Taxes . The discrete method is applied when the application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. In addition, the discrete method treats the year to date period as if it was the annual period and determines the income tax expense or benefit on that basis. The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement reporting and the tax basis of assets and liabilities using enacted tax rates in effect for the period in which the difference is expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period of the change in the provision for income taxes. Further, deferred tax assets are recognized for the expected realization of available net operating loss and tax credit carry forwards. A valuation allowance is recorded on the Company’s gross deferred tax assets when it is “more likely than not” that such asset will not be realized. When evaluating the realizability of the Company’s deferred tax assets, all evidence, both positive and negative, is evaluated. Items considered in this analysis include the ability to carry back losses, the reversal of temporary differences, tax planning strategies, and expectations of future earnings. The Company accounts for the valuation allowance assessment on its deferred tax assets excluding the corporate alternative minimum tax (“CAMT”) credit carryforward without regard to the Company’s future CAMT status. Lastly, the Company accounts for the tax on global intangible low-taxed income (“GILTI”) as incurred and therefore has not recorded deferred taxes related to GILTI on its foreign subsidiaries. Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit that is “more likely than not” to be sustained upon examination. The Company analyzes its tax filing positions in all of the U.S. federal, state, local and foreign tax jurisdictions where it is required to file income tax returns, as well as for all open tax years in these jurisdictions. If, based on this analysis, the Company determines that uncertainties in tax positions exist, a liability is established, which is included in accounts payable, accrued expenses and other liabilities in the unaudited condensed consolidated financial statem

Acquisitions

Acquisitions	9 Months Ended
Acquisitions	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	4. Acquisitions Abingworth Acquisition On August 1, 2022, the Company acquired 100% of the equity interests in Abingworth, a London-based life sciences investment firm. Abingworth has $2 billion in assets under management and is included in the Company’s Global Private Equity business segment. The purchase price consisted of $160.6 million in cash and approximately 0.6 million newly issued, fully vested common shares ($25.0 million based on the value of the shares at closing). The transaction also included an earn-out of up to $130.0 million that is payable upon the achievement of certain revenue and earnings performance targets during 2023 through 2028, which will be accounted for as compensation expense. The Company consolidated the financial position and results of operations of Abingworth effective August 1, 2022 and accounted for this transaction as a business combination. In connection with this transaction, the Company incurred approximately $7.7 million of acquisition costs that are reflected in general, administrative and other expenses in the unaudited condensed consolidated statements of operations for the nine months ended September 30, 2022. The acquisition-date fair value of the consideration transferred and the estimated fair values of the assets acquired and liabilities assumed at the acquisition date are as follows (Dollars in millions): Acquisition-date fair value of consideration transferred (1) Cash $ 160.6 Shares of common stock (see Note 15) 25.0 Total consideration transferred $ 185.6 Estimated fair value of assets acquired and liabilities assumed Cash and receivables $ 11.0 Investments in Abingworth funds 3.8 Lease right-of-use assets, fixed assets, and other assets, net 3.7 Deferred tax assets 6.7 Finite-lived intangible assets 88.0 Goodwill 90.9 Lease liabilities (2.7) Accrued expenses, accrued compensation and benefits, and other liabilities (11.6) Non-controlling interests in Abingworth entities (2) (4.2) Total $ 185.6 (1) The value of the consideration at acquisition is subject to certain post-closing adjustments. (2) Represents assets held by Abingworth entities which are consolidated VIEs. These assets are attributable to employees and are therefore reflected as non-controlling interests, and include investments in funds in which the Company did not acquire direct economic interests, which are presented as investments in Abingworth funds above. The finite-lived intangible assets, which related to management contracts and customer relationships, are amortized over a period ranging from five The amount of revenue and earnings of Abingworth since the acquisition date and the pro forma impact to the Company’s consolidated financial results for the year ended December 31, 2021 as if the acquisition had been consummated as of January 1, 2021, was not significant. Acquisition of CLO Management Contracts from CBAM Partners LLC On March 21, 2022, the Company acquired the management contracts related to a portfolio of assets primarily comprised of U.S. and European CLOs as well as other assets across private credit from CBAM Partners LLC (“CBAM”). The purchase price of $812.9 million consisted of a combination of $618.4 million in cash, including approximately $3.4 million of acquisition costs incurred by the Company in connection with the transaction, and approximately 4.2 million newly issued, fully vested common shares ($194.5 million based on the value of the shares at closing). In connection with the acquisition of the CLO management contracts, the Company acquired CLO senior and subordinated notes of $175.9 million. A portion of these CLO investments is financed through term loans and other financing arrangements with financial institutions, which are secured by the Company’s investments in the respective CLO, have a general unsecured interest in the Carlyle entity that manages the CLO, and generally do not have recourse to any other Carlyle entity (see Note 8). This transaction was accounted for as an asset acquisition and the acquired contractual rights of $794.3 million are finite-lived intangible assets. The finite-lived intangible assets are amortized using straight-line method over a period of primarily seven years. The acquisition-date fair value of the consideration transferred and the allocation of cost to the assets acquired and liabilities assumed at the acquisition date are as follows (Dollars in millions): Acquisition-date fair value of consideration transferred Cash $ 618.4 Shares of common stock (see Note 15) 194.5 Total consideration transferred $ 812.9 Allocation of cost to assets acquired and liabilities assumed Acquired contractual rights $ 794.3 Acquired CLO senior and subordinated notes 175.9 Assumed CLO borrowings outstanding (see Note 8) (157.3) Total cost of assets acquired, net of liabilities assumed $ 812.9

Fair Value Measurement

Fair Value Measurement	9 Months Ended
Fair Value Measurement	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	5. Fair Value Measurement The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of September 30, 2022: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds: Equity securities (1) $ — $ — $ 511.9 $ 511.9 Bonds — — 560.8 560.8 Loans — — 5,054.7 5,054.7 — — 6,127.4 6,127.4 Investments in CLOs and other: Investments in CLOs — — 499.6 499.6 Other investments (2) 1.3 41.7 64.6 107.6 1.3 41.7 564.2 607.2 Corporate treasury investments Commercial paper and other — 69.5 — 69.5 Subtotal $ 1.3 $ 111.2 $ 6,691.6 $ 6,804.1 Investments measured at net asset value (3) 294.6 Total $ 7,098.7 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,303.7 $ 5,303.7 Foreign currency forward contracts — 29.5 — 29.5 Total (5) $ — $ 29.5 $ 5,303.7 $ 5,333.2 (1) This balance includes $453.4 million related to investments that have been bridged by the Company to investment funds that are actively fundraising and are accounted for as consolidated VIEs as of September 30, 2022. (2) The Level III balance excludes a $54.9 million corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (3) Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $282.3 million relates to investments of Consolidated Funds. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $160.5 million of senior notes measured at cost and a $52.7 million revolving credit balance, both related to loans payable of Consolidated Funds. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of December 31, 2021: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds: Equity securities $ — $ — $ 17.9 $ 17.9 Bonds — — 599.5 599.5 Loans — — 5,898.1 5,898.1 — — 6,515.5 6,515.5 Investments in CLOs — — 361.1 361.1 Other investments (1) 1.5 45.6 78.7 125.8 Foreign currency forward contracts — 1.4 — 1.4 Subtotal $ 1.5 $ 47.0 $ 6,955.3 $ 7,003.8 Investments measured at net asset value (2) 161.7 Total $ 7,165.5 Liabilities Loans payable of Consolidated Funds (3) $ — $ — $ 5,811.0 $ 5,811.0 Foreign currency forward contracts — 0.7 — 0.7 Total (4) $ — $ 0.7 $ 5,811.0 $ 5,811.7 (1) The Level III balance excludes a corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . In December 2021, the Company remeasured this investment to a fair value of $54.9 million due to an observable price change. As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (2) Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $145.5 million relates to investments of Consolidated Funds. (3) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (4) Total liabilities balance excludes a $79.0 million revolving credit balance related to loans payable of Consolidated Funds. The changes in financial instruments measured at fair value for which the Company has used Level III inputs to determine fair value are as follows (Dollars in millions): Financial Assets Three Months Ended September 30, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 12.4 $ 669.8 $ 5,516.8 $ 508.6 $ 65.1 $ 6,772.7 Purchases 518.5 46.6 473.9 19.9 — 1,058.9 Sales and distributions — (92.6) (552.4) (7.2) (0.9) (653.1) Settlements — — (130.4) — — (130.4) Realized and unrealized gains (losses), net Included in earnings (18.3) (21.6) (30.0) 7.1 0.4 (62.4) Included in other comprehensive income (0.7) (41.4) (223.2) (28.8) — (294.1) Balance, end of period $ 511.9 $ 560.8 $ 5,054.7 $ 499.6 $ 64.6 $ 6,691.6 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (18.3) $ (22.1) $ (35.7) $ 4.5 $ 0.4 $ (71.2) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.7) $ (34.3) $ (202.2) $ (28.8) $ — $ (266.0) Financial Assets Nine Months Ended September 30, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 17.9 $ 599.5 $ 5,898.1 $ 361.1 $ 78.7 $ 6,955.3 Purchases 518.6 429.0 2,014.8 251.9 0.9 3,215.2 Sales and distributions (7.2) (320.2) (1,566.5) (36.1) (3.8) (1,933.8) Settlements — (0.3) (492.1) — — (492.4) Realized and unrealized gains (losses), net Included in earnings (15.9) (59.6) (277.4) (17.9) (11.2) (382.0) Included in other comprehensive income (1.5) (87.6) (522.2) (59.4) — (670.7) Balance, end of period $ 511.9 $ 560.8 $ 5,054.7 $ 499.6 $ 64.6 $ 6,691.6 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (16.7) $ (57.0) $ (266.3) $ (17.9) $ (11.2) $ (369.1) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (1.3) $ (55.2) $ (422.7) $ (59.4) $ — $ (538.6) Financial Assets Three Months Ended September 30, 2021 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 18.3 $ 542.0 $ 5,543.6 $ 353.1 $ 78.4 $ 6,535.4 Consolidation of funds (1) 3.3 — 490.4 (3.0) — 490.7 Purchases 0.1 108.1 1,058.4 9.6 — 1,176.2 Sales and distributions (1.2) (44.0) (781.0) (14.5) (0.4) (841.1) Settlements — (0.2) (378.4) — — (378.6) Realized and unrealized gains (losses), net Included in earnings (1.3) (11.3) 13.3 6.2 0.7 7.6 Included in other comprehensive income (0.3) (13.5) (93.4) (6.7) — (113.9) Balance, end of period $ 18.9 $ 581.1 $ 5,852.9 $ 344.7 $ 78.7 $ 6,876.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (1.9) $ 1.5 $ (4.2) $ 6.2 $ 1.1 $ 2.7 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.3) $ (13.7) $ (92.3) $ (6.7) $ — $ (113.0) Financial Assets Nine Months Ended September 30, 2021 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments (2) Total Balance, beginning of period $ 9.4 $ 550.4 $ 5,497.1 $ 489.4 $ 81.4 $ 6,627.7 Deconsolidation/consolidation of funds (1) 5.7 — 314.2 23.1 — 343.0 Purchases 0.6 472.0 3,375.3 71.7 — 3,919.6 Sales and distributions (3.5) (405.2) (2,199.0) (238.4) (16.5) (2,862.6) Settlements — (3.8) (1,020.2) — — (1,024.0) Realized and unrealized gains (losses), net Included in earnings 7.3 (1.3) 103.1 2.7 13.8 125.6 Included in other comprehensive income (0.6) (31.0) (217.6) (3.8) — (253.0) Balance, end of period $ 18.9 $ 581.1 $ 5,852.9 $ 344.7 $ 78.7 $ 6,876.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ 5.2 $ 7.7 $ 61.1 $ 2.3 $ 14.0 $ 90.3 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.4) $ (22.0) $ (185.3) $ (3.8) $ — $ (211.5) (1) As a result of the consolidation of one CLO during the three months ended September 30, 2021 and two CLOs during the nine months ended September 30, 2021, the investments that the Company held in those CLOs are now eliminated in consolidation and no longer included in investments in CLOs and other. As a result of the deconsolidation of one CLO during the nine months ended September 30, 2021, the investment that the Company held in that CLO is no longer eliminated in consolidation and is now included in investments in CLOs and other. (2) The beginning balance of Other Investments has been revised to reflect the exclusion of Fund Investments measured at fair value using the NAV per share practical expedient from the fair value hierarchy. Financial Liabilities Loans Payable of Consolidated Funds Three Months Ended September 30, 2022 2021 Balance, beginning of period $ 5,757.8 $ 5,373.9 Consolidation of funds — 480.0 Borrowings 26.4 1,133.0 Paydowns (1.8) (712.0) Sales (193.9) (237.5) Realized and unrealized (gains) losses, net Included in earnings (40.8) (2.4) Included in other comprehensive income (244.0) (96.7) Balance, end of period $ 5,303.7 $ 5,938.3 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ (41.3) $ 3.7 Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ (235.5) $ (127.0) Financial Liabilities Loans Payable of Consolidated Funds Nine Months Ended September 30, 2022 2021 Balance, beginning of period $ 5,811.0 $ 5,563.0 Deconsolidation/consolidation of funds — 360.8 Borrowings 1,597.7 1,966.6 Paydowns (419.1) (1,303.0) Sales (863.4) (515.2) Realized and unrealized (gains) losses, net Included in earnings (268.3) 90.7 Included in other comprehensive income (554.2) (224.6) Balance, end of period $ 5,303.7 $ 5,938.3 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ (262.6) $ 98.1 Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ (567.0) $ (281.4) Realized and unrealized gains and losses included in earnings for Level III investments for investments in CLOs and other investments are included in investment income (loss), and such gains and losses for investments of Consolidated Funds and loans payable of the Consolidated Funds are included in net investment gains (losses) of Consolidated Funds in the unaudited condensed consolidated statements of operations. Gains and losses included in other comprehensive income for all Level III financial asset and liabilities are included in accumulated other comprehensive loss and non-controlling interests in consolidated entities. The following table summarizes quantitative information about the Company’s Level III inputs as of September 30, 2022: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) September 30, 2022 Assets Investments of Consolidated Funds: Equity securities $ 10.4 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 17.00 (0.43) 445.2 Discounted Cash Flow Discount Rates 9% - 10% (9%) 56.3 Other (1) N/A N/A Bonds 560.8 Consensus Pricing Indicative Quotes (% of Par) 55 - 125 (89) Loans 4,853.1 Consensus Pricing Indicative Quotes (% of Par) 0 - 103 (93) 24.0 Discounted Cash Flow Discount Rates 9% - 12% (10%) 116.3 Discounted Cash Flow Discount Rates 7% - 10% (8%) 61.3 Consensus Pricing Indicative Quotes (% of Par) 98% -98% (98%) 6,127.4 Investments in CLOs: Senior secured notes 430.7 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 74 - 100 (95) Discount Margins (Basis Points) 155 - 1,700 (336) Default Rates 1% - 3% (2%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 68.9 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 21 - 66 (49) Discount Rates 13% - 25% (19%) Default Rates 1% - 3% (2%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 61.2 Market Yield Analysis Market Yield 7% - 7% (7%) Aviation subordinated notes 3.4 Discounted Cash Flow Discount Rates 22% - 22% (22%) Total $ 6,691.6 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,085.8 Other (2) N/A N/A Subordinated notes and preferred shares 217.9 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 19 - 103 (43) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Total $ 5,303.7 (1) Fair value approximates transaction price that was in close proximity to the reporting date. (2) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2021: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) December 31, 2021 Assets Investments of Consolidated Funds: Equity securities $ 17.9 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 84.22 (0.63) Bonds 599.5 Consensus Pricing Indicative Quotes (% of Par) 93 - 107 (99) Loans 5,766.0 Consensus Pricing Indicative Quotes (% of Par) 35 - 106 (98) 65.1 Discounted Cash Flow Discount Rates 4% - 8% (5%) 67.0 Market Yield Analysis Market Yields 3% - 8% (5%) 6,515.5 Investments in CLOs: Senior secured notes 289.7 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 86 - 101 (99) Discount Margins (Basis Points) 50 - 1,330 (245) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 71.5 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 46 - 97 (63) Discount Rate 14% - 22% (19%) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 72.5 Market Yield Analysis Market Yield 7% - 7% (7%) Aviation subordinated notes 6.1 Discounted Cash Flow Discount Rates 18% - 18% (18%) Total $ 6,955.3 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,561.1 Other (1) N/A N/A Subordinated notes and preferred shares 249.9 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 40 - 97 (61) Discount Rates 14% - 22% (19%) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Total $ 5,811.0 (1) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The significant unobservable inputs used in the fair value measurement of investments of the Company’s consolidated funds are indicative quotes. Significant decreases in indicative quotes in isolation would result in a significantly lower fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s investments in CLOs and other investments include indicative quotes, discount margins, discount rates, default rates, and recovery rates. Significant decreases in indicative quotes or recovery rates in isolation would result in a significantly lower fair value measurement. Significant increases in discount margins, discount rates or default rates in isolation would result in a significantly lower fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s loans payable of Consolidated Funds are indicative quotes, discount rates, default rates, and recovery rates. Significant increases in discount rates or default rates in isolation would result in a significantly lower fair value measurement. Significant decreases in indicative quotes or recovery rates in isolation would result in a significantly lower fair value measurement.

Investments

Investments	9 Months Ended
Investments	Sep. 30, 2022
Investments [Abstract]
Investments	6. Investments Investments consist of the following: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued performance allocations $ 7,428.7 $ 8,133.0 Principal equity method investments, excluding performance allocations 2,883.8 2,128.6 Principal investments in CLOs 499.6 361.1 Other investments 186.1 209.3 Total $ 10,998.2 $ 10,832.0 Accrued Performance Allocations The components of accrued performance allocations are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity $ 5,866.3 $ 6,412.8 Global Credit 220.1 300.3 Global Investment Solutions (1) 1,342.3 1,419.9 Total $ 7,428.7 $ 8,133.0 (1) The Company’s primary and secondary investments in external funds are generally valued based on its proportionate share of the net assets provided by the third party general partners of the underlying fund partnerships based on the most recent available information which typically has a lag of up to 90 days. As a result, amounts presented may not include the impact of economic activity in the current quarter. Approximately 24% of accrued performance allocations at September 30, 2022 are related to Carlyle Partners VI, L.P. and Carlyle Partners VII, L.P., two of the Company’s Global Private Equity funds. Approximately 25% of accrued performance allocations at December 31, 2021 are related to Carlyle Partners VI, L.P., one of the Company’s Global Private Equity funds. Accrued performance allocations are shown gross of the Company’s accrued performance allocations and incentive fee-related compensation (see Note 9), and accrued giveback obligations, which are separately presented in the unaudited condensed consolidated balance sheets. The components of the accrued giveback obligations are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity $ (18.4) $ (18.4) Global Credit (22.5) (11.8) Total $ (40.9) $ (30.2) Principal Equity Method Investments, Excluding Performance Allocations The Company’s principal equity method investments (excluding performance allocations) include its fund investments in Global Private Equity, Global Credit, and Global Investment Solutions typically as general partner interests, and its strategic investments in Fortitude and iStar through Carlyle-affiliated funds (included within Global Credit) and NGP (included within Global Private Equity), which are not consolidated. Principal investments are related to the following segments: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity (1) $ 1,832.8 $ 1,231.2 Global Credit (2) 960.3 819.7 Global Investment Solutions 90.7 77.7 Total $ 2,883.8 $ 2,128.6 (1) The balance includes $988.2 million and $436.9 million as of September 30, 2022 and December 31, 2021, respectively, related to the Company’s equity method investments in NGP. (2) As of September 30, 2022, the balance includes $645.3 million and $184.2 million, respectively, related to the Company’s strategic investments in Fortitude and iStar through Carlyle-affiliated investment funds. As of December 31, 2021, the balance includes $715.7 million related to the Company’s strategic investment in Fortitude. Strategic Investment in Fortitude On November 13, 2018, the Company acquired a 19.9% interest in Fortitude Group Holdings, LLC (“Fortitude Holdings”), a wholly owned subsidiary of American International Group, Inc. (“AIG”) (the “Minority Transaction”), pursuant to a Membership Interest Purchase Agreement by and among the Company, AIG and Fortitude Holdings, dated as of July 31, 2018 (the “2018 MIPA”). Fortitude Holdings owns 100% of the outstanding common shares of Fortitude Reinsurance Company Ltd., a Bermuda domiciled reinsurer (“Fortitude Re,” f/k/a “DSA Re”) established to reinsure a portfolio of AIG’s legacy life, annuity and property and casualty liabilities. The Company paid $381 million in cash at closing of the Minority Transaction (the “Initial Purchase Price”) and expects to pay up to $95 million in additional deferred consideration following December 31, 2023. In May 2020, the Initial Purchase Price was adjusted upward by $99.5 million in accordance with the 2018 MIPA as Fortitude Holdings chose not to distribute a planned non-pro rata dividend to AIG prior to May 13, 2020. The Company paid $79.6 million of such adjustment in May 2020 and will pay the remaining $19.9 million following December 31, 2023. On June 2, 2020, Carlyle FRL, L.P. (“Carlyle FRL”), a Carlyle-affiliated investment fund, acquired a 51.6% ownership interest in Fortitude Holdings from AIG (the “Control Transaction”) and T&D United Capital Co., Ltd. (“T&D”), a subsidiary of T&D Holdings, Inc., purchased a 25.0% ownership interest as a strategic third-party investor pursuant to a Membership Interest Purchase Agreement by and among the Company, AIG, Carlyle FRL, and T&D, dated as of November 25, 2019 (the “2019 MIPA”). At closing, the Company contributed its existing 19.9% interest in Fortitude Holdings to Carlyle FRL, such that Carlyle FRL held a 71.5% interest in Fortitude Holdings. Taken together, Carlyle FRL and T&D had 96.5% ownership of Fortitude Holdings. On October 1, 2021, Carlyle FRL, T&D and AIG effected a restructuring of the ownership of Fortitude Holdings that interposed FGH Parent, L.P. (“FGH Parent”), as the direct parent company of Fortitude Holdings (the “Restructuring”). Each of Carlyle FRL, T&D and AIG contributed the entirety of their interest in Fortitude Holdings to FGH Parent in exchange for an equivalent ownership interest in FGH Parent. References to “Fortitude” prior to the Restructuring refer to Fortitude Holdings. For periods subsequent to the Restructuring, references to “Fortitude” refer to FGH Parent. In March 2022, the Company raised $2.0 billion in third-party equity capital from certain investors in Carlyle FRL and T&D, and committed $100 million from the Company for additional equity capital in Fortitude. In May 2022, Fortitude called $1.1 billion of the capital raise, with the remaining capital expected to be called in 2023. In connection with the capital raise and subsequent funding, the Company’s indirect ownership of Fortitude decreased from 19.9% to 13.5%. As a result of the dilution, the Company recorded a reduction in the carrying value of its equity method investment and corresponding loss of $176.9 million. At the time the remaining capital is called by Fortitude, the Company’s indirect ownership is expected to further decrease to 10.5%, and the Company expects to record an additional reduction in the carrying value of its equity method investment and corresponding loss of approximately $121 million, based on the carrying value as of September 30, 2022, subject to change based on the timing of the dilution and changes in the carrying value of the investment. As of September 30, 2022, the carrying value of the Company’s investment in Carlyle FRL, which is an investment company that accounts for its investment in Fortitude at fair value, was $645.3 million, relative to its cost of $389.4 million. The Company has a strategic asset management relationship with Fortitude pursuant to which Fortitude committed to allocate assets in asset management strategies and vehicles of the Company and its affiliates. As of September 30, 2022, Fortitude Holdings and certain Fortitude reinsurance counterparties have committed approximately $9.1 billion of capital to-date to various Carlyle strategies. On April 1, 2022, the Company entered into a new strategic advisory services agreement with certain subsidiaries of Fortitude through a newly-formed investment advisor, Carlyle Insurance Solutions Management L.L.C. (“CISM”). Under the agreement, CISM provides Fortitude with certain services, including business development and growth, transaction origination and execution, and capital management services in exchange for a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability. Third party investors who participated in the March 2022 capital raise also made a minority investment in CISM, which is reflected as a non-controlling interest in consolidated entities in the condensed consolidated financial statements. Strategic Investment in NGP The Company has equity interests in NGP Management, the general partners of certain carry funds advised by NGP, and principal investments in certain NGP funds. The Company does not control NGP and accounts for its investments in NGP under the equity method of accounting, and includes these investments in the Global Private Equity segment. These interests entitle the Company to an allocation of income equal to 55.0% of the management fee-related revenues of NGP Management which serves as the investment advisor to certain NGP funds as well as 47.5% of the performance allocations received by certain current and future NGP fund general partners. The Company’s investments in NGP as of September 30, 2022 and December 31, 2021 are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Investment in NGP Management $ 370.1 $ 371.8 Investments in NGP general partners - accrued performance allocations 536.0 3.8 Principal investments in NGP funds 82.1 61.3 Total investments in NGP $ 988.2 $ 436.9 Investment in NGP Management . The Company’s equity interests in NGP Management entitle the Company to an allocation of income equal to 55.0% of the management fee-related revenues of NGP Management, which serves as the investment advisor to the NGP Energy Funds. Management fees are generally calculated as 1.0% to 2.0% of the limited partners’ commitments during the fund’s investment period, and 0.5% to 2.0% based on the lower of cost or fair market value of invested capital following the expiration or termination of the investment period. Management fee-related revenues from NGP Management are primarily driven by NGP XII, NGP XI and NGP X during the three and nine months ended September 30, 2022 and 2021. The Company records investment income (loss) for its equity income allocation from NGP management fee-related revenues and also records its share of any allocated expenses from NGP Management, expenses associated with the compensatory elements of the strategic investment, and the amortization of the basis differences related to the definite-lived identifiable intangible assets of NGP Management. The net investment income (loss) recognized in the Company’s unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Management fee-related revenues from NGP Management $ 18.1 $ 18.2 $ 52.7 $ 54.9 Expenses related to the investment in NGP Management (3.5) (2.9) (8.9) (8.1) Amortization of basis differences from the investment in NGP Management (0.4) (0.7) (1.1) (2.1) Net investment income from NGP Management $ 14.2 $ 14.6 $ 42.7 $ 44.7 The difference between the Company’s remaining carrying value of its investment and its share of the underlying net assets of the investee was $0.4 million and $1.4 million as of September 30, 2022 and December 31, 2021, respectively; these differences are amortized over a period of 10 years from the initial investment date. The Company assesses the remaining carrying value of its equity method investment for impairment whenever events or circumstances indicate that the carrying value may not be recoverable, and considers factors including, but not limited to, expected cash flows from its interest in future management fees and NGP’s ability to raise new funds. Investment in the General Partners of NGP Carry Funds . The Company’s investment in the general partners of the NGP Carry Funds entitle it to 47.5% of the performance allocations received by certain current and future NGP fund general partners. The Company records its equity income allocation from NGP performance allocations in principal investment income (loss) from equity method investments rather than performance allocations in its unaudited condensed consolidated statements of operations. The Company recognized $81.6 million and $532.2 million of net investment earnings related to these performance allocations for the three and nine months ended September 30, 2022, respectively, primarily driven by NGP XI and NGP XII which experienced appreciation of 63% and 58%, respectively, during the nine months ended September 30, 2022. The Company recognized $1.7 million and $2.8 million of net investment earnings related to these performance allocations for the three and nine months ended September 30, 2021, respectively. Principal Investments in NGP Funds . The Company also holds principal investments in the NGP Carry Funds. The Company recognized net investment earnings (losses) of $9.6 million and $5.1 million for the three months ended September 30, 2022 and 2021, respectively, and $43.0 million and $16.8 million for the nine months ended September 30, 2022 and 2021, respectively, related to these investments and which are included in principal investment income in its unaudited condensed consolidated statements of operations. Principal Investments in CLOs and Other Investments Principal investments in CLOs as of September 30, 2022 and December 31, 2021 were $499.6 million and $361.1 million, respectively, and consisted of investments in CLO senior and subordinated notes. In connection with the acquisition of the CBAM CLO management contracts in March 2022, the Company acquired investments in CLO senior and subordinated notes of $175.9 million (see Note 4). A portion of the Company’s principal investments in CLOs is collateral to CLO term loans (see Note 8). As of September 30, 2022 and December 31, 2021, other investments includes the Company’s investment in the BDC Preferred Shares at fair value of $61.2 million and $72.5 million, respectively (see Note 11). Investment Income (Loss) The components of investment income (loss) are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Performance allocations Realized $ 770.5 $ 1,018.1 $ 1,579.0 $ 1,645.6 Unrealized (472.4) (43.6) (232.8) 3,195.7 298.1 974.5 1,346.2 4,841.3 Principal investment income (loss) from equity method investments (excluding performance allocations) Realized 70.6 87.7 34.3 175.5 Unrealized 80.3 30.5 536.5 239.4 150.9 118.2 570.8 414.9 Principal investment income (loss) from investments in CLOs and other investments Realized 6.2 4.4 9.4 3.9 Unrealized (32.9) 37.8 (79.7) 58.4 (26.7) 42.2 (70.3) 62.3 Total $ 422.3 $ 1,134.9 $ 1,846.7 $ 5,318.5 The performance allocations included in revenues are derived from the following segments: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Global Private Equity $ 237.2 $ 777.8 $ 1,106.4 $ 4,142.5 Global Credit 27.2 27.4 (3.6) 124.6 Global Investment Solutions 33.7 169.3 243.4 574.2 Total $ 298.1 $ 974.5 $ 1,346.2 $ 4,841.3 Approximately 27%, or $81.0 million, of performance allocations for the three months ended September 30, 2022 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Europe Partners V, L.P. (Global Private Equity segment) - $79.6 million, • Carlyle Power Partners II, L.P. (Global Private Equity segment) - $63.1 million, • Carlyle Europe Partners IV, L.P. (Global Private Equity segment) - $46.1 million, • Carlyle Partners V, L.P. (Global Private Equity segment) - $45.5 million, • Carlyle Partners VII, L.P. (Global Private Equity segment) - $(16.7) million, and • Carlyle Asia Partners V, L.P. (Global Private Equity segment) - $(29.3) million. Approximately 26%, or $347.1 million, of performance allocations for the nine months ended September 30, 2022 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Realty Partners VIII, L.P. (Global Private Equity segment) - $259.1 million, • Carlyle Europe Partners V, L.P. (Global Private Equity segment) - $220.2 million, • Carlyle Power Partners II, L.P. (Global Private Equity segment) - $198.1 million, • Carlyle Europe Technology Partners IV, L.P. (Global Private Equity segment) - $186.5 million, and • Carlyle Partners VI, L.P. (Global Private Equity segment) - $(340.4) million. Approximately 22%, or $216.0 million, of performance allocations for the three months ended September 30, 2021 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Partners VI, L.P. (Global Private Equity segment) - $130.7 million, and • Carlyle Realty Partners VIII, L.P. (Global Private Equity segment) - $119.1 million. Approximately 35%, or $1,715.9 million, of performance allocations for the nine months ended September 30, 2021 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Partners VI, L.P. (Global Private Equity segment) - $1,281.0 million, and • Carlyle Europe Partners IV, L.P. (Global Private Equity segment) - $579.3 million. Carlyle’s income (loss) from its principal equity method investments consists of: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Global Private Equity $ 124.7 $ 63.8 $ 698.8 $ 272.9 Global Credit 26.8 47.5 (134.6) 120.6 Global Investment Solutions (0.6) 6.9 6.6 21.4 Total $ 150.9 $ 118.2 $ 570.8 $ 414.9 Principal investment loss for Global Credit during the nine months ended September 30, 2022 includes an investment loss of $176.9 million on the Company’s equity method investment in Carlyle FRL related to the dilution of the Company’s indirect ownership in Fortitude from 19.9% to 13.5%. Investments of Consolidated Funds The Company consolidates the financial positions and results of operations of certain CLOs in which it is the primary beneficiary. During the nine months ended September 30, 2022, the Company did not form any new CLOs for which the Company is the primary beneficiary. Investments in Consolidated Funds as of September 30, 2022 also include $453.4 million related to investments that have been bridged by the Company to investment funds that are actively fundraising and are accounted for as consolidated VIEs. There were no individual investments with a fair value greater than five percent of the Company’s total assets for any period presented. Interest and Other Income of Consolidated Funds The components of interest and other income of Consolidated Funds are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Interest income from investments $ 72.5 $ 56.9 $ 188.2 $ 170.4 Other income 7.2 5.2 16.4 14.9 Total $ 79.7 $ 62.1 $ 204.6 $ 185.3 Net Investment Gains (Losses) of Consolidated Funds Net investment gains (losses) of Consolidated Funds include net realized gains (losses) from sales of investments and unrealized gains (losses) resulting from changes in fair value of the Consolidated Funds’ investments. The components of net investment gains (losses) of Consolidated Funds are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Gains (losses) from investments of Consolidated Funds $ (71.2) $ (2.5) $ (319.3) $ 100.3 Gains (losses) from liabilities of CLOs 40.9 2.4 268.3 (90.7) Total $ (30.3) $ (0.1) $ (51.0) $ 9.6 The following table presents realized and unrealized gains (losses) earned from investments of the Consolidated Funds: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Realized gains (losses) $ (9.3) $ (10.7) $ (13.1) $ 6.5 Net change in unrealized gains (losses) (61.9) 8.2 (306.2) 93.8 Total $ (71.2) $ (2.5) $ (319.3) $ 100.3

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
Intangible Assets and Goodwill	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	7. Intangible Assets and Goodwill The following table summarizes the carrying amount of intangible assets as of September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Acquired contractual rights $ 914.6 $ 48.0 Accumulated amortization (92.5) (26.4) Finite-lived intangible assets, net 822.1 21.6 Goodwill 103.0 13.3 Intangible Assets, net $ 925.1 $ 34.9 As discussed in Note 3, the Company reviews its intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. No impairment losses were recorded during the three months ended September 30, 2022. During the nine months ended September 30, 2022, the Company recorded an impairment charge of $4.0 million on certain acquired contractual rights related to Carlyle Aviation Partners as a result of impaired income streams from aircraft under lease in Russia. No impairment losses were recorded during the three and nine months ended September 30, 2021. Intangible asset amortization expense was $32.0 million and $1.8 million for the three months ended September 30, 2022 and 2021, respectively, and $70.7 million and $8.4 million for the nine months ended September 30, 2022 and 2021, respectively, and is included in general, administrative, and other expenses in the unaudited condensed consolidated statements of operations. Certain intangible assets are held by entities of which the functional currency is not the U.S. dollar. Any corresponding currency translation is recorded in other comprehensive income. The following table summarizes the expected amortization expense for 2022 through 2026 and thereafter (Dollars in millions): 2022 (excluding the nine months ended September 30, 2022) $ 33.1 2023 130.4 2024 130.5 2025 130.4 2026 130.3 Thereafter 267.4 $ 822.1

Borrowings

Borrowings	9 Months Ended
Borrowings	Sep. 30, 2022
Debt Disclosure [Abstract]
Borrowings	8. Borrowings The Company borrows and enters into credit agreements for its general operating and investment purposes. The Company’s debt obligations consist of the following: September 30, 2022 December 31, 2021 Borrowing Carrying Borrowing Carrying (Dollars in millions) CLO Borrowings (See below) $ 384.4 $ 381.6 $ 222.6 $ 219.0 5.625% Senior Notes Due 3/30/2043 600.0 600.6 600.0 600.6 5.650% Senior Notes Due 9/15/2048 350.0 346.3 350.0 346.1 3.500% Senior Notes Due 9/19/2029 425.0 421.9 425.0 421.6 4.625% Subordinated Notes Due 5/15/2061 500.0 484.6 500.0 484.3 Total debt obligations $ 2,259.4 $ 2,235.0 $ 2,097.6 $ 2,071.6 Senior Credit Facility As of September 30, 2022, the senior credit facility, which was amended on April 29, 2022, included $1.0 billion in a revolving credit facility. The revolving credit facility is scheduled to mature on April 29, 2027, and principal amounts outstanding under the revolving credit facility accrue interest, at the option of the borrowers, either (a) at an alternate base rate plus an applicable margin not to exceed 0.50%, or (b) at SOFR (or similar benchmark for non-U.S. dollar borrowings) plus a 0.10% adjustment and an applicable margin not to exceed 1.50% (at September 30, 2022, the interest rate was 4.14%). Prior to the April 2022 amendment, the size of the revolving credit facility was $775.0 million, which was scheduled to mature February 11, 2024, and accrued interest either (a) at an alternate base rate plus an applicable margin not to exceed 0.50%, or (b) at LIBOR plus an applicable margin not to exceed 1.50%. The Company made no borrowings under the senior credit facility during the three and nine months ended September 30, 2022 and there were no amounts outstanding at September 30, 2022. Global Credit Revolving Credit Facility On December 17, 2018, certain subsidiaries of the Company established a revolving line of credit, primarily intended to support certain lending activities within the Global Credit segment. The credit facility, which was amended in December 2019, December 2020 and September 2021, is scheduled to mature in September 2024, and has capacity of $250.0 million. Principal amounts outstanding under the facility accrue interest, at the option of the borrowers, either (a) at an alternate base rate plus an applicable margin not to exceed 1.00%, or (b) at the Eurocurrency rate plus an applicable margin, not to exceed 2.00%. The Company made no borrowings under the credit facility during the three and nine months ended September 30, 2022, and there was no balance outstanding as of September 30, 2022. CLO Borrowings For certain of the Company’s CLOs, the Company finances a portion of its investment in the CLOs through the proceeds received from term loans and other financing arrangements with financial institutions. The Company’s outstanding CLO borrowings consist of the following (Dollars in millions): Formation Date Borrowing Outstanding September 30, 2022 Borrowing Outstanding December 31, 2021 Maturity Date (1) Interest Rate as of September 30, 2022 February 28, 2017 $ 35.4 $ 51.3 November 17, 2031 2.33% (2) June 29, 2017 54.8 — July 20, 2030 4.36% (4),(7) December 6, 2017 43.8 — January 15, 2031 3.88% (5),(7) March 15, 2019 1.6 1.9 March 15, 2032 8.11% (3) August 20, 2019 3.5 4.1 August 15, 2032 5.06% (3) September 15, 2020 17.4 20.3 April 15, 2033 1.59% (3) January 8, 2021 18.2 21.3 January 15, 2034 2.49% (3) March 9, 2021 17.4 20.3 August 15, 2030 1.69% (3) March 30, 2021 16.4 19.1 March 15, 2032 1.71% (3) April 21, 2021 3.2 3.7 April 15, 2033 5.85% (3) April 28, 2021 6.5 — April 28, 2023 2.03% (6),(7) May 21, 2021 13.7 15.9 November 17, 2031 1.36% (3) June 4, 2021 18.3 21.3 January 16, 2034 2.28% (3) June 10, 2021 1.2 1.4 November 17, 2031 2.85% (3) July 15, 2021 13.7 — July 15, 2034 2.30% (3),(7) July 20, 2021 18.2 — July 20, 2031 2.28% (3),(7) August 4, 2021 14.8 17.2 August 15, 2032 2.30% (3) October 27, 2021 21.3 24.8 October 15, 2035 2.40% (3) November 5, 2021 12.7 — January 14, 2034 2.09% (3),(7) January 6, 2022 18.4 — February 15, 2035 2.70% (3) February 22, 2022 18.4 — November 10, 2035 2.75% (3) July 13, 2022 15.5 — February 15, 2035 3.61% $ 384.4 $ 222.6 (1) Maturity date is earlier of date indicated or the date that the CLO is dissolved. (2) Outstanding borrowing of €36.1 million; incurs interest at EURIBOR plus applicable margins as defined in the agreement. (3) Incurs interest at the average effective interest rate of each class of purchased securities plus 0.50% spread percentage. (4) Incurs interest at LIBOR plus 1.65%. (5) Incurs interest at LIBOR plus 1.37%. (6) Incurs interest at EURIBOR plus 1.35%. (7) The respective CLO assets were purchased in connection with the asset acquisition from CBAM in March 2022 (see Note 4). The formation date listed is the original formation date of the related CLO. The CLO term loans are secured by the Company’s investments in the respective CLO, have a general unsecured interest in the Carlyle entity that manages the CLO, and generally do not have recourse to any other Carlyle entity. Interest expense for the three months ended September 30, 2022 and 2021 was $2.8 million and $1.2 million, respectively. Interest expense for the nine months ended September 30, 2022 and 2021 was $6.8 million and $4.4 million, respectively. The fair value of the outstanding balance of the CLO term loans at September 30, 2022 approximated par value based on current market rates for similar debt instruments. These CLO term loans are classified as Level III within the fair value hierarchy. European CLO Financing - February 28, 2017 On February 28, 2017, a subsidiary of the Company entered into a financing agreement with several financial institutions under which these financial institutions have provided a €36.1 million term loan ($35.4 million at September 30, 2022) to the Company. This term loan is secured by the Company’s investments in the retained notes in certain European CLOs that were formed in 2014 and 2015. This term loan will mature on the earlier of November 17, 2031 or the date that the certain European CLO retained notes have been redeemed. The Company may prepay the term loan in whole or in part at any time. Interest on this term loan accrues at EURIBOR plus applicable margins (2.33% at September 30, 2022). Master Credit Agreements - Term Loans In January 2017, the Company entered into a master credit agreement with a financial institution under which the financial institution provided term loans to the Company for the purchase of eligible interests in CLOs. Term loans issued under this master credit agreement were secured by the Company’s investment in the respective CLO as well as any senior management fee and subordinated management fee payable by each CLO. Term loans bore interest at LIBOR plus a weighted average spread over LIBOR on the CLO notes and an applicable margin, which was due quarterly. CLO indentures for the respective CLO borrowings entered on November 30, 2017 and after provided for an alternative rate framework determined at the Company’s discretion upon a trigger event of LIBOR. This agreement terminated in January 2020. All outstanding CLO term loans under this agreement were fully repaid in 2021. The Company assumed liabilities under master credit agreements previously entered into by CBAM under which a financial institution provided term loans to CBAM for the purchase of eligible interests in CLOs (see Note 4). Term loans issued under these master credit agreements are secured by the Company’s investment in the respective CLO as well as any senior management fee and subordinated management fee payable by each CLO. Term loans bear interest at LIBOR plus a weighted average spread over LIBOR on the CLO notes, which is due quarterly. As of September 30, 2022, term loans under these agreements had $98.6 million outstanding. The master credit agreements mature in July 2030 and January 2031, respectively. CLO Repurchase Agreements On February 5, 2019, the Company entered into a master credit facility agreement (the “Carlyle CLO Financing Facility”) to finance a portion of the risk retention investments in certain European CLOs managed by the Company. The maximum facility amount is €100.0 million, but may be expanded on such terms agreed upon by the Company and the counterparty subject to the terms and conditions of the Carlyle CLO Financing Facility. Each transaction entered into under the Carlyle CLO Financing Facility will bear interest at a rate based on the weighted average effective interest rate of each class of securities that have been sold plus a spread to be agreed upon by the parties. As of September 30, 2022, €203.6 million ($199.3 million) was outstanding under the Carlyle CLO Financing Facility. The Company assumed liabilities under a master credit facility agreement previously entered into by CBAM (the “CBAM CLO Financing Facility,” together with the Carlyle CLO Financing Facility, the “CLO Financing Facilities”) to finance a portion of the risk retention investments in certain European CLOs managed by CBAM (see Note 4). The maximum facility amount is €100.0 million, but may be expanded on such terms agreed upon by the Company and the counterparty subject to the terms and conditions of the CBAM CLO Financing Facility. Each transaction entered into under the CBAM CLO Financing Facility will bear interest at a rate based on the weighted average effective interest rate of each class of securities that have been sold plus a spread to be agreed upon by the parties. As of September 30, 2022, €45.6 million ($44.6 million) was outstanding under the CBAM CLO Financing Facility. Each transaction entered into under the CLO Financing Facilities provides for payment netting and, in the case of a default or similar event with respect to the counterparty to the CLO Financing Facilities, provides for netting across transactions. Generally, upon a counterparty default, the Company can terminate all transactions under the CLO Financing Facilities and offset amounts it owes in respect of any one transaction against collateral, if any, or other amounts it has received in respect of any other transactions under the CLO Financing Facilities; provided, however, that in the case of certain defaults, the Company may only be able to terminate and offset solely with respect to the transaction affected by the default. During the term of a transaction entered into under the CLO Financing Facilities, the Company will deliver cash or additional securities acceptable to the counterparty if the securities sold are in default. Upon termination of a transaction, the Company will repurchase the previously sold securities from the counterparty at a previously determined repurchase price. The CLO Financing Facilities may be terminated at any time upon certain defaults or circumstances agreed upon by the parties. The repurchase agreements may result in credit exposure in the event the counterparty to the transaction is unable to fulfill its contractual obligations. The Company minimizes the credit risk associated with these activities by monitoring counterparty credit exposure and collateral values. Other than margin requirements, the Company is not subject to additional terms or contingencies which would expose the Company to additional obligations based upon the performance of the securities pledged as collateral. Senior Notes Certain indirect subsidiaries of the Company have issued long term borrowings in the form of senior notes, on which interest is payable semi-annually in arrears. The following table provides information regarding these senior notes (Dollars in millions): Interest Expense Fair Value (1) Three Months Ended Nine Months Ended Aggregate Principal Amount September 30, 2022 December 31, 2021 2022 2021 2022 2021 3.875% Senior Notes Due 2/1/2023 (2) $ — $ — $ — $ — $ 2.5 $ — $ 7.5 5.625% Senior Notes Due 3/30/2043 (3) 600.0 515.5 795.5 8.4 8.4 25.3 25.3 5.650% Senior Notes Due 9/15/2048 (4) 350.0 312.6 484.7 5.0 5.0 14.9 14.9 3.500% Senior Notes Due 9/19/2029 (5) 425.0 361.6 457.4 3.8 3.8 11.5 11.5 $ 17.2 $ 19.7 $ 51.7 $ 59.2 (1) Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within the fair value hierarchy. (2) Issued in January 2013 at 99.966% of par. In November 2021, the Company completed the redemption of these notes, as discussed below. (3) Issued $400.0 million in aggregate principal at 99.583% of par in March 2013. An additional $200.0 million in aggregate principal was issued at 104.315% of par in March 2014, and is treated as a single class with the outstanding $400.0 million in senior notes previously issued. (4) Issued in September 2018 at 99.914% of par. (5) Issued in September 2019 at 99.841% of par. The issuers may redeem the senior notes, in whole at any time or in part from time to time, at a price equal to the greater of (i) 100% of the principal amount of the notes being redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest on any notes being redeemed discounted to the redemption date on a semiannual basis at the Treasury Rate plus 40 basis points (30 basis points in the case of the 3.875% and 3.500% senior notes), plus in each case accrued and unpaid interest on the principal amounts being redeemed. In November 2021, the Company redeemed the remaining aggregate principal amount of $250.0 million in 3.875% Senior Notes at the make-whole redemption price as set forth in the notes, and recognized $10.1 million of costs in interest expense upon early extinguishment of debt. Subordinated Notes In May 2021, an indirect subsidiary of the Company issued $435.0 million aggregate principal amount of 4.625% Subordinated Notes due May 15, 2061 (the “Subordinated Notes”), on which interest is payable quarterly accruing from May 11, 2021. In June 2021, an additional $65.0 million aggregate principal amount of these Subordinated Notes were issued and are treated as a single series with the already outstanding $435.0 million aggregate principal amount. The Subordinated Notes are unsecured and subordinated obligations of the issuer, and are fully and unconditionally guaranteed (the “Guarantees”), jointly and severally, on a subordinated basis, by the Company, each of the Carlyle Holdings partnerships, and CG Subsidiary Holdings L.L.C., an indirect subsidiary of the Company (collectively, the “Guarantors”). The Consolidated Funds are not guarantors, and as such, the assets of the Consolidated Funds are not available to service the Subordinated Notes under the Guarantee. The Subordinated Notes may be redeemed at the issuer’s option in whole at any time or in part from time to time on or after June 15, 2026 at a redemption price equal to their principal amount plus any accrued and unpaid interest to, but excluding, the date of redemption. If interest due on the Subordinated Notes is deemed no longer to be deductible in the U.S., a “Tax Redemption Event,” the Subordinated Notes may be redeemed, in whole, but not in part, within 120 days of the occurrence of such event at a redemption price equal to their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption. In addition, the Subordinated Notes may be redeemed, in whole, but not in part, at any time prior to May 15, 2026, within 90 days of the rating agencies determining that the Subordinated Notes should no longer receive partial equity treatment pursuant to the rating agency’s criteria, a “rating agency event,” at a redemption price equal to 102% of their principal amount plus any accrued and unpaid interest to, but excluding, the date of redemption. As of September 30, 2022 and December 31, 2021, the fair value of the Subordinated Notes was $344.0 million and $506.0 million, respectively. Fair value is based on active market quotes and the notes are classified as Level I within the fair value hierarchy. For the three and nine months ended September 30, 2022, the Company incurred $5.9 million and $17.6 million, respectively, of interest expense on the Subordinated Notes. For the three months ended September 30, 2021 and for the period from May 11, 2021 through September 30, 2021, the Company incurred $5.6 million and $8.9 million of interest expense on the Subordinated Notes. Debt Covenants The Company is subject to various financial covenants under its loan agreements including, among other items, maintenance of a minimum amount of management fee-earning assets. The Company is also subject to various non-financial covenants under its loan agreements and the indentures governing its senior and subordinated notes. The Company was in compliance with all financial and non-financial covenants under its various loan agreements as of September 30, 2022. Loans Payable of Consolidated Funds Loans payable of Consolidated Funds primarily represent amounts due to holders of debt securities issued by the CLOs. Several of the CLOs issued preferred shares representing the most subordinated interest, however these tranches are mandatorily redeemable upon the maturity dates of the senior secured loans payable, and as a result have been classified as liabilities and are included in loans payable of Consolidated Funds in the unaudited condensed consolidated balance sheets. As of September 30, 2022 and December 31, 2021, the following borrowings were outstanding, which includes preferred shares classified as liabilities (Dollars in millions): As of September 30, 2022 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,466.6 $ 5,085.8 2.62 % 9.77 Subordinated notes, preferred shares and other 146.9 217.9 N/A (2) 9.97 Total $ 5,613.5 $ 5,303.7 As of December 31, 2021 Borrowing Fair Value Weighted Weighted Senior secured notes $ 5,585.4 $ 5,561.1 1.68 % 10.25 Subordinated notes, preferred shares and other 317.6 249.9 N/A (2) 10.41 Total $ 5,903.0 $ 5,811.0 (1) Borrowing Outstanding as of September 30, 2022 includes $160.5 million of senior secured notes that are carried at par value. The fair value of these senior secured notes at September 30, 2022 approximated par value based on current market rates for similar debt instruments. These senior secured notes are classified as Level III within the fair value hierarchy. (2) The subordinated notes and preferred shares do not have contractual interest rates, but instead receive distributions from the excess cash flows of the CLOs. Loans payable of the CLOs are collateralized by the assets held by the CLOs and the assets of one CLO may not be used to satisfy the liabilities of another. This collateral consisted of cash and cash equivalents, corporate loans, corporate bonds and other securities. As of September 30, 2022 and December 31, 2021, the fair value of the CLO assets was $5.6 billion and $6.7 billion, respectively.

Accrued Compensation and Benefi

Accrued Compensation and Benefits	9 Months Ended
Accrued Compensation and Benefits	Sep. 30, 2022
Retirement Benefits [Abstract]
Accrued Compensation and Benefits	9. Accrued Compensation and Benefits Accrued compensation and benefits consist of the following: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued performance allocations and incentive fee related compensation $ 3,784.5 $ 4,087.8 Accrued bonuses 365.2 521.4 Employment-based contingent cash consideration (1) 45.2 6.3 Accrued pension liability (2) 34.1 27.4 Other (3) 118.7 312.1 Total $ 4,347.7 $ 4,955.0 (1) The acquisition of the Carlyle Aviation Partners, Ltd. (“Carlyle Aviation Partners,” formerly known as Apollo Aviation Group) in December 2018 included an earn-out of up to $150.0 million that is payable upon the achievement of certain revenue and earnings performance targets during 2020 through 2025, which is accounted for as compensation expense. See Note 3 to the consolidated financial statements included in the Company’s 2018 Annual Report on Form 10-K for additional information on the Carlyle Aviation Partners acquisition. The Abingworth acquisition included an earn-out of up to $130.0 million. See Note 4 for additional information. (2) Certain employees of AlpInvest are covered by defined benefit pension plans sponsored by AlpInvest. No other employees of the Company are covered by defined benefit pension plans. (3) Includes $27.6 million and $207.0 million of realized performance allocations and incentive fee-related compensation not yet paid to participants as of September 30, 2022 and December 31, 2021, respectively. The following table presents realized and unrealized performance allocations and incentive fee related compensation: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Realized $ 377.0 $ 478.5 $ 776.7 $ 789.8 Unrealized (213.5) 16.7 (35.5) 1,566.0 Total $ 163.5 $ 495.2 $ 741.2 $ 2,355.8

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Capital Commitments The Company and its unconsolidated affiliates have unfunded commitments to entities within the following segments as of September 30, 2022 (Dollars in millions): Unfunded Global Private Equity $ 3,351.2 Global Credit 376.2 Global Investment Solutions 261.0 Total $ 3,988.4 Of the $4.0 billion of unfunded commitments, approximately $3.3 billion is subscribed individually by senior Carlyle professionals, advisors and other professionals, with the balance funded directly by the Company. In addition to these unfunded commitments, the Company may from time to time exercise its right to purchase additional interests in its investment funds that become available in the ordinary course of their operations. In November 2022, the Company entered into agreements to purchase certain third-party interests in a Global Investment Solutions fund for $61.0 million. The Company will incur a loss of $12.7 million upon the closing of the transaction in the fourth quarter of 2022, which represents a premium to the fair market value of the interests acquired. Under the Carlyle Global Capital Markets platform, certain subsidiaries of the Company may act as an underwriter, syndicator or placement agent for security offerings and loan originations. The Company earns fees in connection with these activities and bears the risk of the sale of such securities and placement of such loans, which may be longer dated. As of September 30, 2022, the Company had $99.6 million in unfunded commitments related to the origination and syndication of loans and securities under the Carlyle Global Capital Markets platform, of which $80.0 million was settled in October 2022. Guaranteed Loans From time to time, the Company or its subsidiaries may enter into agreements to guarantee certain obligations of the investment funds related to, for example, credit facilities or equity commitments. Certain consolidated subsidiaries of the Company are the guarantors of revolving credit facilities for certain funds in the Global Investment Solutions segment. The guarantee is limited to the lesser of the total amount drawn under the credit facilities or the net asset value of the guarantor subsidiaries, which was approximately $0.4 million as of September 30, 2022. The outstanding balances are secured by uncalled capital commitments from the underlying funds and the Company believes the likelihood of any material funding under this guarantee to be remote. Contingent Obligations (Giveback) A liability for potential repayment of previously received performance allocations of $40.9 million at September 30, 2022 is shown as accrued giveback obligations in the unaudited condensed consolidated balance sheets, representing the giveback obligation that would need to be paid if the funds were liquidated at their current fair values at September 30, 2022. However, the ultimate giveback obligation, if any, generally is not paid until the end of a fund’s life or earlier if the giveback becomes fixed and early payment is agreed upon by the fund’s partners (see Note 3). The Company had $10.4 million of unbilled receivables from former and current employees and senior Carlyle professionals as of September 30, 2022 related to giveback obligations. Any such receivables are collateralized by investments made by individual senior Carlyle professionals and employees in Carlyle-sponsored funds. In addition, $132.4 million have been withheld from distributions of carried interest to senior Carlyle professionals and employees for potential giveback obligations as of September 30, 2022. Such amounts are held on behalf of the respective current and former Carlyle employees to satisfy any givebacks they may owe and are held by entities not included in the accompanying condensed consolidated balance sheets. Current and former senior Carlyle professionals and employees are personally responsible for their giveback obligations. As of September 30, 2022, approximately $18.9 million of the Company’s accrued giveback obligation is the responsibility of various current and former senior Carlyle professionals and other former limited partners of the Carlyle Holdings partnerships, and the net accrued giveback obligation attributable to the Company is $22.0 million. If, at September 30, 2022, all of the investments held by the Company’s Funds were deemed worthless, a possibility that management views as remote, the amount of realized and distributed carried interest subject to potential giveback would be $1.4 billion, on an after-tax basis where applicable, of which approximately $0.6 billion would be the responsibility of current and former senior Carlyle professionals. Leases The Company’s leases primarily consist of operating leases for office space in various countries around the world, including its largest offices in Washington, D.C., New York City, London and Hong Kong. These leases have remaining lease terms of one year to 14 years, some of which include options to extend for up to five years and some of which include an option to terminate the leases within one year. The Company also has operating leases for office equipment and vehicles, which are not significant. The Company assesses its lease right-of-use assets for impairment consistent with its impairment assessment of other long-lived assets. In connection with the April 1, 2021 sale of Metropolitan Real Estate, the Company entered into a sublease agreement for a portion of its existing office space in New York. As a result of the sublease transaction, the Company recorded a lease impairment charge of $26.8 million, which was the excess of the carrying value of the associated lease right-of-use asset over its estimated fair value. The Company estimated the fair value using discounted cash flows from the estimated net sublease rental income. The impairment charge is included in general, administrative, and other expenses in the condensed consolidated statements of operations during the nine months ended September 30, 2021. The following table summarizes the Company’s lease cost, cash flows and other supplemental information related to its operating leases (Dollars in millions): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Operating lease cost $ 14.0 $ 14.1 $ 42.0 $ 41.6 Sublease income (1.8) (1.0) (4.7) (2.2) Total operating lease cost $ 12.2 $ 13.1 $ 37.3 $ 39.4 Cash paid for amounts included in the measurement of operating lease liabilities $ 15.8 $ 12.4 $ 47.8 $ 35.1 Weighted-average remaining lease term 11.7 years 12.1 years Weighted-average discount rate 4.4 % 4.1 % Maturities of lease liabilities related to operating leases were as follows (Dollars in millions): Year ending December 31, 2022 (excluding the nine months ended September 30, 2022) $ 16.0 2023 65.8 2024 62.9 2025 58.9 2026 56.8 Thereafter 393.5 Total lease payments $ 653.9 Less payments for leases that have not yet commenced (31.1) Less imputed interest (122.9) Total lease liabilities $ 499.9 Legal Matters In the ordinary course of business, the Company is a party to litigation, investigations, inquiries, employment-related matters, disputes and other potential claims. Certain of these matters are described below. The Company is not currently able to estimate the reasonably possible amount of loss or range of loss, in excess of any amounts accrued, for the matters that have not been resolved. The Company does not believe it is probable that the outcome of any existing litigation, investigations, disputes or other potential claims will materially affect the Company or these financial statements in excess of amounts accrued. The Company believes that the claims alleged against it in the matters described below are without merit. The Foy Matter Along with many other companies and individuals in the financial sector, the Company and Carlyle Mezzanine Partners, L.P. (“CMP”) were named as defendants in Foy v. Austin Capital , a case filed in June 2009 in state court in New Mexico, which purported to be a qui tam suit on behalf of the State of New Mexico under the state Fraud Against Taxpayers Act. The trial court dismissed the lawsuit in September 2017, and all appeals have now been dismissed. The matter has been closed. The Authentix Matter Authentix, Inc. (“Authentix”) was a majority-owned portfolio company in one of the Company’s investment funds, Carlyle U.S. Growth Fund III, L.P. (“CGF III”). When Authentix was owned by CGF III, two of the Company’s employees served on Authentix’s board of directors. After a lengthy sale process, Authentix was sold for an aggregate sale price of $87.5 million. In August 2020, certain of the former minority shareholders in Authentix filed suit in Delaware Chancery Court, alleging that the Authentix board of directors, CGF III, and the Company breached various fiduciary duties by agreeing to a sale of Authentix at an inopportune time and at a price that was too low. A trial is scheduled to begin in Delaware in October 2023. The former directors of Authentix are covered by indemnification from Authentix and an Authentix insurance policy. The defendants intend to contest the claims vigorously. The Tax Receivable Agreement Matter The Company came into existence on January 1, 2020, when its predecessor, The Carlyle Group, L.P. (the “PTP”), converted from a partnership into a corporation (the “Conversion”). On July 29, 2022, an alleged stockholder of the Company, the City of Pittsburgh Comprehensive Municipal Trust Fund (the “Plaintiff”), filed suit in the Delaware Court of Chancery, alleging a direct claim against the Company for breach of its certificate of incorporation and a derivative claim on behalf of the Company against certain current and former officers and directors of the Company. Plaintiff challenges the receipt, by certain officers of the PTP and certain directors of the general partner of the PTP, of a right to cash payments associated with the elimination of a tax receivable agreement in connection with the Conversion. Plaintiff is seeking monetary damages, restitution, and an injunction preventing the Company from making any future cash payments for the elimination of the tax receivable agreement in connection with the Conversion. By virtue of the derivative nature of the primary claims (i.e., that the claims are aimed primarily at certain officers and directors), it is remote that the Company itself will pay material damage awards based on the Plaintiff’s claims, although the Company is expected to incur legal defense fees to the extent not covered by insurance. The defendants filed a motion to dismiss the complaint on October 28, 2022, and intend to contest the claims vigorously. SEC Investigation As part of a sweep investigation of financial services and investment advisory firms, in October 2022, the Company received from the SEC a request for information related to the preservation of certain types of electronic business communications (e.g., text messages and messages on WhatsApp, WeChat, and similar applications). The Company intends to cooperate fully with the SEC’s inquiry. The Company currently is and expects to continue to be, from time to time, subject to examinations, formal and informal inquiries and investigations by various U.S. and non-U.S. governmental and regulatory agencies, including but not limited to, the SEC, Department of Justice, state attorneys general, FINRA, National Futures Association and the U.K. Financial Conduct Authority. The Company routinely cooperates with such examinations, inquiries and investigations, and they may result in the commencement of civil, criminal, or administrative or other proceedings against the Company or its personnel. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings and employment-related matters, and some of the matters discussed above involve claims for potentially large and/or indeterminate amounts of damages. Based on information known by management, management does not believe that as of the date of this filing the final resolutions of the matters above will have a material effect upon the Company’s unaudited condensed consolidated financial statements. However, given the potentially large and/or indeterminate amounts of damages sought in certain of these matters and the inherent unpredictability of investigations and litigations, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s financial results in any particular period. The Company accrues an estimated loss contingency liability when it is probable that such a liability has been incurred and the amount of the loss can be reasonably estimated. As of September 30, 2022, the Company had recorded liabilities aggregating to approximately $40 million for litigation-related contingencies, regulatory examinations and inquiries, and other matters. The Company evaluates its outstanding legal and regulatory proceedings and other matters each quarter to assess its loss contingency accruals, and makes adjustments in such accruals, upward or downward, as appropriate, based on management’s best judgment after consultation with counsel. There is no assurance that the Company’s accruals for loss contingencies will not need to be adjusted in the future or that, in light of the uncertainties involved in such matters, the ultimate resolution of these matters will not significantly exceed the accruals that the Company has recorded. Indemnifications In the normal course of business, the Company and its subsidiaries enter into contracts that contain a variety of representations and warranties and provide general indemnifications. The Company’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Company that have not yet occurred. However, based on experience, the Company believes the risk of material loss to be remote. In connection with the sale of the Company’s interest in its local Brazilian management entity in August 2021, the Company provided a guarantee to the acquiring company of up to BRL 100.0 million ($18.5 million as of September 30, 2022) for liabilities arising from tax-related indemnifications. This guarantee, which will expire in August 2027, would only come into effect after all alternative remedies have been exhausted. The Company believes the likelihood of any material funding under this guarantee to be remote. Risks and Uncertainties Carlyle’s funds seek investment opportunities that offer the possibility of attaining substantial capital appreciation. Certain events particular to each industry in which the underlying investees conduct their operations, as well as general economic, political, regulatory and public health conditions, may have a significant negative impact on the Company’s investments and profitability. The funds managed by the Company may also experience a slowdown in the deployment of capital, which could adversely affect the Company’s ability to raise capital for new or successor funds and could also impact the management fees the Company earns on its carry funds and managed accounts. Such events are beyond the Company’s control, and the likelihood that they may occur and the effect on the Company cannot be predicted. Furthermore, certain of the funds’ investments are made in private companies and there are generally no public markets for the underlying securities at the current time. The funds’ ability to liquidate their publicly-traded investments are often subject to limitations, including discounts that may be required to be taken on quoted prices due to the number of shares being sold. The funds’ ability to liquidate their investments and realize value is subject to significant limitations and uncertainties, including among others currency fluctuations and natural disasters. The Company and the funds make investments outside of the United States. Investments outside the United States may be subject to less developed bankruptcy, corporate, partnership and other laws (which may have the effect of disregarding or otherwise circumventing the limited liability structures potentially causing the actions or liabilities of one fund or a portfolio company to adversely impact the Company or an unrelated fund or portfolio company). Non-U.S. investments are subject to the same risks associated with the Company’s U.S. investments as well as additional risks, such as fluctuations in foreign currency exchange rates, unexpected changes in regulatory requirements, heightened risk of political and economic instability, difficulties in managing non-U.S. investments, potentially adverse tax consequences and the burden of complying with a wide variety of foreign laws. Furthermore, Carlyle is exposed to economic risk concentrations related to certain large investments as well as concentrations of investments in certain industries and geographies. Additionally, the Company encounters credit risk. Credit risk is the risk of default by a counterparty in the Company’s investments in debt securities, loans, leases and derivatives that result from a borrower’s, lessee’s or derivative counterparty’s inability or unwillingness to make required or expected payments. The Company considers cash, cash equivalents, securities, receivables, principal equity method investments, accounts payable, accrued expenses, other liabilities, loans, senior notes, assets and liabilities of Consolidated Funds and contingent and other consideration for acquisitions to be its financial instruments. Except for the senior and subordinated notes, the carrying amounts reported in the unaudited condensed consolidated balance sheets for these financial instruments equal or closely approximate their fair values. The fair value of the senior and subordinated notes is disclosed in Note 8.

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	11. Related Party Transactions Due from Affiliates and Other Receivables, Net The Company had the following due from affiliates and other receivables at September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued incentive fees $ 14.5 $ 12.2 Unbilled receivable for giveback obligations from current and former employees 10.4 — Notes receivable and accrued interest from affiliates 41.3 25.3 Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net 420.2 342.1 Total $ 486.4 $ 379.6 Reimbursable expenses and other receivables from certain of the unconsolidated funds and portfolio companies relate to management fees receivable from limited partners, advisory fees receivable and expenses paid on behalf of these entities. These costs represent costs related to the pursuit of actual or proposed investments, professional fees and expenses associated with the acquisition, holding and disposition of the investments. The affiliates are obligated at the discretion of the Company to reimburse the expenses. Based on management’s determination, the Company accrues and charges interest on amounts due from affiliate accounts at interest rates ranging up to 7.02% as of September 30, 2022. The accrued and charged interest to the affiliates was not significant for any period presented. Notes receivable includes loans that the Company has provided to certain unconsolidated funds to meet short-term obligations to purchase investments. Notes receivable as of September 30, 2022 and December 31, 2021 also include interest-bearing loans of $22.3 million and $18.2 million, respectively, to certain eligible Carlyle employees, which excludes Section 16 officers and other members of senior management, to finance their investments in certain Carlyle sponsored funds. These advances accrue interest at the WSJ Prime Rate minus 1.00% floating with a floor rate of 3.50% (5.25% as of September 30, 2022) and are collateralized by each borrower’s interest in the Carlyle sponsored funds. These receivables are assessed regularly for collectability and amounts determined to be uncollectible are charged directly to general, administrative and other expenses in the condensed consolidated statements of operations. A corresponding allowance for doubtful accounts is recorded and such amounts were not significant for any period presented. Due to Affiliates The Company had the following due to affiliates balances at September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Due to affiliates of Consolidated Funds $ 15.6 $ — Due to non-consolidated affiliates 77.2 60.5 Deferred consideration for Carlyle Holdings units 133.7 200.5 Amounts owed under the tax receivable agreement 101.9 101.9 Other 23.2 25.2 Total $ 351.6 $ 388.1 The Company has recorded obligations for amounts due to certain of its affiliates. The Company periodically offsets expenses it has paid on behalf of its affiliates against these obligations. Deferred consideration for Carlyle Holdings units relates to the remaining obligation to the holders of Carlyle Holdings partnership units who will receive cash payments aggregating to $1.50 per Carlyle Holdings partnership unit exchanged in connection with the Conversion, payable in five In connection with the Company’s initial public offering, the Company entered into a tax receivable agreement with the limited partners of the Carlyle Holdings partnerships whereby certain subsidiaries of the Partnership agreed to pay to the limited partners of the Carlyle Holdings partnerships involved in any exchange transaction 85% of the amount of cash tax savings, if any, in U.S. federal, state and local income tax realized as a result of increases in tax basis resulting from exchanges of Carlyle Holdings Partnership units for common units of The Carlyle Group L.P. Other Related Party Transactions In the normal course of business, the Company has made use of aircraft owned by entities controlled by senior Carlyle professionals. The senior Carlyle professionals paid for their purchases of aircraft and bear all operating, personnel and maintenance costs associated with their operation for personal use. Payment by the Company for the business use of these aircraft by senior Carlyle professionals and other employees was made at market rates throughout the year based on budgeted business usage. When actual business use exceeded budgeted aircraft use, the Company made additional payments to the aircraft owner and/or the aircraft management company, as appropriate. Similarly, when the aggregate amount paid for budgeted aircraft use exceeded the calculated costs of actual business use, or results in rates which exceed market aircraft charter rates, we receive reimbursement of such excess payments from the aircraft owner and/or the aircraft management company, as appropriate. These adjustments were calculated annually and payments or reimbursements were generally made after year-end. During the three and nine months ended September 30, 2022, the Company made net payments related to these aircraft totaling $0.4 million and $0.9 million, respectively. During the three and nine months ended September 30, 2021, the Company received net reimbursements related to these aircraft totaling $0.5 million and $1.2 million, respectively. The accrual of aircraft fees is included in general, administrative, and other expenses in the unaudited condensed consolidated statements of operations. During the three months ended September 30, 2022, the Company terminated its remaining aircraft lease agreement and as of September 30, 2022 the Company had no active aircraft lease agreements. On May 5, 2020, the Company purchased 2,000,000 shares of BDC Preferred Shares from CSL in a private placement at a price of $25 per share. Dividends are payable on a quarterly basis in an initial amount equal to 7.0% per annum payable in cash, or, at CSL’s option, 9.0% per annual payable in additional BDC Preferred Shares. The BDC Preferred Shares are convertible at the Company’s option, in whole or in part, into the number of shares of common stock equal to $25 per share plus any accumulated but unpaid dividends divided by an initial conversion price of $9.50 per share, subject to certain adjustments. At any time after May 5, 2023 and with the approval of its board of directors, CSL will have the option to redeem the BDC Preferred Shares, in whole or in part. In such case, the Company has the right to convert its shares, in whole or in part, prior to the date of redemption. The Company recorded dividend income of $0.9 million and $2.6 million during the three and nine months ended September 30, 2022, respectively. The Company recorded dividend income of $0.9 million and $2.6 million, respectively, during the three and nine months ended September 30, 2021. Dividend income from the BDC Preferred Shares is included in interest and other income in the unaudited condensed consolidated statements of operations. The Company’s investment in the BDC Preferred Shares, which is recorded at fair value, was $61.2 million and $72.5 million as of September 30, 2022 and December 31, 2021, respectively, and is included in investments, including accrued performance allocations, in the unaudited condensed consolidated balance sheets. Senior Carlyle professionals and employees are permitted to participate in co-investment entities that invest in Carlyle funds or alongside Carlyle funds. In many cases, participation is limited by law to individuals who qualify under applicable legal requirements. These co-investment entities generally do not require senior Carlyle professionals and employees to pay management fees or performance allocations, however, Carlyle professionals and employees are required to pay their portion of partnership expenses. Carried interest income from the funds can be distributed to senior Carlyle professionals and employees on a current basis, but is subject to repayment by the subsidiary of the Company that acts as general partner of the fund in the event that certain specified return thresholds are not ultimately achieved. The senior Carlyle professionals and certain other investment professionals have personally guaranteed, subject to certain limitations, the obligation of these subsidiaries in respect of this general partner obligation. Such guarantees are several and not joint and are limited to a particular individual’s distributions received. The Company does business with some of its portfolio companies; all such arrangements are on a negotiated basis.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The Company’s provision (benefit) for income taxes was $76.2 million and $153.9 million for the three months ended September 30, 2022 and 2021, respectively, and $274.9 million and $733.5 million for the nine months ended September 30, 2022 and 2021, respectively. The Company’s effective tax rate was approximately 21% and 22% for the three months ended September 30, 2022 and 2021, respectively, and 20% and 24% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate for the nine months ended September 30, 2022 and 2021 is primarily comprised of the 21% U.S. federal corporate income tax rate plus U.S. state and foreign corporate income taxes and tax deductions resulting from the vesting of restricted stock units during the period, the impact of which was greater during the nine months ended September 30, 2022 due to a larger number of vested units. The effective tax rate for the nine months ended September 30, 2022 also reflects a deferred tax benefit resulting from a reduction in certain future foreign withholding taxes as well as the use of foreign tax credits. As of September 30, 2022 and December 31, 2021, the Company had federal, state, local and foreign taxes payable of $64.9 million and $93.3 million, respectively, which is recorded as a component of accounts payable, accrued expenses and other liabilities on the accompanying condensed consolidated balance sheet. In the normal course of business, the Company is subject to examination by federal and certain state, local and foreign tax regulators. With a few exceptions, as of September 30, 2022, the Company’s U.S. federal income tax returns for years 2018 through 2021 are open under the normal three-year statute of limitations and therefore subject to examination. State and local tax returns are generally subject to audit from 2016 to 2021. Foreign tax returns are generally subject to audit from 2011 to 2021. Certain of the Company’s affiliates are currently under audit by federal, state and foreign tax authorities. The Company does not believe that the outcome of these audits will require it to record material reserves for uncertain tax positions or that the outcome will have a material impact on the consolidated financial statements. The Company does not believe that it has any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months. On July 1, 2022, the State of New York issued proposed regulations, related to its 2015 law change, that may require corporate managers of investment funds (non broker dealers) to change how they source income to New York state, which may result in an increase in the Company’s taxable income to New York. These regulations will not be effective until promulgated. The Company has not yet determined the effect of these proposed regulations on its tax provision. On August 16, 2022 the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA enacted a 15% corporate minimum tax effective in 2023, a 1% tax on net share repurchases after December 31, 2022, and created and extended certain tax-related energy incentives. While these tax laws have no immediate effect, the Company is continuing to evaluate the impact of the IRA on its financial statements as further information becomes available.

Non-controlling Interests in Co

Non-controlling Interests in Consolidated Entities	9 Months Ended
Non-controlling Interests in Consolidated Entities	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Non-controlling Interests in Consolidated Entities	13. Non-controlling Interests in Consolidated Entities The components of the Company’s non-controlling interests in consolidated entities are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 346.8 $ 180.1 Non-Carlyle interests in majority-owned subsidiaries 187.4 234.4 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 3.0 12.7 Non-controlling interests in consolidated entities $ 537.2 $ 427.2 The components of the Company’s non-controlling interests in income of consolidated entities are as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ (15.7) $ 0.7 $ 14.0 $ 0.9 Non-Carlyle interests in majority-owned subsidiaries 16.3 13.2 11.9 46.6 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 1.0 0.7 2.4 10.2 Non-controlling interests in income of consolidated entities $ 1.6 $ 14.6 $ 28.3 $ 57.7

Earnings Per Common Share

Earnings Per Common Share	9 Months Ended
Earnings Per Common Share	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Common Share	14. Earnings Per Common Share Basic and diluted net income (loss) per common share are calculated as follows: Three Months Ended Nine Months Ended Basic Diluted Basic Diluted Net income attributable to common shares $ 280,800,000 $ 280,800,000 $ 1,097,800,000 $ 1,097,800,000 Weighted-average common shares outstanding 362,895,064 366,787,149 360,657,999 365,389,217 Net income per common share $ 0.77 $ 0.77 $ 3.04 $ 3.00 Three Months Ended Nine Months Ended Basic Diluted Basic Diluted Net loss attributable to common shares $ 532,800,000 $ 532,800,000 $ 2,327,100,000 $ 2,327,100,000 Weighted-average common shares outstanding 355,954,734 364,740,675 354,903,371 362,471,998 Net income per common share $ 1.50 $ 1.46 $ 6.56 $ 6.42 The weighted-average common shares outstanding, basic and diluted, are calculated as follows: Three Months Ended Nine Months Ended Basic Diluted Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 362,895,064 362,895,064 360,657,999 360,657,999 Unvested restricted stock units — 1,698,568 — 2,845,204 Issuable common shares and performance-vesting restricted stock units — 2,193,517 — 1,886,014 Weighted-average common shares outstanding 362,895,064 366,787,149 360,657,999 365,389,217 Three Months Ended Nine Months Ended Basic Diluted Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 355,954,734 355,954,734 354,903,371 354,903,371 Unvested restricted stock units — 6,716,547 — 5,582,360 Issuable common shares and performance-vesting restricted stock units — 2,069,394 — 1,986,267 Weighted-average common shares outstanding 355,954,734 364,740,675 354,903,371 362,471,998

Equity

Equity	9 Months Ended
Equity	Sep. 30, 2022
Equity [Abstract]
Equity	15. Equity Shares Issued for Performance Allocation Related Compensation In October 2021, the Company commenced a program under which, at the Company’s discretion, up to 20% of realized performance allocations and incentive fee related compensation over a certain threshold amount may be distributed in fully vested, newly issued shares of the Company’s common stock. During the three and nine months ended September 30, 2022, the Company distributed 78,953 and 850,110, respectively, fully vested, newly issued common shares, related to previously accrued performance allocations and incentive fee related compensation of $2.4 million and $38.9 million, respectively. The Company has determined to pause the issuance of shares pursuant to this program. Stock Repurchase Program In October 2021, the Board of Directors of the Company authorized the repurchase of up to $400.0 million of common stock, which replaced an authorization provided in February 2021 effective January 1, 2022. Under this repurchase program, shares of common stock may be repurchased from time to time in open market transactions, in privately negotiated transactions or otherwise, including through Rule 10b5-1 plans. The timing and actual number of shares of common stock repurchased will depend on a variety of factors, including legal requirements, price, and economic and market conditions. This repurchase program may be suspended or discontinued at any time and does not have a specified expiration date. During the nine months ended September 30, 2022 and 2021, the Company paid an aggregate of $146.9 million and $84.5 million, respectively, to repurchase and retire approximately 3.6 million and 1.9 million shares, respectively, with all of the repurchases done via open market and brokered transactions. As of September 30, 2022, $253.1 million of repurchase capacity remained under the program. Shares Issued in Connection with Acquisitions In August 2022, the Company issued 0.6 million shares of common stock, which represented $25.0 million of the purchase price paid in the acquisition of Abingworth. In March 2022, the Company issued 4.2 million shares of common stock, which represented $194.5 million of the purchase price paid in the acquisition of management contracts related to a portfolio of assets from CBAM. See Note 4 to the unaudited condensed consolidated financial statements for a further description of these acquisitions. Dividends The table below presents information regarding the quarterly dividends on the common shares, which were made at the sole discretion of the Board of Directors of the Company. Dividend Record Date Dividend Payment Date Dividend per Common Share Dividend to Common Stockholders (Dollars in millions, except per share data) May 11, 2021 May 19, 2021 $ 0.250 $ 88.7 August 10, 2021 August 17, 2021 0.250 89.3 November 9, 2021 November 17, 2021 0.250 89.1 February 15, 2022 February 23, 2022 0.250 89.5 Total 2021 Dividend Year $ 1.000 $ 356.6 May 10, 2022 May 17, 2022 $ 0.325 $ 117.6 August 9, 2022 August 16, 2022 0.325 118.3 November 18, 2022 November 25, 2022 0.325 118.2 Total 2022 Dividend Year (through Q3 2022) $ 0.975 $ 354.1 The Board of Directors will take into account general economic and business conditions, as well as the Company’s strategic plans and prospects, business and investment opportunities, financial condition and obligations, legal, tax and regulatory restrictions, other constraints on the payment of dividends by the Company to its common stockholders or by subsidiaries to the Company, and other such factors as the Board of Directors may deem relevant. In addition, the terms of the Company’s credit facility provide certain limits on the Company’s ability to pay dividends.

Equity-Based Compensation

Equity-Based Compensation	9 Months Ended
Equity-Based Compensation	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	16. Equity-Based Compensation In May 2012, Carlyle Group Management L.L.C., the general partner of the Partnership, adopted the Equity Incentive Plan. The Equity Incentive Plan, which was amended on January 1, 2020 in connection with the Conversion to reflect shares of the Company’s common stock, is a source of equity-based awards permitting the Company to grant to Carlyle employees, directors and consultants non-qualified options, share appreciation rights, common shares, restricted stock units and other awards based on the Company’s common shares. On June 1, 2021, the shareholders of the Company approved an amended and restated Equity Incentive Plan that removed a provision providing for the automatic increase in the number of the Company’s common shares available for grant and reset the total number of shares of common stock available for grant to 16,000,000 for awards granted under the plan after June 1, 2021. As of September 30, 2022, the total number of the Company’s common shares available for grant under the amended and restated Equity Incentive Plan was 12,994,991. A summary of the status of the Company’s non-vested equity-based awards as of September 30, 2022 and a summary of changes for the nine months ended September 30, 2022, are presented below: Unvested Shares Restricted Weighted- Unvested (1) Weighted- Balance, December 31, 2021 14,775,651 $ 30.70 635,430 $ 29.27 Granted 3,616,132 $ 42.96 188,223 $ 49.06 Vested 5,572,684 $ 27.74 370,773 $ 26.54 Forfeited 1,585,664 $ 29.29 — $ — Balance, September 30, 2022 11,233,435 $ 36.32 452,880 $ 39.73 (1) Includes common shares issued in connection with the Company’s strategic investment in NGP. The Company recorded compensation expense, net of forfeitures, for restricted stock units of $54.2 million and $42.5 million for the three months ended September 30, 2022 and 2021, respectively, with $6.1 million and $8.4 million of corresponding deferred tax benefits, respectively. The Company recorded compensation expense, net of forfeitures, for restricted stock units of $139.3 million and $122.0 million for the nine months ended September 30, 2022 and 2021, respectively, with $23.5 million and $25.6 million of corresponding deferred tax benefits, respectively. As of September 30, 2022, the total unrecognized equity-based compensation expense related to unvested restricted stock units was $271.9 million, which is expected to be recognized over a weighted-average term of 2.0 years.

Segment Reporting

Segment Reporting	9 Months Ended
Segment Reporting	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	17. Segment Reporting Carlyle conducts its operations through three reportable segments: Global Private Equity – The Global Private Equity segment is comprised of the Company’s operations that advise a diverse group of funds that invest in buyout, middle market and growth capital, real estate, infrastructure and natural resources transactions. Global Credit – The Global Credit segment advises a group of funds that pursue investment opportunities across various types of credit, including loans and structured credit, direct lending, opportunistic credit, energy credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions and global capital solutions. Global Investment Solutions – The Global Investment Solutions segment advises global private equity fund of funds programs and related co-investment and secondary activities through AlpInvest. This segment also included Metropolitan Real Estate (“MRE”), a global manager of real estate fund of funds and related co-investment and secondary activities, prior to its sale on April 1, 2021. The Company’s reportable business segments are differentiated by their various investment focuses and strategies. Overhead costs are generally allocated based on cash-based compensation and benefits expense for each segment. The Company’s earnings from its investment in NGP are presented in the respective operating captions within the Global Private Equity segment. Distributable Earnings . Distributable Earnings, or “DE,” is a key performance benchmark used in the Company’s industry and is evaluated regularly by management in making resource deployment and compensation decisions and in assessing performance of the Company’s three reportable segments. Management also uses DE in budgeting, forecasting, and the overall management of the Company’s segments. Management believes that reporting DE is helpful to understanding the Company’s business and that investors should review the same supplemental financial measure that management uses to analyze the Company’s segment performance. DE is intended to show the amount of net realized earnings without the effects of the consolidation of the Consolidated Funds. DE is derived from the Company’s segment reported results and is used to assess performance. Distributable Earnings differs from income (loss) before provision for income taxes computed in accordance with U.S. GAAP in that it includes certain tax expenses associated with certain foreign performance revenues (comprised of performance allocations and incentive fees), and does not include unrealized performance allocations and related compensation expense, unrealized principal investment income, equity-based compensation expense, net income (loss) attributable to non-Carlyle interests in consolidated entities, or charges (credits) related to Carlyle corporate actions and non-recurring items. Charges (credits) related to Carlyle corporate actions and non-recurring items include: charges (credits) associated with acquisitions, dispositions, or strategic investments, changes in the tax receivable agreement liability, amortization and any impairment charges associated with acquired intangible assets, transaction costs associated with acquisitions and dispositions, charges associated with earnouts and contingent consideration including gains and losses associated with the estimated fair value of contingent considerations issued in conjunction with acquisitions or strategic investments, impairment charges associated with lease right-of-use assets, gains and losses from the retirement of debt, charges associated with contract terminations and employee severance. Management believes the inclusion or exclusion of these items provides investors with a meaningful indication of the Company’s core operating performance. Fee Related Earnings . Fee Related Earnings, or “FRE,” is used to assess the ability of the business to cover direct base compensation and operating expenses from total fee revenues. FRE differs from income (loss) before provision for income taxes computed in accordance with U.S. GAAP in that it adjusts for the items included in the calculation of DE and also adjusts DE to exclude net realized performance revenues, realized principal investment income, net interest (interest income less interest expense), and certain general, administrative and other expenses when the timing of any future payment is uncertain. In 2022, the Company began to disclose fee related performance revenues as a separate line item in its segment results. Fee related performance revenues are the realized portion of performance revenues that are measured and received on a recurring basis, are not dependent on the disposition of investments, and which are not at risk of giveback. Previously, these amounts were included as a component of fund management fees. Beginning in 2022, the Company’s Core plus real estate fund, CPI, began to realize recurring fee related performance revenues. Realized net performance revenues for CPI were immaterial in prior periods. The following tables present the financial data for the Company’s three reportable segments for the three and nine months ended September 30, 2022: Three Months Ended September 30, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 330.1 $ 128.4 $ 55.6 $ 514.1 Portfolio advisory and transaction fees, net and other 7.7 27.3 — 35.0 Fee related performance revenues 6.1 14.5 — 20.6 Total fund level fee revenues 343.9 170.2 55.6 569.7 Realized performance revenues 628.4 63.0 73.4 764.8 Realized principal investment income 46.0 9.2 1.5 56.7 Interest income 5.1 4.5 0.9 10.5 Total revenues 1,023.4 246.9 131.4 1,401.7 Segment Expenses Compensation and benefits Cash-based compensation and benefits 146.7 69.9 30.1 246.7 Realized performance revenues related compensation 283.5 28.9 61.3 373.7 Total compensation and benefits 430.2 98.8 91.4 620.4 General, administrative, and other indirect expenses 65.3 26.4 9.1 100.8 Depreciation and amortization expense 6.3 2.1 1.2 9.6 Interest expense 15.9 7.9 2.7 26.5 Total expenses 517.7 135.2 104.4 757.3 Distributable Earnings $ 505.7 $ 111.7 $ 27.0 $ 644.4 (-) Realized Net Performance Revenues 344.9 34.1 12.1 391.1 (-) Realized Principal Investment Income 46.0 9.2 1.5 56.7 (+) Net Interest 10.8 3.4 1.8 16.0 (=) Fee Related Earnings $ 125.6 $ 71.8 $ 15.2 $ 212.6 Nine Months Ended September 30, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 971.3 $ 345.8 $ 167.4 $ 1,484.5 Portfolio advisory and transaction fees, net and other 21.3 72.1 — 93.4 Fee related performance revenues 59.0 41.2 — 100.2 Total fund level fee revenues 1,051.6 459.1 167.4 1,678.1 Realized performance revenues 1,302.1 96.6 122.3 1,521.0 Realized principal investment income 94.4 28.2 4.2 126.8 Interest income 6.7 8.6 1.2 16.5 Total revenues 2,454.8 592.5 295.1 3,342.4 Segment Expenses Compensation and benefits Cash-based compensation and benefits 453.9 214.2 84.1 752.2 Realized performance revenues related compensation 588.7 45.0 107.3 741.0 Total compensation and benefits 1,042.6 259.2 191.4 1,493.2 General, administrative, and other indirect expenses 170.1 70.2 24.7 265.0 Depreciation and amortization expense 18.9 6.0 3.7 28.6 Interest expense 47.7 23.5 8.4 79.6 Total expenses 1,279.3 358.9 228.2 1,866.4 Distributable Earnings $ 1,175.5 $ 233.6 $ 66.9 $ 1,476.0 (-) Realized Net Performance Revenues 713.4 51.6 15.0 780.0 (-) Realized Principal Investment Income 94.4 28.2 4.2 126.8 (+) Net Interest 41.0 14.9 7.2 63.1 (=) Fee Related Earnings $ 408.7 $ 168.7 $ 54.9 $ 632.3 Segment assets as of September 30, 2022 $ 10,046.3 $ 3,205.3 $ 1,741.6 $ 14,993.2 The following tables present the financial data for the Company’s three reportable segments for the three and nine months ended September 30, 2021: Three Months Ended September 30, 2021 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 265.1 $ 81.3 $ 59.3 $ 405.7 Portfolio advisory and transaction fees, net and other 7.3 15.9 — 23.2 Fee related performance revenues — 11.2 — 11.2 Total fund level fee revenues 272.4 108.4 59.3 440.1 Realized performance revenues 962.9 2.1 45.9 1,010.9 Realized principal investment income 61.6 7.4 2.3 71.3 Interest income 0.2 1.3 — 1.5 Total revenues 1,297.1 119.2 107.5 1,523.8 Segment Expenses Compensation and benefits Cash-based compensation and benefits 133.6 58.7 25.7 218.0 Realized performance revenues related compensation 434.5 1.0 41.9 477.4 Total compensation and benefits 568.1 59.7 67.6 695.4 General, administrative, and other indirect expenses 38.4 14.7 6.9 60.0 Depreciation and amortization expense 7.1 2.3 1.3 10.7 Interest expense 17.4 6.8 2.9 27.1 Total expenses 631.0 83.5 78.7 793.2 Distributable Earnings $ 666.1 $ 35.7 $ 28.8 $ 730.6 (-) Realized Net Performance Revenues 528.4 1.1 4.0 533.5 (-) Realized Principal Investment Income 61.6 7.4 2.3 71.3 (+) Net Interest 17.2 5.5 2.9 25.6 (=) Fee Related Earnings $ 93.3 $ 32.7 $ 25.4 $ 151.4 Nine Months Ended September 30, 2021 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 788.7 $ 227.6 $ 171.6 $ 1,187.9 Portfolio advisory and transaction fees, net and other 24.1 34.1 0.3 58.5 Fee related performance revenues — 31.0 — 31.0 Total fund level fee revenues 812.8 292.7 171.9 1,277.4 Realized performance revenues 1,525.9 2.2 105.2 1,633.3 Realized principal investment income 109.3 23.1 6.7 139.1 Interest income 0.9 4.5 0.1 5.5 Total revenues 2,448.9 322.5 283.9 3,055.3 Segment Expenses Compensation and benefits Cash-based compensation and benefits 396.3 168.0 83.3 647.6 Realized performance revenues related compensation 688.3 1.0 97.1 786.4 Total compensation and benefits 1,084.6 169.0 180.4 1,434.0 General, administrative, and other indirect expenses 116.2 39.5 21.5 177.2 Depreciation and amortization expense 19.3 6.2 3.5 29.0 Interest expense 46.9 19.4 7.9 74.2 Total expenses 1,267.0 234.1 213.3 1,714.4 Distributable Earnings $ 1,181.9 $ 88.4 $ 70.6 $ 1,340.9 (-) Realized Net Performance Revenues 837.6 1.2 8.1 846.9 (-) Realized Principal Investment Income 109.3 23.1 6.7 139.1 (+) Net Interest 46.0 14.9 7.8 68.7 (=) Fee Related Earnings $ 281.0 $ 79.0 $ 63.6 $ 423.6 The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the three months ended September 30, 2022 and 2021. Three Months Ended September 30, 2022 Total Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 1,401.7 $ 79.7 $ (392.9) (a) $ 1,088.5 Expenses $ 757.3 $ 62.0 $ (119.7) (b) $ 699.6 Other income $ — $ (30.3) $ — (c) $ (30.3) Distributable earnings $ 644.4 $ (12.6) $ (273.2) (d) $ 358.6 Three Months Ended September 30, 2021 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 1,523.8 $ 62.1 $ 53.6 (a) $ 1,639.5 Expenses $ 793.2 $ 51.9 $ 93.0 (b) $ 938.1 Other income $ — $ (0.1) $ — (c) $ (0.1) Distributable earnings $ 730.6 $ 10.1 $ (39.4) (d) $ 701.3 The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the nine months ended September 30, 2022 and 2021, and Total Assets as of September 30, 2022. Nine Months Ended September 30, 2022 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 3,342.4 $ 204.6 $ 172.3 (a) $ 3,719.3 Expenses $ 1,866.4 $ 166.0 $ 234.9 (b) $ 2,267.3 Other income (loss) $ — $ (51.0) $ — (c) $ (51.0) Distributable earnings $ 1,476.0 $ (12.4) $ (62.6) (d) $ 1,401.0 Total assets $ 14,993.2 $ 6,695.8 $ (596.6) (e) $ 21,092.4 Nine Months Ended September 30, 2021 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 3,055.3 $ 185.3 $ 3,542.4 (a) $ 6,783.0 Expenses $ 1,714.4 $ 162.6 $ 1,797.3 (b) $ 3,674.3 Other income (loss) $ — $ 9.6 $ — (c) $ 9.6 Distributable earnings $ 1,340.9 $ 32.3 $ 1,745.1 (d) $ 3,118.3 (a) The Revenues adjustment principally represents unrealized performance revenues, unrealized principal investment income (loss) (including Fortitude), the principal investment loss from dilution of the indirect investment in Fortitude, revenues earned from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to non-controlling interests in consolidated entities, adjustments related to expenses associated with the investments in NGP Management and its affiliates that are included in operating captions or are excluded from the segment results, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, and the inclusion of tax expenses associated with certain foreign performance revenues, as detailed below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Unrealized performance and fee related performance revenues $ (376.2) $ (29.8) $ 334.8 $ 3,212.7 Unrealized principal investment income (loss) (29.9) 70.4 (33.3) 280.5 Principal investment loss from dilution of indirect investment in Fortitude — — (176.9) — Adjustments related to expenses associated with investments in NGP Management and its affiliates (3.8) (3.6) (9.9) (10.2) Tax expense associated with certain foreign performance revenues 0.1 0.1 — 0.3 Non-controlling interests and other adjustments to present certain costs on a net basis 28.4 33.2 60.0 119.6 Elimination of revenues of Consolidated Funds (11.5) (16.7) (2.4) (60.5) $ (392.9) $ 53.6 $ 172.3 $ 3,542.4 The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S. GAAP measure, the Company’s consolidated fund management fees, for the three and nine months ended September 30, 2022 and 2021. Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Total Reportable Segments - Fund level fee revenues $ 569.7 $ 440.1 $ 1,678.1 $ 1,277.4 Adjustments (1) (33.8) (32.6) (145.2) (94.5) Carlyle Consolidated - Fund management fees $ 535.9 $ 407.5 $ 1,532.9 $ 1,182.9 (1) Adjustments represent the reclassification of NGP management fees from principal investment income, the reclassification of fee related performance revenues from business development companies and other products, management fees earned from consolidated CLOs which were eliminated in consolidation to arrive at the Company’s fund management fees, and the reclassification of certain amounts included in portfolio advisory fees, net and other in the segment results that are included in interest and other income in the U.S. GAAP results. (b) The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds payable to the Company, the inclusion of equity-based compensation, certain tax expenses associated with realized performance revenues related compensation, and unrealized performance revenues related compensation, adjustments related to expenses associated with the investment in NGP Management that are included in operating captions, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, changes in the tax receivable agreement liability, and charges and credits associated with Carlyle corporate actions and non-recurring items, as detailed below: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Unrealized performance and fee related performance revenue compensation expense $ (224.0) $ 15.0 $ (50.4) $ 1,567.1 Equity-based compensation 56.0 44.3 145.0 129.5 Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment 42.4 24.4 124.9 54.7 Tax expense associated with certain foreign performance revenues related compensation 3.7 (2.5) 3.0 (12.1) Non-controlling interests and other adjustments to present certain costs on a net basis 7.5 15.9 35.8 53.2 Right-of-use asset impairment — — — 26.8 Other adjustments including severance 3.1 3.2 5.4 7.2 Elimination of expenses of Consolidated Funds (8.4) (7.3) (28.8) (29.1) $ (119.7) $ 93.0 $ 234.9 $ 1,797.3 (c) The Other Income (Loss) adjustment results from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total Other Income (Loss). (d) The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable Earnings and to Fee Related Earnings: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Income (loss) before provision for income taxes $ 358.6 $ 701.3 $ 1,401.0 $ 3,118.3 Adjustments: Net unrealized performance and fee related performance revenues 152.2 44.8 (385.2) (1,645.6) Unrealized principal investment (income) loss 29.9 (70.4) 33.3 (280.5) Principal investment loss from dilution of indirect investment in Fortitude — — 176.9 — Equity-based compensation (1) 56.0 44.3 145.0 129.5 Acquisition or disposition-related charges (credits), including amortization of intangibles and impairment 42.4 24.4 124.9 54.7 Tax expense associated with certain foreign performance revenues 3.8 (2.4) 3.0 (11.8) Net income attributable to non-controlling interests in consolidated entities (1.6) (14.6) (28.3) (57.7) Right-of-use asset impairment — — — 26.8 Other adjustments including severance 3.1 3.2 5.4 7.2 Distributable Earnings $ 644.4 $ 730.6 $ 1,476.0 $ 1,340.9 Realized performance revenues, net of related compensation (2) 391.1 533.5 780.0 846.9 Realized principal investment income (2) 56.7 71.3 126.8 139.1 Net interest 16.0 25.6 63.1 68.7 Fee Related Earnings $ 212.6 $ 151.4 $ 632.3 $ 423.6 (1) Equity-based compensation for the three and nine months ended September 30, 2022 and 2021 includes amounts that are presented in principal investment income and general, administrative and other expenses in the Company’s U.S. GAAP statement of operations. (2) See reconciliation to most directly comparable U.S. GAAP measure below: Three Months Ended September 30, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 298.1 $ 466.7 $ 764.8 Performance revenues related compensation expense 163.5 210.2 373.7 Net performance revenues $ 134.6 $ 256.5 $ 391.1 Principal investment income (loss) $ 124.2 $ (67.5) $ 56.7 Nine Months Ended September 30, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 1,346.2 $ 174.8 $ 1,521.0 Performance revenues related compensation expense 741.2 (0.2) 741.0 Net performance revenues $ 605.0 $ 175.0 $ 780.0 Principal investment income (loss) $ 500.5 $ (373.7) $ 126.8 Three Months Ended September 30, 2021 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 974.5 $ 36.4 $ 1,010.9 Performance revenues related compensation expense 495.2 (17.8) 477.4 Net performance revenues $ 479.3 $ 54.2 $ 533.5 Principal investment income (loss) $ 160.4 $ (89.1) $ 71.3 Nine Months Ended September 30, 2021 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 4,841.3 $ (3,208.0) $ 1,633.3 Performance revenues related compensation expense 2,355.8 (1,569.4) 786.4 Net performance revenues $ 2,485.5 $ (1,638.6) $ 846.9 Principal investment income (loss) $ 477.2 $ (338.1) $ 139.1 ( 3) Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance allocations net of related compensation expense and unrealized principal investment income, which are excluded from the segment results, (ii) amounts earned from the Consolidated Funds, which were eliminated in the U.S. GAAP consolidation but were included in the segment results, (iii) amounts attributable to non-controlling interests in consolidated entities, which were excluded from the segment results, (iv) the reclassification of NGP performance revenues, which are included in principal investment income in U.S. GAAP financial statements, (v) the reclassification of fee related performance revenues, which are included in fund level fee revenues in the segment results, and (vi) the reclassification of tax expenses associated with certain foreign performance revenues. Adjustments to principal investment income (loss) also include the reclassification of earnings for the investments in NGP Management and its affiliates to the appropriate operating captions for the segment results, the exclusion of charges associated with the investment in NGP Management and its affiliates that are excluded from the segment results and the exclusion of the principal investment loss from dilution of the indirect investment in Fortitude.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events Dividends In November 2022, the Company’s Board of Directors declared a quarterly dividend of $0.325 per share of common stock to common stockholders of record at the close of business on November 18, 2022, payable on November 25, 2022.

Supplemental Financial Informat

Supplemental Financial Information	9 Months Ended
Supplemental Financial Information	Sep. 30, 2022
Condensed Financial Information Disclosure [Abstract]
Supplemental Financial Information	19. Supplemental Financial Information The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the Company’s financial position as of September 30, 2022 and December 31, 2021 and results of operations for the three and nine months ended September 30, 2022 and 2021. The supplemental statement of cash flows is presented without effects of the Consolidated Funds. As of September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,361.9 $ — $ — $ 1,361.9 Cash and cash equivalents held at Consolidated Funds — 177.2 — 177.2 Restricted cash 0.6 — — 0.6 Corporate treasury investments 69.5 — — 69.5 Investments, including performance allocations of $7,428.7 million 11,130.8 — (132.6) 10,998.2 Investments of Consolidated Funds — 6,409.7 — 6,409.7 Due from affiliates and other receivables, net 950.4 — (464.0) 486.4 Due from affiliates and other receivables of Consolidated Funds, net — 108.6 — 108.6 Fixed assets, net 134.4 — — 134.4 Lease right-of-use assets, net 333.5 — — 333.5 Deposits and other 69.1 0.3 — 69.4 Intangible assets, net 925.1 — — 925.1 Deferred tax assets 17.9 — — 17.9 Total assets $ 14,993.2 $ 6,695.8 $ (596.6) $ 21,092.4 Liabilities and equity Debt obligations $ 2,235.0 $ — $ — $ 2,235.0 Loans payable of Consolidated Funds — 5,975.3 (458.4) 5,516.9 Accounts payable, accrued expenses and other liabilities 379.4 — — 379.4 Accrued compensation and benefits 4,347.7 — — 4,347.7 Due to affiliates 336.0 15.7 (0.1) 351.6 Deferred revenue 394.2 — — 394.2 Deferred tax liabilities 449.9 — — 449.9 Other liabilities of Consolidated Funds — 222.1 (0.1) 222.0 Lease liabilities 499.9 — — 499.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,683.0 6,213.1 (458.6) 14,437.5 Common stock 3.6 — — 3.6 Additional paid-in capital 3,123.0 157.2 (157.2) 3,123.0 Retained earnings 3,430.8 — — 3,430.8 Accumulated other comprehensive loss (437.6) (21.3) 19.2 (439.7) Non-controlling interests in consolidated entities 190.4 346.8 — 537.2 Total equity 6,310.2 482.7 (138.0) 6,654.9 Total liabilities and equity $ 14,993.2 $ 6,695.8 $ (596.6) $ 21,092.4 As of December 31, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 2,469.5 $ — $ — $ 2,469.5 Cash and cash equivalents held at Consolidated Funds — 147.8 — 147.8 Restricted cash 5.6 — — 5.6 Investments, including performance allocations of $8,133.0 million 11,022.5 — (190.5) 10,832.0 Investments of Consolidated Funds — 6,661.0 — 6,661.0 Due from affiliates and other receivables, net 384.9 — (5.3) 379.6 Due from affiliates and other receivables of Consolidated Funds, net — 138.8 — 138.8 Fixed assets, net 143.9 — — 143.9 Lease right-of-use assets, net 361.1 — — 361.1 Deposits and other 61.3 0.4 — 61.7 Intangible assets, net 34.9 — — 34.9 Deferred tax assets 14.5 — — 14.5 Total assets $ 14,498.2 $ 6,948.0 $ (195.8) $ 21,250.4 Liabilities and equity Debt obligations $ 2,071.6 $ — $ — $ 2,071.6 Loans payable of Consolidated Funds — 5,890.0 — 5,890.0 Accounts payable, accrued expenses and other liabilities 379.7 — — 379.7 Accrued compensation and benefits 4,955.0 — — 4,955.0 Due to affiliates 388.1 — — 388.1 Deferred revenue 120.8 — — 120.8 Deferred tax liabilities 487.1 — — 487.1 Other liabilities of Consolidated Funds — 684.0 (0.1) 683.9 Lease liabilities 537.8 — — 537.8 Accrued giveback obligations 30.2 — — 30.2 Total liabilities 8,970.3 6,574.0 (0.1) 15,544.2 Common stock 3.6 — — 3.6 Additional paid-in capital 2,717.6 198.6 (198.6) 2,717.6 Retained earnings 2,805.3 — — 2,805.3 Accumulated other comprehensive income (loss) (245.7) (4.7) 2.9 (247.5) Non-controlling interests in consolidated entities 247.1 180.1 — 427.2 Total equity 5,527.9 374.0 (195.7) 5,706.2 Total liabilities and equity $ 14,498.2 $ 6,948.0 $ (195.8) $ 21,250.4 Three Months Ended September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 542.1 $ — $ (6.2) $ 535.9 Incentive fees 15.2 — (0.1) 15.1 Investment income Performance allocations 297.8 — 0.3 298.1 Principal investment income 127.6 — (3.4) 124.2 Total investment income 425.4 — (3.1) 422.3 Interest and other income 37.6 — (2.1) 35.5 Interest and other income of Consolidated Funds — 79.7 — 79.7 Total revenues 1,020.3 79.7 (11.5) 1,088.5 Expenses Compensation and benefits Cash-based compensation and benefits 251.4 — — 251.4 Equity-based compensation 54.2 — — 54.2 Performance allocations and incentive fee related compensation 163.5 — — 163.5 Total compensation and benefits 469.1 — — 469.1 General, administrative and other expenses 149.3 — (0.1) 149.2 Interest 27.3 — — 27.3 Interest and other expenses of Consolidated Funds — 62.0 (8.3) 53.7 Other non-operating expense 0.3 — — 0.3 Total expenses 646.0 62.0 (8.4) 699.6 Other income (loss) Net investment loss of Consolidated Funds — (30.3) — (30.3) Income (loss) before provision for income taxes 374.3 (12.6) (3.1) 358.6 Provision for income taxes 76.2 — — 76.2 Net income (loss) 298.1 (12.6) (3.1) 282.4 Net income attributable to non-controlling interests in consolidated entities 17.3 — (15.7) 1.6 Net income (loss) attributable to The Carlyle Group Inc. $ 280.8 $ (12.6) $ 12.6 $ 280.8 Nine Months Ended September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 1,552.0 $ — $ (19.1) $ 1,532.9 Incentive fees 42.7 — (0.1) 42.6 Investment income Performance allocations 1,350.7 — (4.5) 1,346.2 Principal investment income 463.9 — 36.6 500.5 Total investment income 1,814.6 — 32.1 1,846.7 Interest and other income 107.8 — (15.3) 92.5 Interest and other income of Consolidated Funds — 204.6 — 204.6 Total revenues 3,517.1 204.6 (2.4) 3,719.3 Expenses Compensation and benefits Cash-based compensation and benefits 779.7 — — 779.7 Equity-based compensation 139.3 — — 139.3 Performance allocations and incentive fee related compensation 741.2 — — 741.2 Total compensation and benefits 1,660.2 — — 1,660.2 General, administrative and other expenses 387.1 — 0.1 387.2 Interest 82.0 — — 82.0 Interest and other expenses of Consolidated Funds — 166.0 (28.9) 137.1 Other non-operating expense 0.8 — — 0.8 Total expenses 2,130.1 166.0 (28.8) 2,267.3 Other income (loss) Net investment loss of Consolidated Funds — (51.0) — (51.0) Income (loss) before provision for income taxes 1,387.0 (12.4) 26.4 1,401.0 Provision for income taxes 274.9 — — 274.9 Net income (loss) 1,112.1 (12.4) 26.4 1,126.1 Net income attributable to non-controlling interests in consolidated entities 14.3 — 14.0 28.3 Net income (loss) attributable to The Carlyle Group Inc. $ 1,097.8 $ (12.4) $ 12.4 $ 1,097.8 Three Months Ended September 30, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 414.3 $ — $ (6.8) $ 407.5 Incentive fees 13.1 — — 13.1 Investment income Performance allocations 974.5 — — 974.5 Principal investment income 165.2 — (4.8) 160.4 Total investment income 1,139.7 — (4.8) 1,134.9 Interest and other income 27.0 — (5.1) 21.9 Interest and other income of Consolidated Funds — 62.1 — 62.1 Total revenues 1,594.1 62.1 (16.7) 1,639.5 Expenses Compensation and benefits Cash-based compensation and benefits 224.9 — — 224.9 Equity-based compensation 42.4 — — 42.4 Performance allocations and incentive fee related compensation 495.2 — — 495.2 Total compensation and benefits 762.5 — — 762.5 General, administrative and other expenses 99.6 — — 99.6 Interest 27.9 — — 27.9 Interest and other expenses of Consolidated Funds — 51.9 (7.3) 44.6 Other non-operating income 3.5 — — 3.5 Total expenses 893.5 51.9 (7.3) 938.1 Other income Net investment loss of Consolidated Funds — (0.1) — (0.1) Income before provision for income taxes 700.6 10.1 (9.4) 701.3 Provision for income taxes 153.9 — — 153.9 Net income 546.7 10.1 (9.4) 547.4 Net income attributable to non-controlling interests in consolidated entities 13.9 — 0.7 14.6 Net income attributable to The Carlyle Group Inc. 532.8 10.1 (10.1) 532.8 Nine Months Ended September 30, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 1,201.5 $ — $ (18.6) $ 1,182.9 Incentive fees 33.0 — — 33.0 Investment income Performance allocations 4,841.3 — — 4,841.3 Principal investment income 503.1 — (25.9) 477.2 Total investment income 5,344.4 — (25.9) 5,318.5 Interest and other income 79.3 — (16.0) 63.3 Interest and other income of Consolidated Funds — 185.3 — 185.3 Total revenues 6,658.2 185.3 (60.5) 6,783.0 Expenses Compensation and benefits Cash-based compensation and benefits 685.2 — — 685.2 Equity-based compensation 122.0 — — 122.0 Performance allocations and incentive fee related compensation 2,355.8 — — 2,355.8 Total compensation and benefits 3,163.0 — — 3,163.0 General, administrative and other expenses 300.4 — — 300.4 Interest 76.4 — — 76.4 Interest and other expenses of Consolidated Funds — 162.6 (29.1) 133.5 Other non-operating income 1.0 — — 1.0 Total expenses 3,540.8 162.6 (29.1) 3,674.3 Other income Net investment gain of Consolidated Funds — 9.6 — 9.6 Income before provision for income taxes 3,117.4 32.3 (31.4) 3,118.3 Provision for income taxes 733.5 — — 733.5 Net income 2,383.9 32.3 (31.4) 2,384.8 Net income attributable to non-controlling interests in consolidated entities 56.8 — 0.9 57.7 Net income attributable to The Carlyle Group Inc. 2,327.1 32.3 (32.3) 2,327.1 Nine Months Ended September 30, 2022 2021 (Dollars in millions) Cash flows from operating activities Net income $ 1,112.1 $ 2,383.9 Adjustments to reconcile net income to net cash flows from operating activities: Depreciation and amortization 102.7 40.5 Right-of-use asset impairment, net of broker fees — 24.8 Equity-based compensation 139.3 122.0 Non-cash performance allocations and incentive fees 179.4 (1,662.3) Non-cash principal investment income (434.9) (470.7) Other non-cash amounts (27.4) 20.7 Purchases of investments (582.4) (250.9) Proceeds from the sale of investments 410.2 559.1 Payments of contingent consideration (5.7) (50.0) Change in deferred taxes, net (2.3) 449.1 Change in due from affiliates and other receivables (62.0) (21.1) Change in deposits and other (12.8) (23.3) Change in accounts payable, accrued expenses and other liabilities (27.7) 90.9 Change in accrued compensation and benefits (265.3) 17.3 Change in due to affiliates 2.4 1.4 Change in lease right-of-use asset and lease liability (7.0) 5.9 Change in deferred revenue 274.9 247.6 Net cash provided by operating activities 793.5 1,484.9 Cash flows from investing activities Purchases of corporate treasury investments, net (69.6) — Purchases of fixed assets, net (25.0) (27.0) Purchase of Abingworth, net of cash acquired (150.2) — Purchase of CBAM intangibles and investments, net (618.4) — Proceeds from sale of MRE, net of cash sold — 5.9 Proceeds from sale of Brazil management entity, net of cash sold — 3.3 Net cash used in investing activities (863.2) (17.8) Cash flows from financing activities Borrowings under credit facilities — 70.0 Issuance of 4.625% subordinated notes due 2061, net of financing costs — 484.1 Payments on CLO borrowings (8.9) (231.5) Proceeds from CLO borrowings, net of financing costs 55.2 87.5 Payments of contingent consideration — (0.1) Dividends to common stockholders (325.4) (266.7) Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8) Contributions from non-controlling interest holders 7.2 13.1 Distributions to non-controlling interest holders (52.5) (56.3) Common shares issued for performance allocations 38.9 — Common shares repurchased (146.9) (84.5) Change in due to/from affiliates financing activities (471.6) 21.8 Net cash used in financing activities (972.8) (31.4) Effect of foreign exchange rate changes (70.1) (19.4) Increase (decrease) in cash, cash equivalents and restricted cash (1,112.6) 1,416.3 Cash, cash equivalents and restricted cash, beginning of period 2,475.1 989.6 Cash, cash equivalents and restricted cash, end of period $ 1,362.5 $ 2,405.9 Supplemental non-cash disclosures Issuance of common shares related to the acquisition of CBAM and Abingworth $ 219.5 $ — Reconciliation of cash, cash equivalents and restricted cash, end of period: Cash and cash equivalents $ 1,361.9 $ 2,399.0 Restricted cash 0.6 6.9 Total cash, cash equivalents and restricted cash, end of period $ 1,362.5 $ 2,405.9 Cash and cash equivalents held at Consolidated Funds $ 177.2 $ 134.8

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Company consolidates all entities that it controls either through a majority voting interest or as the primary beneficiary of variable interest entities (“VIEs”). The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3) whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company holds a variable interest, fees (including management fees, incentive fees and performance allocations) that are customary and commensurate with the level of services provided, and where the Company does not hold other economic interests in the entity that would absorb more than an insignificant amount of the expected losses or returns of the entity, are not considered variable interests. The Company considers all economic interests, including indirect interests, to determine if a fee is considered a variable interest. For those entities where the Company holds a variable interest, the Company determines whether each of these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly by the Company. As of September 30, 2022, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $6.7 billion and $5.8 billion, respectively. As of December 31, 2021, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $6.9 billion and $6.6 billion, respectively. Except to the extent of the consolidated assets of the VIEs, the holders of the consolidated VIEs’ liabilities generally do not have recourse to the Company. The Company’s Consolidated Funds includes CLOs, which are VIEs that issue loans payable that are backed by diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for managing the collateral for the CLOs, the Company earns investment management fees, including in some cases subordinated management fees and contingent incentive fees. In cases where the Company consolidates the CLOs (primarily because of a retained interest that is significant to the CLO), those management fees have been eliminated as intercompany transactions. As of September 30, 2022, the Company held $110.7 million of investments in these CLOs which represents its maximum risk of loss. The Company’s investments in these CLOs are generally subordinated to other interests in the entities and entitle the Company to receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs have no recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds also include investment funds that are consolidated as VIEs due to bridged investment activity during the fundraising process. Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest. All significant inter-entity transactions and balances of entities consolidated have been eliminated.
Investments in Unconsolidated Variable Interest Entities	Investments in Unconsolidated Variable Interest Entities The Company holds variable interests in certain VIEs that are not consolidated because the Company is not the primary beneficiary, including its investments in certain CLOs and certain AlpInvest vehicles, as well as its strategic investment in NGP Management Company, L.L.C. (“NGP Management” and, together with its affiliates, “NGP”). Refer to Note 6 for information on the strategic investment in NGP. The Company’s involvement with such entities is in the form of direct or indirect equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to its variable interests in these unconsolidated entities.
Basis of Accounting	Basis of Accounting The accompanying financial statements are prepared in accordance with U.S. GAAP. Management has determined that the Company’s Funds are investment companies under U.S. GAAP for the purposes of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and the unrealized gains and/or losses in an investment’s fair value are recognized on a current basis in the statements of operations. Accordingly, the Funds do not consolidate their majority-owned and controlled investments (the “Portfolio Companies”). In the preparation of these unaudited condensed consolidated financial statements, the Company has retained the specialized accounting for the Funds.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on performance allocations involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements and the resulting impact on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be material.
Business Combinations	Business Combinations The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price of the acquisition is allocated to the assets acquired and liabilities assumed using the fair values determined by
Revenue Recognition and Deferred Revenue	Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers . Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. ASC 606 includes a five-step framework that requires an entity to: (i) identify the contract(s) with a customer, which includes assessing the collectibility of the consideration to which it will be entitled in exchange for the goods or services transferred to the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when the entity satisfies a performance obligation. The Company accounts for performance allocations that represent a performance-based capital allocation from fund limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets within the scope of ASC 323, Investments - Equity Method and Joint Ventures , and therefore are not in the scope of ASC 606. In accordance with ASC 323, the Company records equity method income (losses) as a component of investment income based on the change in its proportionate claim on net assets of the investment fund, including performance allocations, assuming the investment fund was liquidated as of each reporting date pursuant to each fund’s governing agreements. See Note 6 for additional information on the components of investments and investment income. Performance fees that do not meet the definition of performance-based capital allocations are in the scope of ASC 606 and are included in incentive fees in the unaudited condensed consolidated statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the Company’s valuation group, as described in Note 5, Fair Value Measurement. While the determination of who is the customer in a contractual arrangement will be made on a contract-by-contract basis, the customer will generally be the investment fund for the Company’s significant management and advisory contracts. The customer determination impacts the Company’s analysis of the accounting for contract costs. Fund Management Fees The Company provides management services to funds in which it holds a general partner interest or to funds or certain portfolio companies with which it has an investment advisory or investment management agreement. The Company considers the performance obligations in its contracts with its funds to be the promise to provide (or to arrange for third parties to provide) investment management services related to the management, policies and operations of the funds. As it relates to the Company’s performance obligation to provide investment management services, the Company typically satisfies this performance obligation over time as the services are rendered, since the funds simultaneously receive and consume the benefits provided as the Company performs the service. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised services to the funds. Management fees earned from each investment management contract over the contract life represent variable consideration because the consideration the Company is entitled to varies based on fluctuations in the basis for the management fee, for example fund net asset value (“NAV”) or assets under management (“AUM”). Given that the management fee basis is susceptible to market factors outside of the Company’s influence, management fees are constrained and, therefore, estimates of future period management fees are generally not included in the transaction price. Revenue recognized for the investment management services provided is generally the amount determined at the end of the period because that is when the uncertainty for that period is resolved. For closed-end carry funds in the Global Private Equity and Global Credit segments, management fees generally range from 1.0% to 2.0% of commitments during the fund’s investment period based on limited partners’ capital commitments to the funds. Following the expiration or termination of the investment period, management fees generally are based on the lower of cost or fair value of invested capital and the rate charged may also be reduced. These terms may vary for certain separately managed accounts, longer-dated carry funds, and other closed-end funds. The Company will receive management fees during a specified period of time, which is generally ten years from the initial closing date, or, in some instances, from the final closing date, but such termination date may be earlier in certain limited circumstances or later if extended for successive one-year periods, typically up to a maximum of two years. Depending upon the contracted terms of investment advisory or investment management and related agreements, these fees are generally called semi-annually in advance and are recognized as earned over the subsequent six month period. For certain longer-dated carry funds and certain other closed-end funds, management fees are called quarterly over the life of the funds. Within the Global Credit segment, for CLOs and other structured products, management fees generally range from 0.4% to 0.5% based on the total par amount of assets or the aggregate principal amount of the notes in the CLO and are generally due quarterly in arrears based on the terms and recognized over the respective period. Management fees for the CLOs and other structured products are governed by indentures and collateral management agreements. The Company will receive management fees for the CLOs until redemption of the securities issued by the CLOs, which is generally five Under the strategic advisory services agreement with Fortitude, the Company earns a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability and which is due quarterly in arrears. Management fees for the Company’s carry fund vehicles in the Global Investment Solutions segment generally range from 0.25% to 1.0% of the vehicle’s capital commitments during the commitment fee period of the relevant fund. Following the expiration of the commitment fee period, the management fees generally range from 0.25% to 1.0% on (i) the net invested capital; (ii) the lower of cost or net asset value of the capital invested, or (iii) the net asset value for unrealized investments. Management fees for the Global Investment Solutions carry fund vehicles are generally due quarterly in advance and recognized over the related quarter. Fund management fees exclude the reimbursement of any partnership expenses paid by the Company on behalf of the Carlyle funds pursuant to the limited partnership agreements, including amounts related to the pursuit of actual, proposed, or unconsummated investments, professional fees, expenses associated with the acquisition, holding and disposition of investments, and other fund administrative expenses. For the professional fees that the Company arranges for the investment funds, the Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control the services provided by third parties before they are transferred to the customer. Therefore, the Company concluded it is acting in the capacity of an agent. Accordingly, the reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis in general, administrative and other expenses in the unaudited condensed consolidated statements of operations. The Company also incurs certain costs, primarily employee travel and entertainment costs, employee compensation and systems costs, for which it receives reimbursement from the investment funds in connection with its performance obligation to provide investment and management services. For reimbursable travel, compensation and systems costs, the Company concluded it controls the services provided by its employees and the resources used to develop applicable systems before they are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the Company to manage the fund limited partnerships are presented on a gross basis in interest and other income in the unaudited condensed consolidated statements of operations and the expense in general, administrative and other expenses or cash-based compensation and benefits expenses in the unaudited condensed consolidated statements of operations. Incentive Fees In connection with management contracts from certain of its Global Credit funds, the Company is also entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. In such arrangements, incentive fees are recognized when the performance benchmark has been achieved. Incentive fees are variable consideration because they are contingent upon the investment vehicle achieving stipulated investment return hurdles. Investment returns are highly susceptible to market factors outside of the Company’s influence. Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of future period incentive fees are generally not included in the transaction price because these estimates are constrained. The transaction price for incentive fees is generally the amount determined at the end of each accounting period to which they relate because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback. Investment Income (Loss), including Performance Allocations Investment income (loss) represents the unrealized and realized gains and losses resulting from the Company’s equity method investments, including any associated general partner performance allocations, and other principal investments, including CLOs. General partner performance allocations consist of the allocation of profits from certain of the funds to which the Company is entitled (commonly known as carried interest). For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally entitled to a 20% allocation (or approximately 2% to 12.5% for most of the Global Investment Solutions segment carry fund vehicles) of the net realized income or gain as a carried interest after returning the invested capital, the allocation of preferred returns of generally 7% to 9% and return of certain fund costs (generally subject to catch-up provisions as set forth in the fund limited partnership agreement). These terms may vary on longer-dated funds, certain credit funds, or external co-investment vehicles. Carried interest is recognized upon appreciation of the funds’ investment values above certain return hurdles set forth in each respective partnership agreement. The Company recognizes revenues attributable to performance allocations based upon the amount that would be due pursuant to the fund partnership agreement at each period end as if the funds were terminated at that date. Accordingly, the amount recognized as investment income for performance allocations reflects the Company’s share of the gains and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the fair values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is reasonably possible that the difference could be material. Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or when the Company receives or is due cash income, such as dividends or distributions. Unrealized principal investment income (loss) results from the Company’s proportionate share of the investee’s unrealized earnings, including changes in the fair value of the underlying investment, as well as the reversal of unrealized gain (loss) at the time an investment is realized. As it relates to the Company’s investments in NGP (see Note 6), principal investment income includes the related amortization of the basis difference between the Company’s carrying value of its investment and the Company’s share of underlying net assets of the investee, as well as the compensation expense associated with compensatory arrangements provided by the Company to employees of its equity method investee. Interest Income Deferred Revenue Deferred revenue represents management fees and other revenue received prior to the balance sheet date, which has not yet been earned. Deferred revenue also includes transaction and portfolio advisory fees received by the Company that are required to offset fund management fees pursuant to the related fund agreements. The increase in the deferred revenue balance for the nine months ended September 30, 2022 was primarily driven by cash payments received in advance of the Company satisfying its performance obligations, partially offset by revenues recognized that were included in the deferred revenue balance at the beginning of the period.
Credit Losses	Credit Losses Under ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) , the Company is required to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The Company assesses the collection risk characteristics of the outstanding amounts in its due from affiliates balance into the following pools of receivables: • Reimbursable fund expenses receivables, • Management fee receivables, • Incentive fee receivables, • Transaction fee receivables, • Portfolio fee receivables, and • Notes receivable.
Compensation and Benefits	Compensation and Benefits Cash-based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses (discretionary awards and guaranteed amounts), performance payment arrangements and benefits paid and payable to Carlyle employees. Bonuses are accrued over the service period to which they relate. Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is measured at fair value on the grant date. The compensation expense for awards that vest over a future service period is recognized over the relevant service period on a straight-line basis. The compensation expense for awards that do not require future service is recognized immediately. Cash settled equity-based awards are classified as liabilities and are re-measured at the end of each reporting period. The compensation expense for awards that contain performance conditions is recognized when it is probable that the performance conditions will be achieved; in certain instances, such compensation expense may be recognized prior to the grant date of the award. The compensation expense for awards that contain market conditions is based on a grant-date fair value that factors in the probability that the market conditions will be achieved and is recognized over the requisite service period on a straight-line basis. Equity-based awards issued to non-employees are generally recognized as general, administrative and other expenses, except to the extent they are recognized as part of the Company’s equity method earnings because they are issued to employees of equity method investees. The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously recognized compensation expense. The reduction in compensation expense is determined based on the specific awards forfeited during that period. Furthermore, the Company recognizes all excess tax benefits and deficiencies as income tax benefit or expense in the unaudited condensed consolidated statements of operations. Performance Allocations and Incentive Fee Related Compensation – A portion of the performance allocations and incentive fees earned is due to employees and advisors of the Company. These amounts are accounted for as compensation expense in conjunction with the recognition of the related performance allocations and incentive fee revenue and, until paid, are recognized as a component of the accrued compensation and benefits liability. Accordingly, upon a reversal of performance allocations or incentive fee revenue, the related compensation expense, if any, is also reversed. As of September 30, 2022 and December 31, 2021, the Company had recorded a liability of $3.8 billion and $4.1 billion, respectively, related to the portion of accrued performance allocations and incentive fees due to employees and advisors, respectively, which was included in accrued compensation and benefits in the accompanying unaudited condensed consolidated balance sheets. In October 2021, the Company commenced a program under which, at the Company’s discretion, up to 20% of the realized performance allocation related compensation over a threshold amount may be distributed in fully vested, newly issued shares of the Company’s common stock. Shares issued under the program are accounted for as performance allocations and incentive fee related compensation and do not result in incremental compensation expense. The Company has determined to pause the issuance of shares pursuant to this program.
Income Taxes	Income Taxes The Carlyle Group Inc. is a corporation for U.S. federal income tax purposes and thus is subject to U.S. federal, state and local corporate income taxes. Tax positions taken by the Company are subject to periodic audit by U.S. federal, state, local and foreign taxing authorities. The interim provision for income taxes is calculated using the discrete effective tax rate method as allowed by ASC 740, Accounting for Income Taxes . The discrete method is applied when the application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. In addition, the discrete method treats the year to date period as if it was the annual period and determines the income tax expense or benefit on that basis. The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement reporting and the tax basis of assets and liabilities using enacted tax rates in effect for the period in which the difference is expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period of the change in the provision for income taxes. Further, deferred tax assets are recognized for the expected realization of available net operating loss and tax credit carry forwards. A valuation allowance is recorded on the Company’s gross deferred tax assets when it is “more likely than not” that such asset will not be realized. When evaluating the realizability of the Company’s deferred tax assets, all evidence, both positive and negative, is evaluated. Items considered in this analysis include the ability to carry back losses, the reversal of temporary differences, tax planning strategies, and expectations of future earnings. The Company accounts for the valuation allowance assessment on its deferred tax assets excluding the corporate alternative minimum tax (“CAMT”) credit carryforward without regard to the Company’s future CAMT status. Lastly, the Company accounts for the tax on global intangible low-taxed income (“GILTI”) as incurred and therefore has not recorded deferred taxes related to GILTI on its foreign subsidiaries. Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit that is “more likely than not” to be sustained upon examination. The Company analyzes its tax filing positions in all of the U.S. federal, state, local and foreign tax jurisdictions where it is required to file income tax returns, as well as for all open tax years in these jurisdictions. If, based on this analysis, the Company determines that uncertainties in tax positions exist, a liability is established, which is included in accounts payable, accrued expenses and other liabilities in the unaudited condensed consolidated financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax positions in the provision for income taxes. If recognized, the entire amount of unrecognized tax positions would be recorded as a reduction in the provision for income taxes.
Non-controlling Interests	Non-controlling Interests Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third-party investors. These interests are adjusted for general partner allocations which occur during the reporting period. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. Transaction costs incurred in connection with such changes in ownership of a subsidiary are recorded as a direct charge to equity.
Earnings Per Common Share	Earnings Per Common Share The Company computes earnings per common share in accordance with ASC 260, Earnings Per Share . Basic earnings per common share is calculated by dividing net income (loss) attributable to the common shares of the Company by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share reflects the assumed conversion of all dilutive securities. The Company applies the treasury stock method to determine the dilutive weighted-average common shares outstanding for certain equity-based compensation awards. For certain equity-based compensation awards that contain performance or market conditions, the number of contingently issuable common shares is included in diluted earnings per common share based on the number of common shares, if any, that would be issuable under the terms of the awards if the end of the reporting period were the end of the contingency period, if the result is dilutive.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The underlying entities that the Company manages and invests in (and in certain cases, consolidates) are primarily investment companies which account for their investments at estimated fair value. The fair value measurement accounting guidance under ASC Topic 820, Fair Value Measurement (“ASC 820”), establishes a hierarchical disclosure framework which ranks the observability of market price inputs used in measuring financial instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of financial instrument, the characteristics specific to the financial instrument and the state of the marketplace, including the existence and transparency of transactions between market participants. Financial instruments with readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, will generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. Financial instruments measured and reported at fair value are classified and disclosed based on the observability of inputs used in the determination of fair values, as follows: • Level I – inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The type of financial instruments in this category include unrestricted securities, such as equities and derivatives, listed in active markets. The Company does not adjust the quoted price for these instruments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price. • Level II – inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, and certain over-the-counter derivatives where the fair value is based on observable inputs. • Level III – inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. The types of financial instruments in this category include investments in privately-held entities, non-investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives where the fair value is based on unobservable inputs. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. In certain cases, debt and equity securities (including corporate treasury investments) are valued on the basis of prices from an orderly transaction between market participants provided by reputable dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices, market transactions in comparable investments and various relationships between investments. In the absence of observable market prices, the Company values its investments and its funds’ investments using valuation methodologies applied on a consistent basis. For some investments little market activity may exist. Management’s determination of fair value is then based on the best information available in the circumstances and may incorporate management’s own assumptions and involve a significant degree of judgment, taking into consideration a combination of internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks. Investments for which market prices are not observable include private investments in the equity and debt of operating companies and real assets, CLO investments and CLO loans payable and fund investments. The valuation technique for each of these investments is described below: Investments in Operating Companies and Real Assets – The fair values of private investments in operating companies and real assets are generally determined by reference to the income approach (including the discounted cash flow method and the income capitalization method) and the market approach (including the comparable publicly traded company method and the comparable transaction method). Valuations under these approaches are typically derived by reference to investment-specific inputs (such as projected cash flows, earnings before interest, taxes, depreciation and amortization (“EBITDA”), and net operating income) combined with market-based inputs (such as discount rates, EBITDA multiples and capitalization rates). In many cases the investment-specific inputs are unaudited at the time received. Management may also adjust the market-based inputs to account for differences between the subject investment and the companies, asset or investments used to derive the market-based inputs. Adjustments to observable valuation measures are frequently made upon the initial investment to calibrate the initial investment valuation to industry observable inputs. Such adjustments are made to align the investment to observable industry inputs for differences in size, profitability, projected growth rates, geography, capital structure, and other factors as applicable. The adjustments are then reviewed with each subsequent valuation to assess how the investment has evolved relative to the observable inputs. Additionally, the investment may be subject to certain specific risks and/or development milestones which are also taken into account in the valuation assessment. Option pricing models and similar tools may also be considered but do not currently drive a significant portion of operating company or real asset valuations and are used primarily to value warrants, derivatives, certain restrictions and other atypical investment instruments. Credit-Oriented Investments – The fair values of credit-oriented investments (including corporate treasury investments) are generally determined on the basis of prices between market participants provided by reputable dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices, market transactions in comparable investments and various relationships between investments. Specifically, for investments in distressed debt and corporate loans and bonds, the fair values are generally determined by valuations of comparable investments. In some instances, the Company may utilize other valuation techniques, including the discounted cash flow method. CLO Investments and CLO Loans Payable – The Company measures the financial liabilities of its consolidated CLOs based on the fair value of the financial assets of its consolidated CLOs, as the Company believes the fair value of the financial assets are more observable. The fair values of the CLO loan and bond assets are primarily based on quotations from reputable dealers or relevant pricing services. In situations where valuation quotations are unavailable, the assets are valued based on similar securities, market index changes, and other factors. The Company performs certain procedures to ensure the reliability of the quotations from pricing services for its CLO assets and CLO structured asset positions, which generally includes corroborating prices with a discounted cash flow analysis. Generally, the loan and bond assets of the CLOs are not publicly traded and are classified as Level III. The fair values of the CLO structured asset positions are determined based on both discounted cash flow analyses and third party quotes. Those analyses consider the position size, liquidity, current financial condition of the CLOs, the third party financing environment, reinvestment rates, recovery lags, discount rates and default forecasts and are compared to broker quotations from market makers and third party dealers. The Company measures the CLO loan payables held by third party beneficial interest holders on the basis of the fair value of the financial assets of the CLO and the beneficial interests held by the Company. The Company continues to measure the CLO loans payable that it holds at fair value based on relevant pricing services or discounted cash flow analyses, as described above. Fund Investments – The Company’s primary and secondary investments in external funds are valued based on its proportionate share of the net assets provided by the third party general partners of the underlying fund partnerships based on the most recent available information which typically has a lag of up to 90 days. The terms of the investments generally preclude the ability to redeem the investment. Distributions from these investments will be received as the underlying assets in the funds are liquidated, the timing of which cannot be readily determined. Investment professionals with responsibility for the underlying investments are responsible for preparing the investment valuations pursuant to the policies, methodologies and templates prepared by the Company’s valuation group, which is a team made up of dedicated valuation professionals reporting to the Company’s chief accounting officer. The valuation group is responsible for maintaining the Company’s valuation policy and related guidance, templates and systems that are designed to be consistent with the guidance found in ASC 820. These valuations, inputs and preliminary conclusions are reviewed by the fund accounting teams. The valuations are then reviewed and approved by the respective fund valuation subcommittees, which include the respective fund head(s), segment head, chief financial officer and chief accounting officer, as well as members of the valuation group. The valuation group compiles the aggregate results and significant matters and presents them for review and approval by the global valuation committee, which includes the Company’s chief executive officer, chief risk officer, chief financial officer, chief accounting officer, and the business segment heads, and observed by the chief compliance officer, the director of internal audit, the Company’s audit committee and others. Additionally, each quarter a sample of valuations are reviewed by external valuation firms. Valuations of the funds’ investments are used in the calculation of accrued performance allocations, or “carried interest.”
Investments, at Fair Value and Corporate Treasury Investments	Investments, at Fair Value Investments include (i) the Company’s ownership interests (typically general partner interests) in the Funds, (ii) strategic investments made by the Company (both of which are accounted for as equity method investments), (iii) the investments held by the Consolidated Funds (which are presented at fair value in the Company’s unaudited condensed consolidated financial statements), and (iv) certain credit-oriented investments, including investments in the CLOs and the preferred securities of Carlyle Secured Lending, Inc. (“CSL,” formerly known as “TCG BDC, Inc.,” the preferred securities of which are referred to as the “BDC Preferred Shares”) (which are accounted for as trading securities). Upon the sale of a security or other investment, the realized net gain or loss is computed on a weighted average cost basis, with the exception of the investments held by the CLOs, which compute the realized net gain or loss on a first in, first out basis. Securities transactions are recorded on a trade date basis. Corporate Treasury Investments Corporate treasury investments represent investments in U.S. Treasury and government agency obligations, commercial paper, certificates of deposit, other investment grade securities and other investments with original maturities of greater than three months when purchased. These investments are accounted for as trading securities in which changes in the fair value of each investment are recorded through investment income (loss). Any interest earned on debt investments is recorded through interest and other income.
Equity Method Investments	Equity Method Investments The Company accounts for all investments in which it has or is otherwise presumed to have significant influence, including investments in the unconsolidated Funds and strategic investments, using the equity method of accounting. The carrying value of equity method investments is determined based on amounts invested by the Company, adjusted for the equity in earnings or losses of the investee (including performance allocations) allocated based on the respective partnership agreement, less distributions received. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.
Cash and Cash Equivalents	Cash and Cash EquivalentsCash and cash equivalents include cash held at banks and cash held for distributions, including investments with original maturities of less than three months when purchased.
Cash and Cash Equivalents Held at Consolidated Funds	Cash and Cash Equivalents Held at Consolidated Funds Cash and cash equivalents held at Consolidated Funds consists of cash and cash equivalents held by the Consolidated Funds, which, although not legally restricted, is not available to fund the general liquidity needs of the Company.
Restricted Cash	Restricted CashRestricted cash primarily represents cash held by the Company’s foreign subsidiaries due to certain government regulatory capital requirements as well as certain amounts held on behalf of Carlyle funds.
Derivative Instruments	Derivative InstrumentsThe Company uses derivative instruments primarily to reduce its exposure to changes in foreign currency exchange rates. Derivative instruments are recognized at fair value in the unaudited condensed consolidated balance sheets with changes in fair value recognized in the unaudited condensed consolidated statements of operations for all derivatives not designated as hedging instruments.
Securities Sold Under Agreements to Repurchase	Securities Sold Under Agreements to Repurchase As it relates to certain European CLOs sponsored by the Company, securities sold under agreements to repurchase (“repurchase agreements”) are accounted for as collateralized financing transactions. The Company provides securities to counterparties to collateralize amounts borrowed under repurchase agreements on terms that permit the counterparties to repledge or resell the securities to others. As of September 30, 2022, $243.9 million of securities were transferred to counterparties under repurchase agreements and are included within investments in the unaudited condensed consolidated balance sheets. Cash received under repurchase agreements is recognized as a liability within debt obligations in the unaudited condensed consolidated balance sheets. Interest expense is recognized on an effective yield basis and is included within interest expense in the unaudited condensed consolidated statements of operations.
Fixed Assets	Fixed Assets Fixed assets consist of furniture, fixtures and equipment, leasehold improvements, and computer hardware and software and are stated at cost, less accumulated depreciation and amortization. Depreciation is recognized on a straight-line method over three
Leases	Leases The Company accounts for its leases in accordance with ASU 2016-2, Leases (Topic 842) , and recognizes a lease liability and right-of-use asset in the condensed consolidated balance sheet for contracts that it determines are leases or contain a lease. The Company’s leases primarily consist of operating leases for office space in various countries around the world. The Company also has operating leases for office equipment and vehicles, which are not significant. The Company does not separate non-lease components from lease components for its office space and equipment operating leases and instead accounts for each separate lease component and its associated non-lease component as a single lease component. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. The Company’s right-of-use assets and lease liabilities are recognized at lease commencement based on the present value of lease payments over the lease term. Lease right-of-use assets include initial direct costs incurred by the Company and are presented net of deferred rent and lease incentives. Absent an implicit interest rate in the lease, the Company uses its incremental borrowing rate, adjusted for the effects of collateralization, based on the information available at commencement in determining the present value of lease payments. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Lease right-of-use assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company does not recognize a lease liability or right-of-use asset on the balance sheet for short-term leases. Instead, the Company recognizes short-term lease payments as an expense on a straight-line basis over the lease term. A short-term lease is defined as a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise. When determining whether a lease qualifies as a short-term lease, the Company evaluates the lease term and the purchase option in the same manner as all other leases.
Intangible Assets and Goodwill	Intangible Assets and Goodwill The Company’s intangible assets consist of acquired contractual rights to earn future fee income, including management and advisory fees, and customer relationships. Finite-lived intangible assets are amortized over their estimated useful lives, which range from four Goodwill represents the excess of cost over the identifiable net assets of businesses acquired and is recorded in the functional currency of the acquired entity. Goodwill is recognized as an asset and is reviewed for impairment annually as of October 1st and between annual tests when events and circumstances indicate that impairment may have occurred.
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)The Company’s accumulated other comprehensive income (loss) is comprised of foreign currency translation adjustments and gains and losses on defined benefit plans sponsored by AlpInvest.
Foreign Currency Translation	Foreign Currency TranslationNon-U.S. dollar denominated assets and liabilities are translated at period-end rates of exchange, and the unaudited condensed consolidated statements of operations are translated at rates of exchange in effect throughout the period.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on the Company’s consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The amendments in this update provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope , to clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. An entity may elect to adopt the amendments in ASU 2020-04 and ASU 2021-01 at any time after March 12, 2020 but no later than December 31, 2022. The expedients and exceptions provided by the amendments do not apply to contract modifications and hedging relationships entered into or evaluated after December 31, 2022, except for hedging transactions as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. The Company does not expect this guidance to impact its consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which modifies ASC 805 to require an acquiring entity in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. Under current GAAP, an acquirer generally recognizes such items at fair value on the acquisition date. This guidance is effective for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company adopted this guidance on July 1, 2022, and applied the guidance prospectively to business combinations that occurred after this date. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2022
Accounting Policies [Abstract]
Assets recognized in consolidated balance sheets related to non-consolidated VIEs	The assets recognized in the Company’s consolidated balance sheets related to the Company’s variable interests in these non-consolidated VIEs were as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Investments $ 1,096.8 $ 901.9 Accrued performance revenues 391.1 368.7 Management fee receivables 44.3 27.2 Total $ 1,532.2 $ 1,297.8
Components of accumulated other comprehensive income (loss)	The components of accumulated other comprehensive income (loss) as of September 30, 2022 and December 31, 2021 were as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Currency translation adjustments $ (420.0) $ (231.8) Unrealized losses on defined benefit plans (19.7) (15.7) Total $ (439.7) $ (247.5)

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
Acquisitions (Tables)	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of estimated fair values of the assets acquired and liabilities	The acquisition-date fair value of the consideration transferred and the estimated fair values of the assets acquired and liabilities assumed at the acquisition date are as follows (Dollars in millions): Acquisition-date fair value of consideration transferred (1) Cash $ 160.6 Shares of common stock (see Note 15) 25.0 Total consideration transferred $ 185.6 Estimated fair value of assets acquired and liabilities assumed Cash and receivables $ 11.0 Investments in Abingworth funds 3.8 Lease right-of-use assets, fixed assets, and other assets, net 3.7 Deferred tax assets 6.7 Finite-lived intangible assets 88.0 Goodwill 90.9 Lease liabilities (2.7) Accrued expenses, accrued compensation and benefits, and other liabilities (11.6) Non-controlling interests in Abingworth entities (2) (4.2) Total $ 185.6 (1) The value of the consideration at acquisition is subject to certain post-closing adjustments. (2) Represents assets held by Abingworth entities which are consolidated VIEs. These assets are attributable to employees and are therefore reflected as non-controlling interests, and include investments in funds in which the Company did not acquire direct economic interests, which are presented as investments in Abingworth funds above.
Schedule of acquisition-date fair value of consideration transferred and estimated fair values of assets acquired and liabilities assumed	The acquisition-date fair value of the consideration transferred and the allocation of cost to the assets acquired and liabilities assumed at the acquisition date are as follows (Dollars in millions): Acquisition-date fair value of consideration transferred Cash $ 618.4 Shares of common stock (see Note 15) 194.5 Total consideration transferred $ 812.9 Allocation of cost to assets acquired and liabilities assumed Acquired contractual rights $ 794.3 Acquired CLO senior and subordinated notes 175.9 Assumed CLO borrowings outstanding (see Note 8) (157.3) Total cost of assets acquired, net of liabilities assumed $ 812.9

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
Fair Value Measurement (Tables)	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Summary of assets and liabilities measured at fair value on recurring basis	The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of September 30, 2022: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds: Equity securities (1) $ — $ — $ 511.9 $ 511.9 Bonds — — 560.8 560.8 Loans — — 5,054.7 5,054.7 — — 6,127.4 6,127.4 Investments in CLOs and other: Investments in CLOs — — 499.6 499.6 Other investments (2) 1.3 41.7 64.6 107.6 1.3 41.7 564.2 607.2 Corporate treasury investments Commercial paper and other — 69.5 — 69.5 Subtotal $ 1.3 $ 111.2 $ 6,691.6 $ 6,804.1 Investments measured at net asset value (3) 294.6 Total $ 7,098.7 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,303.7 $ 5,303.7 Foreign currency forward contracts — 29.5 — 29.5 Total (5) $ — $ 29.5 $ 5,303.7 $ 5,333.2 (1) This balance includes $453.4 million related to investments that have been bridged by the Company to investment funds that are actively fundraising and are accounted for as consolidated VIEs as of September 30, 2022. (2) The Level III balance excludes a $54.9 million corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (3) Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $282.3 million relates to investments of Consolidated Funds. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $160.5 million of senior notes measured at cost and a $52.7 million revolving credit balance, both related to loans payable of Consolidated Funds. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of December 31, 2021: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds: Equity securities $ — $ — $ 17.9 $ 17.9 Bonds — — 599.5 599.5 Loans — — 5,898.1 5,898.1 — — 6,515.5 6,515.5 Investments in CLOs — — 361.1 361.1 Other investments (1) 1.5 45.6 78.7 125.8 Foreign currency forward contracts — 1.4 — 1.4 Subtotal $ 1.5 $ 47.0 $ 6,955.3 $ 7,003.8 Investments measured at net asset value (2) 161.7 Total $ 7,165.5 Liabilities Loans payable of Consolidated Funds (3) $ — $ — $ 5,811.0 $ 5,811.0 Foreign currency forward contracts — 0.7 — 0.7 Total (4) $ — $ 0.7 $ 5,811.0 $ 5,811.7 (1) The Level III balance excludes a corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . In December 2021, the Company remeasured this investment to a fair value of $54.9 million due to an observable price change. As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (2) Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $145.5 million relates to investments of Consolidated Funds. (3) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (4) Total liabilities balance excludes a $79.0 million revolving credit balance related to loans payable of Consolidated Funds.
Changes in Level III financial assets measured at fair value	The changes in financial instruments measured at fair value for which the Company has used Level III inputs to determine fair value are as follows (Dollars in millions): Financial Assets Three Months Ended September 30, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 12.4 $ 669.8 $ 5,516.8 $ 508.6 $ 65.1 $ 6,772.7 Purchases 518.5 46.6 473.9 19.9 — 1,058.9 Sales and distributions — (92.6) (552.4) (7.2) (0.9) (653.1) Settlements — — (130.4) — — (130.4) Realized and unrealized gains (losses), net Included in earnings (18.3) (21.6) (30.0) 7.1 0.4 (62.4) Included in other comprehensive income (0.7) (41.4) (223.2) (28.8) — (294.1) Balance, end of period $ 511.9 $ 560.8 $ 5,054.7 $ 499.6 $ 64.6 $ 6,691.6 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (18.3) $ (22.1) $ (35.7) $ 4.5 $ 0.4 $ (71.2) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.7) $ (34.3) $ (202.2) $ (28.8) $ — $ (266.0) Financial Assets Nine Months Ended September 30, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 17.9 $ 599.5 $ 5,898.1 $ 361.1 $ 78.7 $ 6,955.3 Purchases 518.6 429.0 2,014.8 251.9 0.9 3,215.2 Sales and distributions (7.2) (320.2) (1,566.5) (36.1) (3.8) (1,933.8) Settlements — (0.3) (492.1) — — (492.4) Realized and unrealized gains (losses), net Included in earnings (15.9) (59.6) (277.4) (17.9) (11.2) (382.0) Included in other comprehensive income (1.5) (87.6) (522.2) (59.4) — (670.7) Balance, end of period $ 511.9 $ 560.8 $ 5,054.7 $ 499.6 $ 64.6 $ 6,691.6 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (16.7) $ (57.0) $ (266.3) $ (17.9) $ (11.2) $ (369.1) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (1.3) $ (55.2) $ (422.7) $ (59.4) $ — $ (538.6) Financial Assets Three Months Ended September 30, 2021 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 18.3 $ 542.0 $ 5,543.6 $ 353.1 $ 78.4 $ 6,535.4 Consolidation of funds (1) 3.3 — 490.4 (3.0) — 490.7 Purchases 0.1 108.1 1,058.4 9.6 — 1,176.2 Sales and distributions (1.2) (44.0) (781.0) (14.5) (0.4) (841.1) Settlements — (0.2) (378.4) — — (378.6) Realized and unrealized gains (losses), net Included in earnings (1.3) (11.3) 13.3 6.2 0.7 7.6 Included in other comprehensive income (0.3) (13.5) (93.4) (6.7) — (113.9) Balance, end of period $ 18.9 $ 581.1 $ 5,852.9 $ 344.7 $ 78.7 $ 6,876.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (1.9) $ 1.5 $ (4.2) $ 6.2 $ 1.1 $ 2.7 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.3) $ (13.7) $ (92.3) $ (6.7) $ — $ (113.0) Financial Assets Nine Months Ended September 30, 2021 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments (2) Total Balance, beginning of period $ 9.4 $ 550.4 $ 5,497.1 $ 489.4 $ 81.4 $ 6,627.7 Deconsolidation/consolidation of funds (1) 5.7 — 314.2 23.1 — 343.0 Purchases 0.6 472.0 3,375.3 71.7 — 3,919.6 Sales and distributions (3.5) (405.2) (2,199.0) (238.4) (16.5) (2,862.6) Settlements — (3.8) (1,020.2) — — (1,024.0) Realized and unrealized gains (losses), net Included in earnings 7.3 (1.3) 103.1 2.7 13.8 125.6 Included in other comprehensive income (0.6) (31.0) (217.6) (3.8) — (253.0) Balance, end of period $ 18.9 $ 581.1 $ 5,852.9 $ 344.7 $ 78.7 $ 6,876.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ 5.2 $ 7.7 $ 61.1 $ 2.3 $ 14.0 $ 90.3 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.4) $ (22.0) $ (185.3) $ (3.8) $ — $ (211.5) (1) As a result of the consolidation of one CLO during the three months ended September 30, 2021 and two CLOs during the nine months ended September 30, 2021, the investments that the Company held in those CLOs are now eliminated in consolidation and no longer included in investments in CLOs and other. As a result of the deconsolidation of one CLO during the nine months ended September 30, 2021, the investment that the Company held in that CLO is no longer eliminated in consolidation and is now included in investments in CLOs and other. (2) The beginning balance of Other Investments has been revised to reflect the exclusion of Fund Investments measured at fair value using the NAV per share practical expedient from the fair value hierarchy.
Changes in Level III financial liabilities measured at fair value	Financial Liabilities Loans Payable of Consolidated Funds Three Months Ended September 30, 2022 2021 Balance, beginning of period $ 5,757.8 $ 5,373.9 Consolidation of funds — 480.0 Borrowings 26.4 1,133.0 Paydowns (1.8) (712.0) Sales (193.9) (237.5) Realized and unrealized (gains) losses, net Included in earnings (40.8) (2.4) Included in other comprehensive income (244.0) (96.7) Balance, end of period $ 5,303.7 $ 5,938.3 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ (41.3) $ 3.7 Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ (235.5) $ (127.0) Financial Liabilities Loans Payable of Consolidated Funds Nine Months Ended September 30, 2022 2021 Balance, beginning of period $ 5,811.0 $ 5,563.0 Deconsolidation/consolidation of funds — 360.8 Borrowings 1,597.7 1,966.6 Paydowns (419.1) (1,303.0) Sales (863.4) (515.2) Realized and unrealized (gains) losses, net Included in earnings (268.3) 90.7 Included in other comprehensive income (554.2) (224.6) Balance, end of period $ 5,303.7 $ 5,938.3 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ (262.6) $ 98.1 Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ (567.0) $ (281.4)
Summary of quantitative information about Level III inputs	The following table summarizes quantitative information about the Company’s Level III inputs as of September 30, 2022: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) September 30, 2022 Assets Investments of Consolidated Funds: Equity securities $ 10.4 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 17.00 (0.43) 445.2 Discounted Cash Flow Discount Rates 9% - 10% (9%) 56.3 Other (1) N/A N/A Bonds 560.8 Consensus Pricing Indicative Quotes (% of Par) 55 - 125 (89) Loans 4,853.1 Consensus Pricing Indicative Quotes (% of Par) 0 - 103 (93) 24.0 Discounted Cash Flow Discount Rates 9% - 12% (10%) 116.3 Discounted Cash Flow Discount Rates 7% - 10% (8%) 61.3 Consensus Pricing Indicative Quotes (% of Par) 98% -98% (98%) 6,127.4 Investments in CLOs: Senior secured notes 430.7 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 74 - 100 (95) Discount Margins (Basis Points) 155 - 1,700 (336) Default Rates 1% - 3% (2%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 68.9 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 21 - 66 (49) Discount Rates 13% - 25% (19%) Default Rates 1% - 3% (2%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 61.2 Market Yield Analysis Market Yield 7% - 7% (7%) Aviation subordinated notes 3.4 Discounted Cash Flow Discount Rates 22% - 22% (22%) Total $ 6,691.6 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,085.8 Other (2) N/A N/A Subordinated notes and preferred shares 217.9 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 19 - 103 (43) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Total $ 5,303.7 (1) Fair value approximates transaction price that was in close proximity to the reporting date. (2) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2021: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) December 31, 2021 Assets Investments of Consolidated Funds: Equity securities $ 17.9 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 84.22 (0.63) Bonds 599.5 Consensus Pricing Indicative Quotes (% of Par) 93 - 107 (99) Loans 5,766.0 Consensus Pricing Indicative Quotes (% of Par) 35 - 106 (98) 65.1 Discounted Cash Flow Discount Rates 4% - 8% (5%) 67.0 Market Yield Analysis Market Yields 3% - 8% (5%) 6,515.5 Investments in CLOs: Senior secured notes 289.7 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 86 - 101 (99) Discount Margins (Basis Points) 50 - 1,330 (245) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 71.5 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 46 - 97 (63) Discount Rate 14% - 22% (19%) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 72.5 Market Yield Analysis Market Yield 7% - 7% (7%) Aviation subordinated notes 6.1 Discounted Cash Flow Discount Rates 18% - 18% (18%) Total $ 6,955.3 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,561.1 Other (1) N/A N/A Subordinated notes and preferred shares 249.9 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 40 - 97 (61) Discount Rates 14% - 22% (19%) Default Rates 1% - 2% (1%) Recovery Rates 50% - 70% (60%) Total $ 5,811.0 (1) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services.

Investments (Tables)

Investments (Tables)	9 Months Ended
Investments (Tables)	Sep. 30, 2022
Investments [Abstract]
Schedule of investments	Investments consist of the following: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued performance allocations $ 7,428.7 $ 8,133.0 Principal equity method investments, excluding performance allocations 2,883.8 2,128.6 Principal investments in CLOs 499.6 361.1 Other investments 186.1 209.3 Total $ 10,998.2 $ 10,832.0
Components of accrued performance fees	The components of accrued performance allocations are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity $ 5,866.3 $ 6,412.8 Global Credit 220.1 300.3 Global Investment Solutions (1) 1,342.3 1,419.9 Total $ 7,428.7 $ 8,133.0
Components of accrued giveback obligations	The components of the accrued giveback obligations are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity $ (18.4) $ (18.4) Global Credit (22.5) (11.8) Total $ (40.9) $ (30.2)
Schedule of equity method investments	Principal investments are related to the following segments: As of September 30, 2022 December 31, 2021 (Dollars in millions) Global Private Equity (1) $ 1,832.8 $ 1,231.2 Global Credit (2) 960.3 819.7 Global Investment Solutions 90.7 77.7 Total $ 2,883.8 $ 2,128.6 (1) The balance includes $988.2 million and $436.9 million as of September 30, 2022 and December 31, 2021, respectively, related to the Company’s equity method investments in NGP. (2) As of September 30, 2022, the balance includes $645.3 million and $184.2 million, respectively, related to the Company’s strategic investments in Fortitude and iStar through Carlyle-affiliated investment funds. As of December 31, 2021, the balance includes $715.7 million related to the Company’s strategic investment in Fortitude. The Company’s investments in NGP as of September 30, 2022 and December 31, 2021 are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Investment in NGP Management $ 370.1 $ 371.8 Investments in NGP general partners - accrued performance allocations 536.0 3.8 Principal investments in NGP funds 82.1 61.3 Total investments in NGP $ 988.2 $ 436.9 Carlyle’s income (loss) from its principal equity method investments consists of: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Global Private Equity $ 124.7 $ 63.8 $ 698.8 $ 272.9 Global Credit 26.8 47.5 (134.6) 120.6 Global Investment Solutions (0.6) 6.9 6.6 21.4 Total $ 150.9 $ 118.2 $ 570.8 $ 414.9
Schedule of net investment income (loss)	The net investment income (loss) recognized in the Company’s unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Management fee-related revenues from NGP Management $ 18.1 $ 18.2 $ 52.7 $ 54.9 Expenses related to the investment in NGP Management (3.5) (2.9) (8.9) (8.1) Amortization of basis differences from the investment in NGP Management (0.4) (0.7) (1.1) (2.1) Net investment income from NGP Management $ 14.2 $ 14.6 $ 42.7 $ 44.7
Components of investment income (loss)	The components of investment income (loss) are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Performance allocations Realized $ 770.5 $ 1,018.1 $ 1,579.0 $ 1,645.6 Unrealized (472.4) (43.6) (232.8) 3,195.7 298.1 974.5 1,346.2 4,841.3 Principal investment income (loss) from equity method investments (excluding performance allocations) Realized 70.6 87.7 34.3 175.5 Unrealized 80.3 30.5 536.5 239.4 150.9 118.2 570.8 414.9 Principal investment income (loss) from investments in CLOs and other investments Realized 6.2 4.4 9.4 3.9 Unrealized (32.9) 37.8 (79.7) 58.4 (26.7) 42.2 (70.3) 62.3 Total $ 422.3 $ 1,134.9 $ 1,846.7 $ 5,318.5
Performance allocations included in revenues	The performance allocations included in revenues are derived from the following segments: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Global Private Equity $ 237.2 $ 777.8 $ 1,106.4 $ 4,142.5 Global Credit 27.2 27.4 (3.6) 124.6 Global Investment Solutions 33.7 169.3 243.4 574.2 Total $ 298.1 $ 974.5 $ 1,346.2 $ 4,841.3
Components of interest and other income of consolidated funds	The components of interest and other income of Consolidated Funds are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Interest income from investments $ 72.5 $ 56.9 $ 188.2 $ 170.4 Other income 7.2 5.2 16.4 14.9 Total $ 79.7 $ 62.1 $ 204.6 $ 185.3
Components of net investment gains (losses) of consolidated funds	The components of net investment gains (losses) of Consolidated Funds are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Gains (losses) from investments of Consolidated Funds $ (71.2) $ (2.5) $ (319.3) $ 100.3 Gains (losses) from liabilities of CLOs 40.9 2.4 268.3 (90.7) Total $ (30.3) $ (0.1) $ (51.0) $ 9.6
Schedule of realized and unrealized gains (losses) earned from investments of consolidated funds	The following table presents realized and unrealized gains (losses) earned from investments of the Consolidated Funds: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Realized gains (losses) $ (9.3) $ (10.7) $ (13.1) $ 6.5 Net change in unrealized gains (losses) (61.9) 8.2 (306.2) 93.8 Total $ (71.2) $ (2.5) $ (319.3) $ 100.3

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
Intangible Assets and Goodwill (Tables)	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Carrying amount of intangible assets	The following table summarizes the carrying amount of intangible assets as of September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Acquired contractual rights $ 914.6 $ 48.0 Accumulated amortization (92.5) (26.4) Finite-lived intangible assets, net 822.1 21.6 Goodwill 103.0 13.3 Intangible Assets, net $ 925.1 $ 34.9
Schedule of estimated amortization expense	The following table summarizes the expected amortization expense for 2022 through 2026 and thereafter (Dollars in millions): 2022 (excluding the nine months ended September 30, 2022) $ 33.1 2023 130.4 2024 130.5 2025 130.4 2026 130.3 Thereafter 267.4 $ 822.1

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
Borrowings (Tables)	Sep. 30, 2022
Debt Instrument [Line Items]
Schedule of debt obligations	The Company borrows and enters into credit agreements for its general operating and investment purposes. The Company’s debt obligations consist of the following: September 30, 2022 December 31, 2021 Borrowing Carrying Borrowing Carrying (Dollars in millions) CLO Borrowings (See below) $ 384.4 $ 381.6 $ 222.6 $ 219.0 5.625% Senior Notes Due 3/30/2043 600.0 600.6 600.0 600.6 5.650% Senior Notes Due 9/15/2048 350.0 346.3 350.0 346.1 3.500% Senior Notes Due 9/19/2029 425.0 421.9 425.0 421.6 4.625% Subordinated Notes Due 5/15/2061 500.0 484.6 500.0 484.3 Total debt obligations $ 2,259.4 $ 2,235.0 $ 2,097.6 $ 2,071.6
Summary of loans payable of consolidated funds	As of September 30, 2022 and December 31, 2021, the following borrowings were outstanding, which includes preferred shares classified as liabilities (Dollars in millions): As of September 30, 2022 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,466.6 $ 5,085.8 2.62 % 9.77 Subordinated notes, preferred shares and other 146.9 217.9 N/A (2) 9.97 Total $ 5,613.5 $ 5,303.7 As of December 31, 2021 Borrowing Fair Value Weighted Weighted Senior secured notes $ 5,585.4 $ 5,561.1 1.68 % 10.25 Subordinated notes, preferred shares and other 317.6 249.9 N/A (2) 10.41 Total $ 5,903.0 $ 5,811.0 (1) Borrowing Outstanding as of September 30, 2022 includes $160.5 million of senior secured notes that are carried at par value. The fair value of these senior secured notes at September 30, 2022 approximated par value based on current market rates for similar debt instruments. These senior secured notes are classified as Level III within the fair value hierarchy. (2) The subordinated notes and preferred shares do not have contractual interest rates, but instead receive distributions from the excess cash flows of the CLOs.
CLO Borrowings
Debt Instrument [Line Items]
Schedule of debt obligations	The Company’s outstanding CLO borrowings consist of the following (Dollars in millions): Formation Date Borrowing Outstanding September 30, 2022 Borrowing Outstanding December 31, 2021 Maturity Date (1) Interest Rate as of September 30, 2022 February 28, 2017 $ 35.4 $ 51.3 November 17, 2031 2.33% (2) June 29, 2017 54.8 — July 20, 2030 4.36% (4),(7) December 6, 2017 43.8 — January 15, 2031 3.88% (5),(7) March 15, 2019 1.6 1.9 March 15, 2032 8.11% (3) August 20, 2019 3.5 4.1 August 15, 2032 5.06% (3) September 15, 2020 17.4 20.3 April 15, 2033 1.59% (3) January 8, 2021 18.2 21.3 January 15, 2034 2.49% (3) March 9, 2021 17.4 20.3 August 15, 2030 1.69% (3) March 30, 2021 16.4 19.1 March 15, 2032 1.71% (3) April 21, 2021 3.2 3.7 April 15, 2033 5.85% (3) April 28, 2021 6.5 — April 28, 2023 2.03% (6),(7) May 21, 2021 13.7 15.9 November 17, 2031 1.36% (3) June 4, 2021 18.3 21.3 January 16, 2034 2.28% (3) June 10, 2021 1.2 1.4 November 17, 2031 2.85% (3) July 15, 2021 13.7 — July 15, 2034 2.30% (3),(7) July 20, 2021 18.2 — July 20, 2031 2.28% (3),(7) August 4, 2021 14.8 17.2 August 15, 2032 2.30% (3) October 27, 2021 21.3 24.8 October 15, 2035 2.40% (3) November 5, 2021 12.7 — January 14, 2034 2.09% (3),(7) January 6, 2022 18.4 — February 15, 2035 2.70% (3) February 22, 2022 18.4 — November 10, 2035 2.75% (3) July 13, 2022 15.5 — February 15, 2035 3.61% $ 384.4 $ 222.6 (1) Maturity date is earlier of date indicated or the date that the CLO is dissolved. (2) Outstanding borrowing of €36.1 million; incurs interest at EURIBOR plus applicable margins as defined in the agreement. (3) Incurs interest at the average effective interest rate of each class of purchased securities plus 0.50% spread percentage. (4) Incurs interest at LIBOR plus 1.65%. (5) Incurs interest at LIBOR plus 1.37%. (6) Incurs interest at EURIBOR plus 1.35%. (7) The respective CLO assets were purchased in connection with the asset acquisition from CBAM in March 2022 (see Note 4). The formation date listed is the original formation date of the related CLO.
Senior Notes
Debt Instrument [Line Items]
Schedule of debt obligations	Senior Notes Certain indirect subsidiaries of the Company have issued long term borrowings in the form of senior notes, on which interest is payable semi-annually in arrears. The following table provides information regarding these senior notes (Dollars in millions): Interest Expense Fair Value (1) Three Months Ended Nine Months Ended Aggregate Principal Amount September 30, 2022 December 31, 2021 2022 2021 2022 2021 3.875% Senior Notes Due 2/1/2023 (2) $ — $ — $ — $ — $ 2.5 $ — $ 7.5 5.625% Senior Notes Due 3/30/2043 (3) 600.0 515.5 795.5 8.4 8.4 25.3 25.3 5.650% Senior Notes Due 9/15/2048 (4) 350.0 312.6 484.7 5.0 5.0 14.9 14.9 3.500% Senior Notes Due 9/19/2029 (5) 425.0 361.6 457.4 3.8 3.8 11.5 11.5 $ 17.2 $ 19.7 $ 51.7 $ 59.2 (1) Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within the fair value hierarchy. (2) Issued in January 2013 at 99.966% of par. In November 2021, the Company completed the redemption of these notes, as discussed below. (3) Issued $400.0 million in aggregate principal at 99.583% of par in March 2013. An additional $200.0 million in aggregate principal was issued at 104.315% of par in March 2014, and is treated as a single class with the outstanding $400.0 million in senior notes previously issued. (4) Issued in September 2018 at 99.914% of par. (5) Issued in September 2019 at 99.841% of par.

Accrued Compensation and Bene_2

Accrued Compensation and Benefits (Tables)	9 Months Ended
Accrued Compensation and Benefits (Tables)	Sep. 30, 2022
Retirement Benefits [Abstract]
Components of accrued compensation and benefits	Accrued compensation and benefits consist of the following: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued performance allocations and incentive fee related compensation $ 3,784.5 $ 4,087.8 Accrued bonuses 365.2 521.4 Employment-based contingent cash consideration (1) 45.2 6.3 Accrued pension liability (2) 34.1 27.4 Other (3) 118.7 312.1 Total $ 4,347.7 $ 4,955.0 (1) The acquisition of the Carlyle Aviation Partners, Ltd. (“Carlyle Aviation Partners,” formerly known as Apollo Aviation Group) in December 2018 included an earn-out of up to $150.0 million that is payable upon the achievement of certain revenue and earnings performance targets during 2020 through 2025, which is accounted for as compensation expense. See Note 3 to the consolidated financial statements included in the Company’s 2018 Annual Report on Form 10-K for additional information on the Carlyle Aviation Partners acquisition. The Abingworth acquisition included an earn-out of up to $130.0 million. See Note 4 for additional information. (2) Certain employees of AlpInvest are covered by defined benefit pension plans sponsored by AlpInvest. No other employees of the Company are covered by defined benefit pension plans. (3) Includes $27.6 million and $207.0 million of realized performance allocations and incentive fee-related compensation not yet paid to participants as of September 30, 2022 and December 31, 2021, respectively.
Schedule of performance allocations and incentive fee related compensation	The following table presents realized and unrealized performance allocations and incentive fee related compensation: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Realized $ 377.0 $ 478.5 $ 776.7 $ 789.8 Unrealized (213.5) 16.7 (35.5) 1,566.0 Total $ 163.5 $ 495.2 $ 741.2 $ 2,355.8

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of unfunded commitments	The Company and its unconsolidated affiliates have unfunded commitments to entities within the following segments as of September 30, 2022 (Dollars in millions): Unfunded Global Private Equity $ 3,351.2 Global Credit 376.2 Global Investment Solutions 261.0 Total $ 3,988.4
Lease cost, cash flows and other supplemental information related to operating leases	The following table summarizes the Company’s lease cost, cash flows and other supplemental information related to its operating leases (Dollars in millions): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Operating lease cost $ 14.0 $ 14.1 $ 42.0 $ 41.6 Sublease income (1.8) (1.0) (4.7) (2.2) Total operating lease cost $ 12.2 $ 13.1 $ 37.3 $ 39.4 Cash paid for amounts included in the measurement of operating lease liabilities $ 15.8 $ 12.4 $ 47.8 $ 35.1 Weighted-average remaining lease term 11.7 years 12.1 years Weighted-average discount rate 4.4 % 4.1 %
Maturities of operating lease liabilities	Maturities of lease liabilities related to operating leases were as follows (Dollars in millions): Year ending December 31, 2022 (excluding the nine months ended September 30, 2022) $ 16.0 2023 65.8 2024 62.9 2025 58.9 2026 56.8 Thereafter 393.5 Total lease payments $ 653.9 Less payments for leases that have not yet commenced (31.1) Less imputed interest (122.9) Total lease liabilities $ 499.9

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
Related Party Transactions (Tables)	Sep. 30, 2022
Related Party Transactions [Abstract]
Amounts due from affiliates and other receivables	The Company had the following due from affiliates and other receivables at September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Accrued incentive fees $ 14.5 $ 12.2 Unbilled receivable for giveback obligations from current and former employees 10.4 — Notes receivable and accrued interest from affiliates 41.3 25.3 Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net 420.2 342.1 Total $ 486.4 $ 379.6
Amounts due to affiliates	The Company had the following due to affiliates balances at September 30, 2022 and December 31, 2021: As of September 30, 2022 December 31, 2021 (Dollars in millions) Due to affiliates of Consolidated Funds $ 15.6 $ — Due to non-consolidated affiliates 77.2 60.5 Deferred consideration for Carlyle Holdings units 133.7 200.5 Amounts owed under the tax receivable agreement 101.9 101.9 Other 23.2 25.2 Total $ 351.6 $ 388.1

Non-controlling Interests in _2

Non-controlling Interests in Consolidated Entities (Tables)	9 Months Ended
Non-controlling Interests in Consolidated Entities (Tables)	Sep. 30, 2022
Noncontrolling Interest [Abstract]
Components of non-controlling interests in consolidated entities	The components of the Company’s non-controlling interests in consolidated entities are as follows: As of September 30, 2022 December 31, 2021 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 346.8 $ 180.1 Non-Carlyle interests in majority-owned subsidiaries 187.4 234.4 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 3.0 12.7 Non-controlling interests in consolidated entities $ 537.2 $ 427.2
Components of non-controlling interests in income (loss) of consolidated entities	The components of the Company’s non-controlling interests in income of consolidated entities are as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ (15.7) $ 0.7 $ 14.0 $ 0.9 Non-Carlyle interests in majority-owned subsidiaries 16.3 13.2 11.9 46.6 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 1.0 0.7 2.4 10.2 Non-controlling interests in income of consolidated entities $ 1.6 $ 14.6 $ 28.3 $ 57.7

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	9 Months Ended
Earnings Per Common Share (Tables)	Sep. 30, 2022
Earnings Per Share [Abstract]
Summary of basic and diluted net income (loss) per common unit	Basic and diluted net income (loss) per common share are calculated as follows: Three Months Ended Nine Months Ended Basic Diluted Basic Diluted Net income attributable to common shares $ 280,800,000 $ 280,800,000 $ 1,097,800,000 $ 1,097,800,000 Weighted-average common shares outstanding 362,895,064 366,787,149 360,657,999 365,389,217 Net income per common share $ 0.77 $ 0.77 $ 3.04 $ 3.00 Three Months Ended Nine Months Ended Basic Diluted Basic Diluted Net loss attributable to common shares $ 532,800,000 $ 532,800,000 $ 2,327,100,000 $ 2,327,100,000 Weighted-average common shares outstanding 355,954,734 364,740,675 354,903,371 362,471,998 Net income per common share $ 1.50 $ 1.46 $ 6.56 $ 6.42
Summary of weighted-average common units outstanding, basic and diluted	The weighted-average common shares outstanding, basic and diluted, are calculated as follows: Three Months Ended Nine Months Ended Basic Diluted Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 362,895,064 362,895,064 360,657,999 360,657,999 Unvested restricted stock units — 1,698,568 — 2,845,204 Issuable common shares and performance-vesting restricted stock units — 2,193,517 — 1,886,014 Weighted-average common shares outstanding 362,895,064 366,787,149 360,657,999 365,389,217 Three Months Ended Nine Months Ended Basic Diluted Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 355,954,734 355,954,734 354,903,371 354,903,371 Unvested restricted stock units — 6,716,547 — 5,582,360 Issuable common shares and performance-vesting restricted stock units — 2,069,394 — 1,986,267 Weighted-average common shares outstanding 355,954,734 364,740,675 354,903,371 362,471,998

Equity (Tables)

Equity (Tables)	9 Months Ended
Equity (Tables)	Sep. 30, 2022
Equity [Abstract]
Quarterly distributions on common units	The table below presents information regarding the quarterly dividends on the common shares, which were made at the sole discretion of the Board of Directors of the Company. Dividend Record Date Dividend Payment Date Dividend per Common Share Dividend to Common Stockholders (Dollars in millions, except per share data) May 11, 2021 May 19, 2021 $ 0.250 $ 88.7 August 10, 2021 August 17, 2021 0.250 89.3 November 9, 2021 November 17, 2021 0.250 89.1 February 15, 2022 February 23, 2022 0.250 89.5 Total 2021 Dividend Year $ 1.000 $ 356.6 May 10, 2022 May 17, 2022 $ 0.325 $ 117.6 August 9, 2022 August 16, 2022 0.325 118.3 November 18, 2022 November 25, 2022 0.325 118.2 Total 2022 Dividend Year (through Q3 2022) $ 0.975 $ 354.1

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	9 Months Ended
Equity-Based Compensation (Tables)	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Summary of status of non-vested equity-based awards	A summary of the status of the Company’s non-vested equity-based awards as of September 30, 2022 and a summary of changes for the nine months ended September 30, 2022, are presented below: Unvested Shares Restricted Weighted- Unvested (1) Weighted- Balance, December 31, 2021 14,775,651 $ 30.70 635,430 $ 29.27 Granted 3,616,132 $ 42.96 188,223 $ 49.06 Vested 5,572,684 $ 27.74 370,773 $ 26.54 Forfeited 1,585,664 $ 29.29 — $ — Balance, September 30, 2022 11,233,435 $ 36.32 452,880 $ 39.73 (1) Includes common shares issued in connection with the Company’s strategic investment in NGP.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
Segment Reporting (Tables)	Sep. 30, 2022
Segment Reporting [Abstract]
Reportable segments financial data	The following tables present the financial data for the Company’s three reportable segments for the three and nine months ended September 30, 2022: Three Months Ended September 30, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 330.1 $ 128.4 $ 55.6 $ 514.1 Portfolio advisory and transaction fees, net and other 7.7 27.3 — 35.0 Fee related performance revenues 6.1 14.5 — 20.6 Total fund level fee revenues 343.9 170.2 55.6 569.7 Realized performance revenues 628.4 63.0 73.4 764.8 Realized principal investment income 46.0 9.2 1.5 56.7 Interest income 5.1 4.5 0.9 10.5 Total revenues 1,023.4 246.9 131.4 1,401.7 Segment Expenses Compensation and benefits Cash-based compensation and benefits 146.7 69.9 30.1 246.7 Realized performance revenues related compensation 283.5 28.9 61.3 373.7 Total compensation and benefits 430.2 98.8 91.4 620.4 General, administrative, and other indirect expenses 65.3 26.4 9.1 100.8 Depreciation and amortization expense 6.3 2.1 1.2 9.6 Interest expense 15.9 7.9 2.7 26.5 Total expenses 517.7 135.2 104.4 757.3 Distributable Earnings $ 505.7 $ 111.7 $ 27.0 $ 644.4 (-) Realized Net Performance Revenues 344.9 34.1 12.1 391.1 (-) Realized Principal Investment Income 46.0 9.2 1.5 56.7 (+) Net Interest 10.8 3.4 1.8 16.0 (=) Fee Related Earnings $ 125.6 $ 71.8 $ 15.2 $ 212.6 Nine Months Ended September 30, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 971.3 $ 345.8 $ 167.4 $ 1,484.5 Portfolio advisory and transaction fees, net and other 21.3 72.1 — 93.4 Fee related performance revenues 59.0 41.2 — 100.2 Total fund level fee revenues 1,051.6 459.1 167.4 1,678.1 Realized performance revenues 1,302.1 96.6 122.3 1,521.0 Realized principal investment income 94.4 28.2 4.2 126.8 Interest income 6.7 8.6 1.2 16.5 Total revenues 2,454.8 592.5 295.1 3,342.4 Segment Expenses Compensation and benefits Cash-based compensation and benefits 453.9 214.2 84.1 752.2 Realized performance revenues related compensation 588.7 45.0 107.3 741.0 Total compensation and benefits 1,042.6 259.2 191.4 1,493.2 General, administrative, and other indirect expenses 170.1 70.2 24.7 265.0 Depreciation and amortization expense 18.9 6.0 3.7 28.6 Interest expense 47.7 23.5 8.4 79.6 Total expenses 1,279.3 358.9 228.2 1,866.4 Distributable Earnings $ 1,175.5 $ 233.6 $ 66.9 $ 1,476.0 (-) Realized Net Performance Revenues 713.4 51.6 15.0 780.0 (-) Realized Principal Investment Income 94.4 28.2 4.2 126.8 (+) Net Interest 41.0 14.9 7.2 63.1 (=) Fee Related Earnings $ 408.7 $ 168.7 $ 54.9 $ 632.3 Segment assets as of September 30, 2022 $ 10,046.3 $ 3,205.3 $ 1,741.6 $ 14,993.2 The following tables present the financial data for the Company’s three reportable segments for the three and nine months ended September 30, 2021: Three Months Ended September 30, 2021 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 265.1 $ 81.3 $ 59.3 $ 405.7 Portfolio advisory and transaction fees, net and other 7.3 15.9 — 23.2 Fee related performance revenues — 11.2 — 11.2 Total fund level fee revenues 272.4 108.4 59.3 440.1 Realized performance revenues 962.9 2.1 45.9 1,010.9 Realized principal investment income 61.6 7.4 2.3 71.3 Interest income 0.2 1.3 — 1.5 Total revenues 1,297.1 119.2 107.5 1,523.8 Segment Expenses Compensation and benefits Cash-based compensation and benefits 133.6 58.7 25.7 218.0 Realized performance revenues related compensation 434.5 1.0 41.9 477.4 Total compensation and benefits 568.1 59.7 67.6 695.4 General, administrative, and other indirect expenses 38.4 14.7 6.9 60.0 Depreciation and amortization expense 7.1 2.3 1.3 10.7 Interest expense 17.4 6.8 2.9 27.1 Total expenses 631.0 83.5 78.7 793.2 Distributable Earnings $ 666.1 $ 35.7 $ 28.8 $ 730.6 (-) Realized Net Performance Revenues 528.4 1.1 4.0 533.5 (-) Realized Principal Investment Income 61.6 7.4 2.3 71.3 (+) Net Interest 17.2 5.5 2.9 25.6 (=) Fee Related Earnings $ 93.3 $ 32.7 $ 25.4 $ 151.4 Nine Months Ended September 30, 2021 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 788.7 $ 227.6 $ 171.6 $ 1,187.9 Portfolio advisory and transaction fees, net and other 24.1 34.1 0.3 58.5 Fee related performance revenues — 31.0 — 31.0 Total fund level fee revenues 812.8 292.7 171.9 1,277.4 Realized performance revenues 1,525.9 2.2 105.2 1,633.3 Realized principal investment income 109.3 23.1 6.7 139.1 Interest income 0.9 4.5 0.1 5.5 Total revenues 2,448.9 322.5 283.9 3,055.3 Segment Expenses Compensation and benefits Cash-based compensation and benefits 396.3 168.0 83.3 647.6 Realized performance revenues related compensation 688.3 1.0 97.1 786.4 Total compensation and benefits 1,084.6 169.0 180.4 1,434.0 General, administrative, and other indirect expenses 116.2 39.5 21.5 177.2 Depreciation and amortization expense 19.3 6.2 3.5 29.0 Interest expense 46.9 19.4 7.9 74.2 Total expenses 1,267.0 234.1 213.3 1,714.4 Distributable Earnings $ 1,181.9 $ 88.4 $ 70.6 $ 1,340.9 (-) Realized Net Performance Revenues 837.6 1.2 8.1 846.9 (-) Realized Principal Investment Income 109.3 23.1 6.7 139.1 (+) Net Interest 46.0 14.9 7.8 68.7 (=) Fee Related Earnings $ 281.0 $ 79.0 $ 63.6 $ 423.6
Reconciliation of total segments to income before provision for taxes	The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the three months ended September 30, 2022 and 2021. Three Months Ended September 30, 2022 Total Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 1,401.7 $ 79.7 $ (392.9) (a) $ 1,088.5 Expenses $ 757.3 $ 62.0 $ (119.7) (b) $ 699.6 Other income $ — $ (30.3) $ — (c) $ (30.3) Distributable earnings $ 644.4 $ (12.6) $ (273.2) (d) $ 358.6 Three Months Ended September 30, 2021 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 1,523.8 $ 62.1 $ 53.6 (a) $ 1,639.5 Expenses $ 793.2 $ 51.9 $ 93.0 (b) $ 938.1 Other income $ — $ (0.1) $ — (c) $ (0.1) Distributable earnings $ 730.6 $ 10.1 $ (39.4) (d) $ 701.3 The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the nine months ended September 30, 2022 and 2021, and Total Assets as of September 30, 2022. Nine Months Ended September 30, 2022 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 3,342.4 $ 204.6 $ 172.3 (a) $ 3,719.3 Expenses $ 1,866.4 $ 166.0 $ 234.9 (b) $ 2,267.3 Other income (loss) $ — $ (51.0) $ — (c) $ (51.0) Distributable earnings $ 1,476.0 $ (12.4) $ (62.6) (d) $ 1,401.0 Total assets $ 14,993.2 $ 6,695.8 $ (596.6) (e) $ 21,092.4 Nine Months Ended September 30, 2021 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 3,055.3 $ 185.3 $ 3,542.4 (a) $ 6,783.0 Expenses $ 1,714.4 $ 162.6 $ 1,797.3 (b) $ 3,674.3 Other income (loss) $ — $ 9.6 $ — (c) $ 9.6 Distributable earnings $ 1,340.9 $ 32.3 $ 1,745.1 (d) $ 3,118.3 (a) The Revenues adjustment principally represents unrealized performance revenues, unrealized principal investment income (loss) (including Fortitude), the principal investment loss from dilution of the indirect investment in Fortitude, revenues earned from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to non-controlling interests in consolidated entities, adjustments related to expenses associated with the investments in NGP Management and its affiliates that are included in operating captions or are excluded from the segment results, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, and the inclusion of tax expenses associated with certain foreign performance revenues, as detailed below: Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Unrealized performance and fee related performance revenues $ (376.2) $ (29.8) $ 334.8 $ 3,212.7 Unrealized principal investment income (loss) (29.9) 70.4 (33.3) 280.5 Principal investment loss from dilution of indirect investment in Fortitude — — (176.9) — Adjustments related to expenses associated with investments in NGP Management and its affiliates (3.8) (3.6) (9.9) (10.2) Tax expense associated with certain foreign performance revenues 0.1 0.1 — 0.3 Non-controlling interests and other adjustments to present certain costs on a net basis 28.4 33.2 60.0 119.6 Elimination of revenues of Consolidated Funds (11.5) (16.7) (2.4) (60.5) $ (392.9) $ 53.6 $ 172.3 $ 3,542.4 The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S. GAAP measure, the Company’s consolidated fund management fees, for the three and nine months ended September 30, 2022 and 2021. Three Months Ended Nine Months Ended 2022 2021 2022 2021 (Dollars in millions) Total Reportable Segments - Fund level fee revenues $ 569.7 $ 440.1 $ 1,678.1 $ 1,277.4 Adjustments (1) (33.8) (32.6) (145.2) (94.5) Carlyle Consolidated - Fund management fees $ 535.9 $ 407.5 $ 1,532.9 $ 1,182.9 (1) Adjustments represent the reclassification of NGP management fees from principal investment income, the reclassification of fee related performance revenues from business development companies and other products, management fees earned from consolidated CLOs which were eliminated in consolidation to arrive at the Company’s fund management fees, and the reclassification of certain amounts included in portfolio advisory fees, net and other in the segment results that are included in interest and other income in the U.S. GAAP results. (b) The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds payable to the Company, the inclusion of equity-based compensation, certain tax expenses associated with realized performance revenues related compensation, and unrealized performance revenues related compensation, adjustments related to expenses associated with the investment in NGP Management that are included in operating captions, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, changes in the tax receivable agreement liability, and charges and credits associated with Carlyle corporate actions and non-recurring items, as detailed below: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Unrealized performance and fee related performance revenue compensation expense $ (224.0) $ 15.0 $ (50.4) $ 1,567.1 Equity-based compensation 56.0 44.3 145.0 129.5 Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment 42.4 24.4 124.9 54.7 Tax expense associated with certain foreign performance revenues related compensation 3.7 (2.5) 3.0 (12.1) Non-controlling interests and other adjustments to present certain costs on a net basis 7.5 15.9 35.8 53.2 Right-of-use asset impairment — — — 26.8 Other adjustments including severance 3.1 3.2 5.4 7.2 Elimination of expenses of Consolidated Funds (8.4) (7.3) (28.8) (29.1) $ (119.7) $ 93.0 $ 234.9 $ 1,797.3 (c) The Other Income (Loss) adjustment results from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total Other Income (Loss). (d) The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable Earnings and to Fee Related Earnings: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (Dollars in millions) Income (loss) before provision for income taxes $ 358.6 $ 701.3 $ 1,401.0 $ 3,118.3 Adjustments: Net unrealized performance and fee related performance revenues 152.2 44.8 (385.2) (1,645.6) Unrealized principal investment (income) loss 29.9 (70.4) 33.3 (280.5) Principal investment loss from dilution of indirect investment in Fortitude — — 176.9 — Equity-based compensation (1) 56.0 44.3 145.0 129.5 Acquisition or disposition-related charges (credits), including amortization of intangibles and impairment 42.4 24.4 124.9 54.7 Tax expense associated with certain foreign performance revenues 3.8 (2.4) 3.0 (11.8) Net income attributable to non-controlling interests in consolidated entities (1.6) (14.6) (28.3) (57.7) Right-of-use asset impairment — — — 26.8 Other adjustments including severance 3.1 3.2 5.4 7.2 Distributable Earnings $ 644.4 $ 730.6 $ 1,476.0 $ 1,340.9 Realized performance revenues, net of related compensation (2) 391.1 533.5 780.0 846.9 Realized principal investment income (2) 56.7 71.3 126.8 139.1 Net interest 16.0 25.6 63.1 68.7 Fee Related Earnings $ 212.6 $ 151.4 $ 632.3 $ 423.6 (1) Equity-based compensation for the three and nine months ended September 30, 2022 and 2021 includes amounts that are presented in principal investment income and general, administrative and other expenses in the Company’s U.S. GAAP statement of operations. (2) See reconciliation to most directly comparable U.S. GAAP measure below: Three Months Ended September 30, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 298.1 $ 466.7 $ 764.8 Performance revenues related compensation expense 163.5 210.2 373.7 Net performance revenues $ 134.6 $ 256.5 $ 391.1 Principal investment income (loss) $ 124.2 $ (67.5) $ 56.7 Nine Months Ended September 30, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 1,346.2 $ 174.8 $ 1,521.0 Performance revenues related compensation expense 741.2 (0.2) 741.0 Net performance revenues $ 605.0 $ 175.0 $ 780.0 Principal investment income (loss) $ 500.5 $ (373.7) $ 126.8 Three Months Ended September 30, 2021 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 974.5 $ 36.4 $ 1,010.9 Performance revenues related compensation expense 495.2 (17.8) 477.4 Net performance revenues $ 479.3 $ 54.2 $ 533.5 Principal investment income (loss) $ 160.4 $ (89.1) $ 71.3 Nine Months Ended September 30, 2021 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 4,841.3 $ (3,208.0) $ 1,633.3 Performance revenues related compensation expense 2,355.8 (1,569.4) 786.4 Net performance revenues $ 2,485.5 $ (1,638.6) $ 846.9 Principal investment income (loss) $ 477.2 $ (338.1) $ 139.1 ( 3) Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance allocations net of related compensation expense and unrealized principal investment income, which are excluded from the segment results, (ii) amounts earned from the Consolidated Funds, which were eliminated in the U.S. GAAP consolidation but were included in the segment results, (iii) amounts attributable to non-controlling interests in consolidated entities, which were excluded from the segment results, (iv) the reclassification of NGP performance revenues, which are included in principal investment income in U.S. GAAP financial statements, (v) the reclassification of fee related performance revenues, which are included in fund level fee revenues in the segment results, and (vi) the reclassification of tax expenses associated with certain foreign performance revenues. Adjustments to principal investment income (loss) also include the reclassification of earnings for the investments in NGP Management and its affiliates to the appropriate operating captions for the segment results, the exclusion of charges associated with the investment in NGP Management and its affiliates that are excluded from the segment results and the exclusion of the principal investment loss from dilution of the indirect investment in Fortitude.

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	9 Months Ended
Supplemental Financial Information (Tables)	Sep. 30, 2022
Condensed Financial Information Disclosure [Abstract]
Supplemental financial position	As of September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,361.9 $ — $ — $ 1,361.9 Cash and cash equivalents held at Consolidated Funds — 177.2 — 177.2 Restricted cash 0.6 — — 0.6 Corporate treasury investments 69.5 — — 69.5 Investments, including performance allocations of $7,428.7 million 11,130.8 — (132.6) 10,998.2 Investments of Consolidated Funds — 6,409.7 — 6,409.7 Due from affiliates and other receivables, net 950.4 — (464.0) 486.4 Due from affiliates and other receivables of Consolidated Funds, net — 108.6 — 108.6 Fixed assets, net 134.4 — — 134.4 Lease right-of-use assets, net 333.5 — — 333.5 Deposits and other 69.1 0.3 — 69.4 Intangible assets, net 925.1 — — 925.1 Deferred tax assets 17.9 — — 17.9 Total assets $ 14,993.2 $ 6,695.8 $ (596.6) $ 21,092.4 Liabilities and equity Debt obligations $ 2,235.0 $ — $ — $ 2,235.0 Loans payable of Consolidated Funds — 5,975.3 (458.4) 5,516.9 Accounts payable, accrued expenses and other liabilities 379.4 — — 379.4 Accrued compensation and benefits 4,347.7 — — 4,347.7 Due to affiliates 336.0 15.7 (0.1) 351.6 Deferred revenue 394.2 — — 394.2 Deferred tax liabilities 449.9 — — 449.9 Other liabilities of Consolidated Funds — 222.1 (0.1) 222.0 Lease liabilities 499.9 — — 499.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,683.0 6,213.1 (458.6) 14,437.5 Common stock 3.6 — — 3.6 Additional paid-in capital 3,123.0 157.2 (157.2) 3,123.0 Retained earnings 3,430.8 — — 3,430.8 Accumulated other comprehensive loss (437.6) (21.3) 19.2 (439.7) Non-controlling interests in consolidated entities 190.4 346.8 — 537.2 Total equity 6,310.2 482.7 (138.0) 6,654.9 Total liabilities and equity $ 14,993.2 $ 6,695.8 $ (596.6) $ 21,092.4 As of December 31, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 2,469.5 $ — $ — $ 2,469.5 Cash and cash equivalents held at Consolidated Funds — 147.8 — 147.8 Restricted cash 5.6 — — 5.6 Investments, including performance allocations of $8,133.0 million 11,022.5 — (190.5) 10,832.0 Investments of Consolidated Funds — 6,661.0 — 6,661.0 Due from affiliates and other receivables, net 384.9 — (5.3) 379.6 Due from affiliates and other receivables of Consolidated Funds, net — 138.8 — 138.8 Fixed assets, net 143.9 — — 143.9 Lease right-of-use assets, net 361.1 — — 361.1 Deposits and other 61.3 0.4 — 61.7 Intangible assets, net 34.9 — — 34.9 Deferred tax assets 14.5 — — 14.5 Total assets $ 14,498.2 $ 6,948.0 $ (195.8) $ 21,250.4 Liabilities and equity Debt obligations $ 2,071.6 $ — $ — $ 2,071.6 Loans payable of Consolidated Funds — 5,890.0 — 5,890.0 Accounts payable, accrued expenses and other liabilities 379.7 — — 379.7 Accrued compensation and benefits 4,955.0 — — 4,955.0 Due to affiliates 388.1 — — 388.1 Deferred revenue 120.8 — — 120.8 Deferred tax liabilities 487.1 — — 487.1 Other liabilities of Consolidated Funds — 684.0 (0.1) 683.9 Lease liabilities 537.8 — — 537.8 Accrued giveback obligations 30.2 — — 30.2 Total liabilities 8,970.3 6,574.0 (0.1) 15,544.2 Common stock 3.6 — — 3.6 Additional paid-in capital 2,717.6 198.6 (198.6) 2,717.6 Retained earnings 2,805.3 — — 2,805.3 Accumulated other comprehensive income (loss) (245.7) (4.7) 2.9 (247.5) Non-controlling interests in consolidated entities 247.1 180.1 — 427.2 Total equity 5,527.9 374.0 (195.7) 5,706.2 Total liabilities and equity $ 14,498.2 $ 6,948.0 $ (195.8) $ 21,250.4
Supplemental results of operations	Three Months Ended September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 542.1 $ — $ (6.2) $ 535.9 Incentive fees 15.2 — (0.1) 15.1 Investment income Performance allocations 297.8 — 0.3 298.1 Principal investment income 127.6 — (3.4) 124.2 Total investment income 425.4 — (3.1) 422.3 Interest and other income 37.6 — (2.1) 35.5 Interest and other income of Consolidated Funds — 79.7 — 79.7 Total revenues 1,020.3 79.7 (11.5) 1,088.5 Expenses Compensation and benefits Cash-based compensation and benefits 251.4 — — 251.4 Equity-based compensation 54.2 — — 54.2 Performance allocations and incentive fee related compensation 163.5 — — 163.5 Total compensation and benefits 469.1 — — 469.1 General, administrative and other expenses 149.3 — (0.1) 149.2 Interest 27.3 — — 27.3 Interest and other expenses of Consolidated Funds — 62.0 (8.3) 53.7 Other non-operating expense 0.3 — — 0.3 Total expenses 646.0 62.0 (8.4) 699.6 Other income (loss) Net investment loss of Consolidated Funds — (30.3) — (30.3) Income (loss) before provision for income taxes 374.3 (12.6) (3.1) 358.6 Provision for income taxes 76.2 — — 76.2 Net income (loss) 298.1 (12.6) (3.1) 282.4 Net income attributable to non-controlling interests in consolidated entities 17.3 — (15.7) 1.6 Net income (loss) attributable to The Carlyle Group Inc. $ 280.8 $ (12.6) $ 12.6 $ 280.8 Nine Months Ended September 30, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 1,552.0 $ — $ (19.1) $ 1,532.9 Incentive fees 42.7 — (0.1) 42.6 Investment income Performance allocations 1,350.7 — (4.5) 1,346.2 Principal investment income 463.9 — 36.6 500.5 Total investment income 1,814.6 — 32.1 1,846.7 Interest and other income 107.8 — (15.3) 92.5 Interest and other income of Consolidated Funds — 204.6 — 204.6 Total revenues 3,517.1 204.6 (2.4) 3,719.3 Expenses Compensation and benefits Cash-based compensation and benefits 779.7 — — 779.7 Equity-based compensation 139.3 — — 139.3 Performance allocations and incentive fee related compensation 741.2 — — 741.2 Total compensation and benefits 1,660.2 — — 1,660.2 General, administrative and other expenses 387.1 — 0.1 387.2 Interest 82.0 — — 82.0 Interest and other expenses of Consolidated Funds — 166.0 (28.9) 137.1 Other non-operating expense 0.8 — — 0.8 Total expenses 2,130.1 166.0 (28.8) 2,267.3 Other income (loss) Net investment loss of Consolidated Funds — (51.0) — (51.0) Income (loss) before provision for income taxes 1,387.0 (12.4) 26.4 1,401.0 Provision for income taxes 274.9 — — 274.9 Net income (loss) 1,112.1 (12.4) 26.4 1,126.1 Net income attributable to non-controlling interests in consolidated entities 14.3 — 14.0 28.3 Net income (loss) attributable to The Carlyle Group Inc. $ 1,097.8 $ (12.4) $ 12.4 $ 1,097.8 Three Months Ended September 30, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 414.3 $ — $ (6.8) $ 407.5 Incentive fees 13.1 — — 13.1 Investment income Performance allocations 974.5 — — 974.5 Principal investment income 165.2 — (4.8) 160.4 Total investment income 1,139.7 — (4.8) 1,134.9 Interest and other income 27.0 — (5.1) 21.9 Interest and other income of Consolidated Funds — 62.1 — 62.1 Total revenues 1,594.1 62.1 (16.7) 1,639.5 Expenses Compensation and benefits Cash-based compensation and benefits 224.9 — — 224.9 Equity-based compensation 42.4 — — 42.4 Performance allocations and incentive fee related compensation 495.2 — — 495.2 Total compensation and benefits 762.5 — — 762.5 General, administrative and other expenses 99.6 — — 99.6 Interest 27.9 — — 27.9 Interest and other expenses of Consolidated Funds — 51.9 (7.3) 44.6 Other non-operating income 3.5 — — 3.5 Total expenses 893.5 51.9 (7.3) 938.1 Other income Net investment loss of Consolidated Funds — (0.1) — (0.1) Income before provision for income taxes 700.6 10.1 (9.4) 701.3 Provision for income taxes 153.9 — — 153.9 Net income 546.7 10.1 (9.4) 547.4 Net income attributable to non-controlling interests in consolidated entities 13.9 — 0.7 14.6 Net income attributable to The Carlyle Group Inc. 532.8 10.1 (10.1) 532.8 Nine Months Ended September 30, 2021 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 1,201.5 $ — $ (18.6) $ 1,182.9 Incentive fees 33.0 — — 33.0 Investment income Performance allocations 4,841.3 — — 4,841.3 Principal investment income 503.1 — (25.9) 477.2 Total investment income 5,344.4 — (25.9) 5,318.5 Interest and other income 79.3 — (16.0) 63.3 Interest and other income of Consolidated Funds — 185.3 — 185.3 Total revenues 6,658.2 185.3 (60.5) 6,783.0 Expenses Compensation and benefits Cash-based compensation and benefits 685.2 — — 685.2 Equity-based compensation 122.0 — — 122.0 Performance allocations and incentive fee related compensation 2,355.8 — — 2,355.8 Total compensation and benefits 3,163.0 — — 3,163.0 General, administrative and other expenses 300.4 — — 300.4 Interest 76.4 — — 76.4 Interest and other expenses of Consolidated Funds — 162.6 (29.1) 133.5 Other non-operating income 1.0 — — 1.0 Total expenses 3,540.8 162.6 (29.1) 3,674.3 Other income Net investment gain of Consolidated Funds — 9.6 — 9.6 Income before provision for income taxes 3,117.4 32.3 (31.4) 3,118.3 Provision for income taxes 733.5 — — 733.5 Net income 2,383.9 32.3 (31.4) 2,384.8 Net income attributable to non-controlling interests in consolidated entities 56.8 — 0.9 57.7 Net income attributable to The Carlyle Group Inc. 2,327.1 32.3 (32.3) 2,327.1
Supplemental statement of cash flows	Nine Months Ended September 30, 2022 2021 (Dollars in millions) Cash flows from operating activities Net income $ 1,112.1 $ 2,383.9 Adjustments to reconcile net income to net cash flows from operating activities: Depreciation and amortization 102.7 40.5 Right-of-use asset impairment, net of broker fees — 24.8 Equity-based compensation 139.3 122.0 Non-cash performance allocations and incentive fees 179.4 (1,662.3) Non-cash principal investment income (434.9) (470.7) Other non-cash amounts (27.4) 20.7 Purchases of investments (582.4) (250.9) Proceeds from the sale of investments 410.2 559.1 Payments of contingent consideration (5.7) (50.0) Change in deferred taxes, net (2.3) 449.1 Change in due from affiliates and other receivables (62.0) (21.1) Change in deposits and other (12.8) (23.3) Change in accounts payable, accrued expenses and other liabilities (27.7) 90.9 Change in accrued compensation and benefits (265.3) 17.3 Change in due to affiliates 2.4 1.4 Change in lease right-of-use asset and lease liability (7.0) 5.9 Change in deferred revenue 274.9 247.6 Net cash provided by operating activities 793.5 1,484.9 Cash flows from investing activities Purchases of corporate treasury investments, net (69.6) — Purchases of fixed assets, net (25.0) (27.0) Purchase of Abingworth, net of cash acquired (150.2) — Purchase of CBAM intangibles and investments, net (618.4) — Proceeds from sale of MRE, net of cash sold — 5.9 Proceeds from sale of Brazil management entity, net of cash sold — 3.3 Net cash used in investing activities (863.2) (17.8) Cash flows from financing activities Borrowings under credit facilities — 70.0 Issuance of 4.625% subordinated notes due 2061, net of financing costs — 484.1 Payments on CLO borrowings (8.9) (231.5) Proceeds from CLO borrowings, net of financing costs 55.2 87.5 Payments of contingent consideration — (0.1) Dividends to common stockholders (325.4) (266.7) Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8) Contributions from non-controlling interest holders 7.2 13.1 Distributions to non-controlling interest holders (52.5) (56.3) Common shares issued for performance allocations 38.9 — Common shares repurchased (146.9) (84.5) Change in due to/from affiliates financing activities (471.6) 21.8 Net cash used in financing activities (972.8) (31.4) Effect of foreign exchange rate changes (70.1) (19.4) Increase (decrease) in cash, cash equivalents and restricted cash (1,112.6) 1,416.3 Cash, cash equivalents and restricted cash, beginning of period 2,475.1 989.6 Cash, cash equivalents and restricted cash, end of period $ 1,362.5 $ 2,405.9 Supplemental non-cash disclosures Issuance of common shares related to the acquisition of CBAM and Abingworth $ 219.5 $ — Reconciliation of cash, cash equivalents and restricted cash, end of period: Cash and cash equivalents $ 1,361.9 $ 2,399.0 Restricted cash 0.6 6.9 Total cash, cash equivalents and restricted cash, end of period $ 1,362.5 $ 2,405.9 Cash and cash equivalents held at Consolidated Funds $ 177.2 $ 134.8

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - segment	3 Months Ended		9 Months Ended
Organization and Basis of Presentation (Details) - segment	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	3	3	3	3

Recent Transactions (Details)

Recent Transactions (Details) - USD ($) $ in Thousands			1 Months Ended		3 Months Ended
Recent Transactions (Details) - USD ($) $ in Thousands	Aug. 01, 2022	Mar. 21, 2022	May 31, 2022	Mar. 31, 2022	Sep. 30, 2022
Abingworth
Asset Acquisition [Line Items]
Base purchase price	$ 185,600
Shares of common stock	25,000
Contingent consideration, estimated maximum range	$ 130,000				$ 130,000
Performance revenues percentage includes acquisition	15%
Management Contracts
Asset Acquisition [Line Items]
Purchase price		$ 812,900
Acquired CLO senior and subordinated notes		$ 175,900
iStar Triple Net Lease Portfolio
Asset Acquisition [Line Items]
Diversified portfolio of triple net leases value				$ 3,000,000
Investment fund’s acquisition of the debt				2,000,000
Investment fund’s acquisition of the equity				1,000,000
Investment fund, maximum contribution as minority interest				200,000
Carlyle FRL
Asset Acquisition [Line Items]
Equity capital raised			$ 1,100,000	2,000,000
Carlyle FRL \| T&D
Asset Acquisition [Line Items]
Payments to acquire equity method investments				$ 100,000
Carlyle FRL \| Fortitude Group Holdings, LLC
Asset Acquisition [Line Items]
Business acquisition further decrease funding percentage			10.50%		10.50%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Maximum
Asset Acquisition [Line Items]
Ownership percentage			19.90%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Minimum
Asset Acquisition [Line Items]
Ownership percentage			13.50%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Variable Interest Entities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Consolidated VIEs, assets	$ 21,092.4	$ 21,250.4
Consolidated VIEs, liabilities	14,437.5	15,544.2
Consolidated VIEs
Variable Interest Entity [Line Items]
Consolidated VIEs, assets	6,700	6,900
Consolidated VIEs, liabilities	5,800	$ 6,600
Consolidated VIEs \| Collateralized Loan Obligations
Variable Interest Entity [Line Items]
Investments in CLOs	$ 110.7

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Investments in Unconsolidated Variable Interest Entities (Details) - Unconsolidated VIEs - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Investments	$ 1,096.8	$ 901.9
Accrued performance revenues	391.1	368.7
Management fee receivables	44.3	27.2
Total	$ 1,532.2	$ 1,297.8

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Net Investment Income [Line Items]
Period of time for which management fees will be received by partners from the initial closing date			10 years
Subsequent period in which management fees are recognized after these fees are called			6 months
Percentage of management fees for CLOs on the total par amount of assets in the fund			1%
Management fee receivable	$ 217.9		$ 217.9		$ 164.5
Transaction and advisory fees	34.5	$ 21.9	$ 92.3	$ 54.3
Incentive Fees
Performance fees allocation percentage to partnership (percent)			20%
Accrued giveback obligations	40.9		$ 40.9		$ 30.2
Interest Income
Interest income from investments	$ 72.5	$ 56.9	$ 188.2	$ 170.4
Minimum
Net Investment Income [Line Items]
Percentage of management fees earned			1%
Extension period for fund closing			1 year
Percentage of management fees for CLOs on the total par amount of assets in the fund			0.40%
Period of management fees related to collateralized loan obligation			5 years
Percentage of management fees for business development companies			1%
Percentage of management fees from funds of funds during the commitment fee period			0.25%
Percentage of management fees from fund of funds following the expiration of the weighted-average investment period			0.25%
Incentive Fees
Percentage of allocation based performance fees related to fund of funds vehicles (percent)			2%
Percent of preferred returns (percent)			7%
Maximum
Net Investment Income [Line Items]
Percentage of management fees earned			2%
Extension period for fund closing			2 years
Percentage of management fees for CLOs on the total par amount of assets in the fund			0.50%
Period of management fees related to collateralized loan obligation			10 years
Percentage of management fees for business development companies			1.50%
Percentage of management fees from funds of funds during the commitment fee period			1%
Percentage of management fees from fund of funds following the expiration of the weighted-average investment period			1%
Incentive Fees
Percentage of allocation based performance fees related to fund of funds vehicles (percent)			12.50%
Percent of preferred returns (percent)			9%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Oct. 31, 2021
Accounting Policies [Abstract]
Accrued performance allocations and incentive fee related compensation	$ 4,087.8	$ 3,784.5		$ 3,784.5
Realized performance allocation related compensation percentage (percent)						20%
Maximum lag period for which the partnership investments in funds are valued	90 days			90 days
Securities transferred to counterparties under repurchase agreements		243.9		$ 243.9
Foreign currency transaction gain (loss)		$ 15.9	$ (9.9)	$ 39.1	$ (11.8)

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Fixed Assets (Details)	9 Months Ended
	Sep. 30, 2022
Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of other fixed assets	3 years
Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of other fixed assets	7 years

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)	9 Months Ended
	Sep. 30, 2022
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite lived intangible assets	4 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite lived intangible assets	8 years

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ (439.7)	$ (247.5)
Currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(420)	(231.8)
Unrealized losses on defined benefit plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ (19.7)	$ (15.7)

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions			1 Months Ended	9 Months Ended
	Aug. 01, 2022	Mar. 21, 2022	Mar. 31, 2022	Sep. 30, 2022
Minimum
Asset Acquisition [Line Items]
Amortization period				4 years
Maximum
Asset Acquisition [Line Items]
Amortization period				8 years
Management Contracts
Asset Acquisition [Line Items]
Purchase price		$ 812,900
Payments for acquisition		618,400
Business acquisition costs		$ 3,400
Newly issued common shares (in shares)		4.2	4.2
Newly issued common shares		$ 194,500
Acquired CLO senior and subordinated notes		$ 175,900
Amortization period		7 years
Management Contracts \| Contractual Rights
Asset Acquisition [Line Items]
Acquired contractual rights		$ 794,300
Abingworth
Asset Acquisition [Line Items]
Equity interests acquired	100%
Total consideration transferred	$ 2,000,000
Purchase of Abingworth, net of cash acquired	$ 160,600
Issuance of common stock (in shares)	0.6
Shares of common stock	$ 25,000
Earnout payable	$ 130,000
Acquisition costs incurred				$ 7,700
Abingworth \| Minimum
Asset Acquisition [Line Items]
Amortization period	5 years
Abingworth \| Maximum
Asset Acquisition [Line Items]
Amortization period	8 years

Acquisitions - Schedule of Esti

Acquisitions - Schedule of Estimated Fair Values of the Assets Acquired and Liabilities (Details) - USD ($) $ in Thousands	Aug. 01, 2022	Sep. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 103,000	$ 13,300
Abingworth
Business Acquisition [Line Items]
Purchase of Abingworth, net of cash acquired	$ 160,600
Shares of common stock	25,000
Total consideration transferred	185,600
Cash and receivables	11,000
Investments in Abingworth funds	3,800
Lease right-of-use assets, fixed assets, and other assets, net	3,700
Deferred tax assets	6,700
Finite-lived intangible assets	88,000
Goodwill	90,900
Lease liabilities	(2,700)
Accrued expenses, accrued compensation and benefits, and other liabilities	(11,600)
Non-controlling interests in legacy Abingworth entities	(4,200)
Total	$ 185,600

Acquisitions - Schedule of Acqu

Acquisitions - Schedule of Acquisition-date Fair Value of Consideration Transferred and Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details) - Management Contracts $ in Millions	Mar. 21, 2022 USD ($)
Acquisition-date fair value of consideration transferred
Cash	$ 618.4
Shares of common stock (see Note 15)	194.5
Total consideration transferred	812.9
Allocation of cost to assets acquired and liabilities assumed
Acquired CLO senior and subordinated notes	175.9
Assumed CLO borrowings outstanding (see Note 8)	(157.3)
Total cost of assets acquired, net of liabilities assumed	812.9
Contractual Rights
Allocation of cost to assets acquired and liabilities assumed
Acquired contractual rights	$ 794.3

Fair Value Measurement - Assets

Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Dec. 31, 2021	Sep. 30, 2022
Assets
Subtotal	$ 7,003.8	$ 7,098.7
Investments measured at net asset value	$ 7,165.5
Maximum lag period for which the partnership investments in funds are valued	90 days	90 days
Liabilities
Loans payable of Consolidated Funds	$ 5,811	$ 5,303.7
Foreign currency forward contracts	0.7	29.5
Total	5,811.7	5,333.2
Revolving Credit Facility
Liabilities
Total	79	52.7
Senior secured notes
Liabilities
Total		160.5
Equity securities
Assets
Investments	17.9
Equity securities \| Consolidated VIEs
Assets
Investments measured at net asset value		453.4
Bonds
Assets
Investments	599.5
Loans
Assets
Investments	5,898.1
Investments of Consolidated Funds
Assets
Investments	6,515.5
Investments in CLOs
Assets
Investments	361.1
Other investments
Assets
Investments	125.8
Foreign currency forward contracts
Assets
Foreign currency forward contracts	1.4
Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments		607.2
Level I
Assets
Subtotal	1.5	1.3
Liabilities
Loans payable of Consolidated Funds	0	0
Foreign currency forward contracts	0	0
Total	0	0
Level I \| Equity securities
Assets
Investments	0	0
Level I \| Bonds
Assets
Investments	0	0
Level I \| Loans
Assets
Investments	0	0
Level I \| Investments of Consolidated Funds
Assets
Investments	0	0
Level I \| Investments in CLOs
Assets
Investments	0	0
Level I \| Other investments
Assets
Investments	1.5	1.3
Level I \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	0
Level I \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments		1.3
Level I \| Commercial paper and other
Assets
Subtotal		0
Level II
Assets
Subtotal	47	111.2
Liabilities
Loans payable of Consolidated Funds	0	0
Foreign currency forward contracts	0.7	29.5
Total	0.7	29.5
Level II \| Equity securities
Assets
Investments	0	0
Level II \| Bonds
Assets
Investments	0	0
Level II \| Loans
Assets
Investments	0	0
Level II \| Investments of Consolidated Funds
Assets
Investments	0	0
Level II \| Investments in CLOs
Assets
Investments	0	0
Level II \| Other investments
Assets
Investments	45.6	41.7
Level II \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	1.4
Level II \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments		41.7
Level II \| Commercial paper and other
Assets
Subtotal		69.5
Level III
Assets
Subtotal	6,955.3	6,691.6
Liabilities
Loans payable of Consolidated Funds	5,811	5,303.7
Foreign currency forward contracts	0	0
Total	5,811	5,303.7
Level III \| Equity securities
Assets
Investments	17.9	511.9
Subtotal		56.3
Investments measured at net asset value		54.9
Level III \| Bonds
Assets
Investments	599.5	560.8
Level III \| Loans
Assets
Investments	5,898.1	5,054.7
Level III \| Investments of Consolidated Funds
Assets
Investments	6,515.5	6,127.4
Subtotal	6,515.5	6,127.4
Level III \| Investments in CLOs
Assets
Investments	361.1	499.6
Level III \| Other investments
Assets
Investments	78.7	64.6
Level III \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	0
Level III \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments		564.2
Level III \| Commercial paper and other
Assets
Subtotal		0
Fair Value, Inputs, Level 1, 2 and 3
Assets
Subtotal		6,804.1
Fair Value, Inputs, Level 1, 2 and 3 \| Equity securities
Assets
Investments		511.9
Fair Value, Inputs, Level 1, 2 and 3 \| Bonds
Assets
Investments		560.8
Fair Value, Inputs, Level 1, 2 and 3 \| Loans
Assets
Investments		5,054.7
Fair Value, Inputs, Level 1, 2 and 3 \| Investments of Consolidated Funds
Assets
Investments		6,127.4
Fair Value, Inputs, Level 1, 2 and 3 \| Investments in CLOs
Assets
Investments		499.6
Investments measured at net asset value	54.9
Fair Value, Inputs, Level 1, 2 and 3 \| Other investments
Assets
Investments		107.6
Fair Value, Inputs, Level 1, 2 and 3 \| Commercial paper and other
Assets
Subtotal		69.5
Fair Value Measured at NAV
Assets
Investments measured at net asset value	161.7	294.6
Fair Value Measured at NAV \| Consolidated VIEs
Assets
Investments measured at net asset value	$ 145.5	$ 282.3

Fair Value Measurement - Level

Fair Value Measurement - Level III Financial Assets Measured at Fair Value (Details) - Level III - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 6,772.7	$ 6,535.4	$ 6,955.3	$ 6,627.7
Deconsolidation/consolidation of funds		490.7		343
Purchases	1,058.9	1,176.2	3,215.2	3,919.6
Sales and distributions	(653.1)	(841.1)	(1,933.8)	(2,862.6)
Settlements	(130.4)	(378.6)	(492.4)	(1,024)
Realized and unrealized gains (losses), net
Included in earnings	(62.4)	7.6	(382)	125.6
Included in other comprehensive income	(294.1)	(113.9)	(670.7)	(253)
Balance, end of period	6,691.6	6,876.3	6,691.6	6,876.3
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(71.2)	2.7	(369.1)	90.3
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	(266)	(113)	(538.6)	(211.5)
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	12.4	18.3	17.9	9.4
Deconsolidation/consolidation of funds		3.3		5.7
Purchases	518.5	0.1	518.6	0.6
Sales and distributions	0	(1.2)	(7.2)	(3.5)
Settlements	0	0	0	0
Realized and unrealized gains (losses), net
Included in earnings	(18.3)	(1.3)	(15.9)	7.3
Included in other comprehensive income	(0.7)	(0.3)	(1.5)	(0.6)
Balance, end of period	511.9	18.9	511.9	18.9
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(18.3)	(1.9)	(16.7)	5.2
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	(0.7)	(0.3)	(1.3)	(0.4)
Bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	669.8	542	599.5	550.4
Deconsolidation/consolidation of funds		0		0
Purchases	46.6	108.1	429	472
Sales and distributions	(92.6)	(44)	(320.2)	(405.2)
Settlements	0	(0.2)	(0.3)	(3.8)
Realized and unrealized gains (losses), net
Included in earnings	(21.6)	(11.3)	(59.6)	(1.3)
Included in other comprehensive income	(41.4)	(13.5)	(87.6)	(31)
Balance, end of period	560.8	581.1	560.8	581.1
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(22.1)	1.5	(57)	7.7
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	(34.3)	(13.7)	(55.2)	(22)
Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	5,516.8	5,543.6	5,898.1	5,497.1
Deconsolidation/consolidation of funds		490.4		314.2
Purchases	473.9	1,058.4	2,014.8	3,375.3
Sales and distributions	(552.4)	(781)	(1,566.5)	(2,199)
Settlements	(130.4)	(378.4)	(492.1)	(1,020.2)
Realized and unrealized gains (losses), net
Included in earnings	(30)	13.3	(277.4)	103.1
Included in other comprehensive income	(223.2)	(93.4)	(522.2)	(217.6)
Balance, end of period	5,054.7	5,852.9	5,054.7	5,852.9
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(35.7)	(4.2)	(266.3)	61.1
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	(202.2)	(92.3)	(422.7)	(185.3)
Investments in CLOs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	508.6	353.1	361.1	489.4
Deconsolidation/consolidation of funds		(3)		23.1
Purchases	19.9	9.6	251.9	71.7
Sales and distributions	(7.2)	(14.5)	(36.1)	(238.4)
Settlements	0	0	0	0
Realized and unrealized gains (losses), net
Included in earnings	7.1	6.2	(17.9)	2.7
Included in other comprehensive income	(28.8)	(6.7)	(59.4)	(3.8)
Balance, end of period	499.6	344.7	499.6	344.7
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	4.5	6.2	(17.9)	2.3
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	(28.8)	(6.7)	(59.4)	(3.8)
Other investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	65.1	78.4	78.7	81.4
Purchases	0	0	0.9	0
Sales and distributions	(0.9)	(0.4)	(3.8)	(16.5)
Settlements	0	0	0	0
Realized and unrealized gains (losses), net
Included in earnings	0.4	0.7	(11.2)	13.8
Included in other comprehensive income	0	0	0	0
Balance, end of period	64.6	78.7	64.6	78.7
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	0.4	1.1	(11.2)	14
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	$ 0	$ 0	$ 0	$ 0

Fair Value Measurement - Leve_2

Fair Value Measurement - Level III Financial Liabilities Measured at Fair Value (Details) - Level III - Loans Payable of Consolidated Funds - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 5,757.8	$ 5,373.9	$ 5,811	$ 5,563
Deconsolidation/consolidation of funds	0	480	0	360.8
Borrowings	26.4	1,133	1,597.7	1,966.6
Paydowns	(1.8)	(712)	(419.1)	(1,303)
Sales	(193.9)	(237.5)	(863.4)	(515.2)
Realized and unrealized (gains) losses, net
Included in earnings	(40.8)	(2.4)	(268.3)	90.7
Included in other comprehensive income	(244)	(96.7)	(554.2)	(224.6)
Balance, end of period	5,303.7	5,938.3	5,303.7	5,938.3
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date	(41.3)	3.7	(262.6)	98.1
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date	$ (235.5)	$ (127)	$ (567)	$ (281.4)

Fair Value Measurement - Summar

Fair Value Measurement - Summary of Quantitative Information about Level III Inputs (Details) $ in Millions	Sep. 30, 2022 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 7,098.7	$ 7,003.8
Fair value of liabilities	5,333.2	5,811.7
Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	6,691.6	6,955.3
Fair value of liabilities	5,303.7	5,811
Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	5,085.8	5,561.1
Investments of Consolidated Funds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	6,127.4	6,515.5
Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	56.3
Consensus Pricing \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	10.4	17.9
Consensus Pricing \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	560.8	599.5
Consensus Pricing \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 4,853.1	$ 5,766
Consensus Pricing \| Indicative Quotes \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0
Consensus Pricing \| Indicative Quotes \| Minimum \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	55	0.93
Consensus Pricing \| Indicative Quotes \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0.35
Consensus Pricing \| Indicative Quotes \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	17	84.22
Consensus Pricing \| Indicative Quotes \| Maximum \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1.25	1.07
Consensus Pricing \| Indicative Quotes \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1.03	1.06
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.43	0.63
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.89	0.99
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.93	0.98
Discounted Cash Flow \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 445.2
Discounted Cash Flow \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	24	$ 65.1
Discounted Cash Flow \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 3.4	$ 6.1
Discounted Cash Flow \| Discount Rates \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.09
Discounted Cash Flow \| Discount Rates \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.09	0.04
Discounted Cash Flow \| Discount Rates \| Minimum \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.22	0.18
Discounted Cash Flow \| Discount Rates \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10
Discounted Cash Flow \| Discount Rates \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.12	0.08
Discounted Cash Flow \| Discount Rates \| Maximum \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.22	0.18
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.09
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10	0.05
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.22	0.18
Market Yield Analysis \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 61.3	$ 67
Market Yield Analysis \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 61.2	$ 72.5
Market Yield Analysis \| Market Yield \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.03
Market Yield Analysis \| Market Yield \| Minimum \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07	0.07
Market Yield Analysis \| Market Yield \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.08
Market Yield Analysis \| Market Yield \| Maximum \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07	0.07
Market Yield Analysis \| Market Yield \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.05
Market Yield Analysis \| Market Yield \| Weighted Average \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07	0.07
Consensus Pricing with Discounted Cash Flow \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	$ 217.9	$ 249.9
Consensus Pricing with Discounted Cash Flow \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	430.7	289.7
Consensus Pricing with Discounted Cash Flow \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 68.9	$ 71.5
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.19	0.40
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.74	0.86
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.21	0.46
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	1.03	0.97
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1	1.01
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.66	0.97
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.43	0.61
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.95	0.99
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.49	0.63
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.0155	0.0050
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.1700	0.1330
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.0336	0.0245
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.02	0.01
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.01	0.01
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.01	0.01
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.03	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.03	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.03	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.02	0.01
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.01
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.01
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.50	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.50	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.50	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.70	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.70	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.70	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.60	0.60
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.60
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.60
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.15	0.14
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.13	0.14
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.25	0.22
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.25	0.22
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.20	0.19
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.19	0.19
Other \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 116.3
Other \| Discount Rates \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07
Other \| Discount Rates \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10
Other \| Discount Rates \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.08

Investments - Schedule of Inves

Investments - Schedule of Investments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Investments [Abstract]
Accrued performance allocations	$ 7,428.7	$ 8,133
Principal equity method investments, excluding performance allocations	2,883.8	2,128.6
Principal investments in CLOs	499.6	361.1
Other investments	186.1	209.3
Total	$ 10,998.2	$ 10,832

Investments - Investment Compon

Investments - Investment Components of Accrued Performance Fees (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Dec. 31, 2021	Sep. 30, 2022
Segment Reporting Information [Line Items]
Accrued performance allocations	$ 8,133	$ 7,428.7
Maximum lag period for which the partnership investments in funds are valued	90 days	90 days
Global Private Equity
Segment Reporting Information [Line Items]
Accrued performance allocations	$ 6,412.8	$ 5,866.3
Global Credit
Segment Reporting Information [Line Items]
Accrued performance allocations	300.3	220.1
Global Investment Solutions
Segment Reporting Information [Line Items]
Accrued performance allocations	$ 1,419.9	$ 1,342.3

Investments - Additional Inform

Investments - Additional Information, Accrued Performance Fees (Details) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2022 USD ($) financingVehicle	Mar. 31, 2022	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) financingVehicle	Sep. 30, 2021 USD ($)	Dec. 31, 2021 fund
Concentration Risk [Line Items]
Number of partnerships corporate private equity funds related to accrued performance fees	2			2		1
Total	$ 298.1		$ 974.5	$ 1,346.2	$ 4,841.3
Carlyle Partners VI, L.P. \| Accrued performance allocations \| Customer concentration risk
Concentration Risk [Line Items]
Percentage of accrued performance fees related to certain Corporate Private Equity funds (percent)		25%		24%

Investments - Components of Acc

Investments - Components of Accrued Giveback Obligations (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Accrued giveback obligations	$ (40.9)	$ (30.2)
Global Private Equity
Segment Reporting Information [Line Items]
Accrued giveback obligations	(18.4)	(18.4)
Global Credit
Segment Reporting Information [Line Items]
Accrued giveback obligations	$ (22.5)	$ (11.8)

Investments - Principal Investm

Investments - Principal Investments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Total	$ 2,883.8	$ 2,128.6
NGP Management
Segment Reporting Information [Line Items]
Total	988.2	436.9
Fortitude Group Holdings, LLC
Segment Reporting Information [Line Items]
Total	645.3	715.7
iStar
Segment Reporting Information [Line Items]
Total	184.2
Global Private Equity
Segment Reporting Information [Line Items]
Total	1,832.8	1,231.2
Global Credit
Segment Reporting Information [Line Items]
Total	960.3	819.7
Global Investment Solutions
Segment Reporting Information [Line Items]
Total	$ 90.7	$ 77.7

Investments - Strategic Investm

Investments - Strategic Investment in Fortitude (Details) - USD ($) $ in Millions			1 Months Ended					3 Months Ended	9 Months Ended
	Jun. 02, 2020	Nov. 13, 2018	Dec. 31, 2023	Sep. 30, 2022	May 31, 2022	Mar. 31, 2022	May 31, 2020	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Investment				$ 2,883.8				$ 2,883.8	$ 2,883.8	$ 2,128.6
Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired		19.90%
Payments to acquire equity method investments		$ 381
Deferred consideration, maximum		$ 95
Purchase price adjustment, maximum							$ 99.5
Purchase price adjustment, payable upon inability to make distribution							$ 79.6
Investment				645.3				645.3	645.3	$ 715.7
Fortitude Group Holdings, LLC \| Fortitude Re \| Maximum
Schedule of Equity Method Investments [Line Items]
Committed capital				9,100				9,100	9,100
Fortitude Group Holdings, LLC \| Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Ownership interest transferred	19.90%
Fortitude Group Holdings, LLC \| Forecast
Schedule of Equity Method Investments [Line Items]
Purchase price adjustment, payable upon inability to make distribution			$ 19.9
Fortitude Group Holdings, LLC \| Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired	51.60%
Ownership percentage	71.50%
Fortitude Group Holdings, LLC \| T&D
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired	25%
Fortitude Group Holdings, LLC \| Carlyle FRL and T&D
Schedule of Equity Method Investments [Line Items]
Ownership percentage	96.50%
Fortitude Re \| Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership percentage		100%
Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Equity capital raised					$ 1,100	$ 2,000
Investment loss				121	$ 176.9				176.9
Investment				645.3				645.3	645.3
Investment, cost				$ 389.4				$ 389.4	$ 389.4
Carlyle FRL \| Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Business acquisition further decrease funding percentage					10.50%			10.50%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Maximum
Schedule of Equity Method Investments [Line Items]
Ownership percentage					19.90%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Minimum
Schedule of Equity Method Investments [Line Items]
Ownership percentage					13.50%
Carlyle FRL \| T&D
Schedule of Equity Method Investments [Line Items]
Investment company, committed capital						$ 100

Investments - Strategic Inves_2

Investments - Strategic Investment in NGP - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Performance allocations, percentage (percent)			47.50%
Basis difference	$ 0.4		$ 0.4		$ 1.4
Amortization period of basis difference			10 years
NGP Management
Schedule of Equity Method Investments [Line Items]
Net investment earnings related to performance allocations	81.6	$ 1.7	$ 532.2	$ 2.8
Net investment earnings related to principal investment income	$ 9.6	$ 5.1	$ 43	$ 16.8
NGP Management \| NGP XI
Schedule of Equity Method Investments [Line Items]
Performance allocations, percentage (percent)			63%
NGP Management \| NGP XII
Schedule of Equity Method Investments [Line Items]
Performance allocations, percentage (percent)			58%
Minimum \| NGP Management
Schedule of Equity Method Investments [Line Items]
Management fee, percentage of commitments (percent)			1%
Management fee, percentage of invested capital (percent)			0.50%
Maximum \| NGP Management
Schedule of Equity Method Investments [Line Items]
Management fee, percentage of commitments (percent)			2%
Management fee, percentage of invested capital (percent)			2%
Management Fee Related Revenues
Schedule of Equity Method Investments [Line Items]
Management fee-related revenues, allocation percentage (percent)			55%

Investments - Investments in NG

Investments - Investments in NGP (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Total	$ 2,883.8	$ 2,128.6
Investment in NGP Management
Schedule of Equity Method Investments [Line Items]
Total	370.1	371.8
Investments in NGP general partners - accrued performance allocations
Schedule of Equity Method Investments [Line Items]
Total	536	3.8
Principal investments in NGP funds
Schedule of Equity Method Investments [Line Items]
Total	82.1	61.3
Total investments in NGP
Schedule of Equity Method Investments [Line Items]
Total	$ 988.2	$ 436.9

Investments - Schedule of Net I

Investments - Schedule of Net Investment Earnings (Loss) (Details) - NGP Management - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule of Equity Method Investments [Line Items]
Management fee-related revenues from NGP Management	$ 18.1	$ 18.2	$ 52.7	$ 54.9
Expenses related to the investment in NGP Management	(3.5)	(2.9)	(8.9)	(8.1)
Amortization of basis differences from the investment in NGP Management	(0.4)	(0.7)	(1.1)	(2.1)
Net investment income from NGP Management	$ 14.2	$ 14.6	$ 42.7	$ 44.7

Investments - Principal Inves_2

Investments - Principal Investments in CLOs and Other Investments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Mar. 21, 2022	Dec. 31, 2021
Management Contracts
Debt and Equity Securities, FV-NI [Line Items]
Acquired CLO senior and subordinated notes		$ 175.9
TCG BDC, Inc.
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 61.2		$ 72.5
Corporate Mezzanine Securities Bonds and Warrants
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 499.6		$ 361.1

Investments - Components of Inv

Investments - Components of Investment Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Investment Income [Line Items]
Investment income (loss)	$ 422.3	$ 1,134.9	$ 1,846.7	$ 5,318.5
Performance allocations - realized
Net Investment Income [Line Items]
Investment income (loss)	770.5	1,018.1	1,579	1,645.6
Performance allocations - unrealized
Net Investment Income [Line Items]
Investment income (loss)	(472.4)	(43.6)	(232.8)	3,195.7
Performance allocations
Net Investment Income [Line Items]
Investment income (loss)	298.1	974.5	1,346.2	4,841.3
Principal investment income (loss) from equity method investments (excluding performance allocations) - realized
Net Investment Income [Line Items]
Investment income (loss)	70.6	87.7	34.3	175.5
Principal investment income (loss) from equity method investments (excluding performance allocations) - unrealized
Net Investment Income [Line Items]
Investment income (loss)	80.3	30.5	536.5	239.4
Principal investment income (loss) from equity method investments (excluding performance allocations)
Net Investment Income [Line Items]
Investment income (loss)	150.9	118.2	570.8	414.9
Principal investment income (loss) from investments in CLOs and other investments - realized
Net Investment Income [Line Items]
Investment income (loss)	6.2	4.4	9.4	3.9
Principal investment income (loss) from investments in CLOs and other investments - unrealized
Net Investment Income [Line Items]
Investment income (loss)	(32.9)	37.8	(79.7)	58.4
Principal investment income (loss) from investments in CLOs and other investments
Net Investment Income [Line Items]
Investment income (loss)	$ (26.7)	$ 42.2	$ (70.3)	$ 62.3

Investments - Schedule of Perfo

Investments - Schedule of Performance Allocations Included in Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule of Investments [Line Items]
Total	$ 298.1	$ 974.5	$ 1,346.2	$ 4,841.3
Global Private Equity
Schedule of Investments [Line Items]
Total	237.2	777.8	1,106.4	4,142.5
Global Credit
Schedule of Investments [Line Items]
Total	27.2	27.4	(3.6)	124.6
Global Investment Solutions
Schedule of Investments [Line Items]
Total	$ 33.7	$ 169.3	$ 243.4	$ 574.2

Investments - Additional Info_2

Investments - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Gain (loss) from investments	$ 298.1	$ 974.5	$ 1,346.2	$ 4,841.3
Performance Fee Revenue \| Customer concentration risk
Segment Reporting Information [Line Items]
Percentage of performance fees related to certain Corporate Private Equity funds (percent)	27%	22%	26%	35%
Gain (loss) from investments	$ 81	$ 216	$ 347.1	$ 1,715.9
Performance Fee Revenue \| Customer concentration risk \| Carlyle Europe Partners V, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments	79.6		220.2
Performance Fee Revenue \| Customer concentration risk \| Carlyle Power Partners II, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments	63.1		198.1
Performance Fee Revenue \| Customer concentration risk \| Carlyle Europe Partners IV, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments	46.1			579.3
Performance Fee Revenue \| Customer concentration risk \| Carlyle Partners V, L.P
Segment Reporting Information [Line Items]
Gain (loss) from investments	45.5
Performance Fee Revenue \| Customer concentration risk \| Carlyle Partners VII, L.P
Segment Reporting Information [Line Items]
Gain (loss) from investments	(16.7)
Performance Fee Revenue \| Customer concentration risk \| Carlyle Asia Partners V, L.P
Segment Reporting Information [Line Items]
Gain (loss) from investments	$ (29.3)
Performance Fee Revenue \| Customer concentration risk \| Carlyle Realty Partners VIII, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments		119.1	259.1
Performance Fee Revenue \| Customer concentration risk \| Carlyle Europe Technology Partners IV, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments			186.5
Performance Fee Revenue \| Customer concentration risk \| Carlyle Partners VI, L.P.
Segment Reporting Information [Line Items]
Gain (loss) from investments		$ 130.7	$ (340.4)	$ 1,281

Investments - Income (Loss) fro

Investments - Income (Loss) from Principal Investments (Details) - USD ($) $ in Millions	1 Months Ended		3 Months Ended		9 Months Ended
	Sep. 30, 2022	May 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule of Investments [Line Items]
Principal investment income from equity method investments			$ 150.9	$ 118.2	$ 570.8	$ 414.9
Carlyle FRL
Schedule of Investments [Line Items]
Investment loss	$ 121	$ 176.9			176.9
Carlyle FRL \| Maximum \| Fortitude Group Holdings, LLC
Schedule of Investments [Line Items]
Ownership percentage		19.90%
Carlyle FRL \| Minimum \| Fortitude Group Holdings, LLC
Schedule of Investments [Line Items]
Ownership percentage		13.50%
Global Private Equity
Schedule of Investments [Line Items]
Principal investment income from equity method investments			124.7	63.8	698.8	272.9
Global Credit
Schedule of Investments [Line Items]
Principal investment income from equity method investments			26.8	47.5	(134.6)	120.6
Global Investment Solutions
Schedule of Investments [Line Items]
Principal investment income from equity method investments			$ (0.6)	$ 6.9	$ 6.6	$ 21.4

Investments - Investments of Co

Investments - Investments of Consolidated Funds (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Investments measured at net asset value		$ 7,165.5
Minimum percent of aggregate assets for individual investments with fair value	5%
Consolidated VIEs \| Equity securities
Schedule of Investments [Line Items]
Investments measured at net asset value	$ 453.4

Investments - Interest and Othe

Investments - Interest and Other Income of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments [Abstract]
Interest income from investments	$ 72.5	$ 56.9	$ 188.2	$ 170.4
Other income	7.2	5.2	16.4	14.9
Total	$ 79.7	$ 62.1	$ 204.6	$ 185.3

Investments - Net Investment Ga

Investments - Net Investment Gains (Losses) of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments [Abstract]
Gains (losses) from investments of Consolidated Funds	$ (71.2)	$ (2.5)	$ (319.3)	$ 100.3
Gains (losses) from liabilities of CLOs	40.9	2.4	268.3	(90.7)
Total	$ (30.3)	$ (0.1)	$ (51)	$ 9.6

Investments - Realized and Unre

Investments - Realized and Unrealized Gains (Losses) Earned from Investments of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments [Abstract]
Realized gains (losses)	$ (9.3)	$ (10.7)	$ (13.1)	$ 6.5
Net change in unrealized gains (losses)	(61.9)	8.2	(306.2)	93.8
Total	$ (71.2)	$ (2.5)	$ (319.3)	$ 100.3

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Carrying Amount of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Acquired contractual rights	$ 914.6	$ 48
Accumulated amortization	(92.5)	(26.4)
Finite-lived intangible assets, net	822.1	21.6
Goodwill	103	13.3
Intangible Assets, net	$ 925.1	$ 34.9

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of intangible assets	$ 0	$ 0	$ 4,000,000	$ 0
Intangible asset amortization expense	$ 32,000,000	$ 1,800,000	$ 70,700,000	$ 8,400,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Estimated Amortization Expense (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (excluding the nine months ended September 30, 2022)	$ 33.1
2023	130.4
2024	130.5
2025	130.4
2026	130.3
Thereafter	267.4
Finite-lived intangible assets, net	$ 822.1	$ 21.6

Borrowings - Debt Obligations (

Borrowings - Debt Obligations (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	May 31, 2021
Debt Instrument [Line Items]
Borrowing Outstanding	$ 2,259.4	$ 2,097.6
Carrying Value	2,235	2,071.6
CLO Borrowings
Debt Instrument [Line Items]
Borrowing Outstanding	384.4	222.6
Carrying Value	$ 381.6	219
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Interest rate (percent)	5.625%
Borrowing Outstanding	$ 600	600
Carrying Value	$ 600.6	600.6
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Interest rate (percent)	5.65%
Borrowing Outstanding	$ 350	350
Carrying Value	$ 346.3	346.1
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)	3.50%
Borrowing Outstanding	$ 425	425
Carrying Value	$ 421.9	421.6
4.625% Subordinated Notes Due 5/15/2061
Debt Instrument [Line Items]
Interest rate (percent)	4.625%		4.625%
Borrowing Outstanding	$ 500	500
Carrying Value	$ 484.6	$ 484.3

Borrowings - Additional Informa

Borrowings - Additional Information (Details) € in Millions		1 Months Ended	3 Months Ended			5 Months Ended	9 Months Ended
Borrowings - Additional Information (Details) € in Millions	Dec. 17, 2018	Nov. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)	May 31, 2021 USD ($)	Feb. 05, 2019 EUR (€)	Feb. 28, 2017 EUR (€)	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)
Debt Instrument [Line Items]
Borrowings under credit facilities							$ 0	$ 70,000,000
Interest expense			$ 27,300,000		$ 27,900,000		82,000,000	76,400,000
Outstanding borrowings			2,235,000,000				2,235,000,000			$ 2,071,600,000
Interest expense			17,200,000		19,700,000		51,700,000	59,200,000
Fair value of collateralized loan obligation assets			5,600,000,000				$ 5,600,000,000			6,700,000,000
Senior Notes
Debt Instrument [Line Items]
Debt redemption price percentage (percent)							100%
Interest expense		$ 10,100,000
CLO Borrowings
Debt Instrument [Line Items]
Interest expense			2,800,000		1,200,000		$ 6,800,000	4,400,000
Outstanding borrowings			381,600,000				381,600,000			219,000,000
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Debt principal amount \| €														€ 36.1
Outstanding borrowings			$ 35,400,000				$ 35,400,000
CLO Term Loan Maturing November 2031 \| Euribor
Debt Instrument [Line Items]
Interest rate under credit facility			2.33%				2.33%		2.33%
Master Credit Agreements - Term Loans
Debt Instrument [Line Items]
Outstanding borrowings			$ 98,600,000				$ 98,600,000
CLO Financing Facility
Debt Instrument [Line Items]
Borrowing capacity \| €													€ 100
Outstanding borrowings			199,300,000				199,300,000		€ 203.6
CBAM CLO Financing Facility
Debt Instrument [Line Items]
Borrowing capacity \| €									100
Outstanding borrowings			44,600,000				44,600,000		€ 45.6
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Outstanding borrowings			$ 346,300,000				$ 346,300,000			346,100,000
Interest rate (percent)			5.65%				5.65%		5.65%
5.650% Senior Notes Due 9/15/2048 \| Senior Notes
Debt Instrument [Line Items]
Debt principal amount			$ 350,000,000				$ 350,000,000
Interest expense			5,000,000		5,000,000		14,900,000	14,900,000
Fair value of debt			312,600,000				$ 312,600,000			484,700,000
5.650% Senior Notes Due 9/15/2048 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate							0.40%
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Outstanding borrowings			$ 600,600,000				$ 600,600,000			600,600,000
Interest rate (percent)			5.625%				5.625%		5.625%
5.625% Senior Notes Due 3/30/2043 \| Senior Notes
Debt Instrument [Line Items]
Debt principal amount			$ 600,000,000				$ 600,000,000								$ 200,000,000	$ 400,000,000
Interest expense			8,400,000		8,400,000		25,300,000	25,300,000
Fair value of debt			515,500,000				$ 515,500,000			795,500,000
5.625% Senior Notes Due 3/30/2043 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate							0.40%
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Outstanding borrowings			$ 421,900,000				$ 421,900,000			421,600,000
Interest rate (percent)			3.50%				3.50%		3.50%
3.500% Senior Notes Due 9/19/2029 \| Senior Notes
Debt Instrument [Line Items]
Debt principal amount			$ 425,000,000				$ 425,000,000
Interest rate (percent)			3.50%				3.50%		3.50%
Interest expense			$ 3,800,000		3,800,000		$ 11,500,000	11,500,000
Fair value of debt			$ 361,600,000				$ 361,600,000			457,400,000
3.500% Senior Notes Due 9/19/2029 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate							0.30%
3.875% Senior Notes Due 2/01/2023
Debt Instrument [Line Items]
Interest rate (percent)		3.875%	3.875%				3.875%		3.875%
3.875% Senior Notes Due 2/01/2023 \| Senior Notes
Debt Instrument [Line Items]
Debt principal amount		$ 250,000,000	$ 0				$ 0
Interest rate (percent)			3.875%				3.875%		3.875%
Interest expense			$ 0		2,500,000		$ 0	$ 7,500,000
Fair value of debt			0				$ 0			0
3.875% Senior Notes Due 2/01/2023 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate							0.30%
4.625% Subordinated Notes Due 5/15/2061
Debt Instrument [Line Items]
Interest expense			5,900,000		$ 5,600,000	$ 8,900,000	$ 17,600,000
Debt principal amount											$ 65,000,000	$ 435,000,000
Outstanding borrowings			$ 484,600,000				$ 484,600,000			484,300,000
Debt redemption price percentage (percent)							102%
Interest rate (percent)			4.625%				4.625%		4.625%			4.625%
Period from Tax Redemption Event that debt may be redeemed							120 days
Period from rating agency event that debt may be redeemed							90 days
Fair value of debt			$ 344,000,000				$ 344,000,000			$ 506,000,000
Revolving Credit Facility \| Senior Credit Facility Due 2/11/2024
Debt Instrument [Line Items]
Borrowing capacity			$ 1,000,000,000	$ 775,000,000			$ 1,000,000,000
Interest rate under credit facility			4.14%				4.14%		4.14%
Borrowings under credit facilities			$ 0				$ 0
Repayments under credit facility			0				0
Outstanding borrowings			0				$ 0
Revolving Credit Facility \| Senior Credit Facility Due 2/11/2024 \| Base rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)				0.50%			0.50%
Revolving Credit Facility \| Senior Credit Facility Due 2/11/2024 \| SOFR
Debt Instrument [Line Items]
Margin spread on interest rate (percent)							0.10%
Revolving Credit Facility \| Senior Credit Facility Due 2/11/2024 \| LIBOR
Debt Instrument [Line Items]
Margin spread on interest rate (percent)				1.50%			1.50%
Revolving Credit Facility \| Global Credit Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing capacity			250,000,000				$ 250,000,000
Outstanding borrowings			0				0
Borrowings under credit facility			$ 0				$ 0
Revolving Credit Facility \| Global Credit Revolving Credit Facility \| Base rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	1%
Revolving Credit Facility \| Global Credit Revolving Credit Facility \| Eurocurrency
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	2%

Borrowings - CLO Borrowings (De

Borrowings - CLO Borrowings (Details) € in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Borrowing Outstanding	$ 2,259.4		$ 2,097.6
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 35.4	€ 36.1	51.3
CLO Term Loan Maturing November 2031 \| Euribor
Debt Instrument [Line Items]
Interest Rate	2.33%	2.33%
CLO Term Loan June 2017 Maturing July 20, 2030
Debt Instrument [Line Items]
Borrowing Outstanding	$ 54.8		0
CLO Term Loan June 2017 Maturing July 20, 2030 \| LIBOR
Debt Instrument [Line Items]
Interest Rate	4.36%	4.36%
Margin spread on interest rate (percent)	1.65%
CLO Term Loan December 2017 Maturing January 15, 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 43.8		0
CLO Term Loan December 2017 Maturing January 15, 2031 \| LIBOR
Debt Instrument [Line Items]
Interest Rate	3.88%	3.88%
Margin spread on interest rate (percent)	1.37%
CLO Term Loan Maturing March 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 1.6		1.9
CLO Term Loan Maturing March 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	8.11%	8.11%
CLO Term Loan August 2021 Maturing August 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 3.5		4.1
CLO Term Loan August 2021 Maturing August 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.06%	5.06%
CLO Term Loan Maturing April 2033
Debt Instrument [Line Items]
Borrowing Outstanding	$ 17.4		20.3
CLO Term Loan Maturing April 2033 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	1.59%	1.59%
CLO Term Loan Maturing January 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.2		21.3
CLO Term Loan Maturing January 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.49%	2.49%
CLO Term Loan Maturing August 2030
Debt Instrument [Line Items]
Borrowing Outstanding	$ 17.4		20.3
CLO Term Loan Maturing August 2030 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	1.69%	1.69%
CLO Term Loan Maturing March 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 16.4		19.1
CLO Term Loan Maturing March 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	1.71%	1.71%
CLO Term Loan Maturing April 2033
Debt Instrument [Line Items]
Borrowing Outstanding	$ 3.2		3.7
CLO Term Loan Maturing April 2033 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.85%	5.85%
CLO Term Loan April 2021 Maturing April 28, 2023
Debt Instrument [Line Items]
Borrowing Outstanding	$ 6.5		0
CLO Term Loan April 2021 Maturing April 28, 2023 \| Euribor
Debt Instrument [Line Items]
Interest Rate	2.03%	2.03%
Margin spread on interest rate (percent)	1.35%
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 13.7		15.9
CLO Term Loan Maturing November 2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	1.36%	1.36%
CLO Term Loan Maturing January 16 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.3		21.3
CLO Term Loan Maturing January 16 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.28%	2.28%
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 1.2		1.4
CLO Term Loan Maturing November 2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.85%	2.85%
CLO Term Loan July 2021 Maturing July 15, 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 13.7		0
CLO Term Loan July 2021 Maturing July 15, 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.30%	2.30%
CLO Term Loan July 2021 Maturing July 20, 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.2		0
CLO Term Loan July 2021 Maturing July 20, 2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.28%	2.28%
CLO Term Loan Maturing August 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 14.8		17.2
CLO Term Loan Maturing August 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.30%	2.30%
CLO Term Loan October 2021 Maturing October 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 21.3		24.8
CLO Term Loan October 2021 Maturing October 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.40%	2.40%
CLO Term Loan November 2021 Maturing January 14, 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 12.7		0
CLO Term Loan November 2021 Maturing January 14, 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.09%	2.09%
CLO Term Loan January 2022 Maturing February 15, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.4		0
CLO Term Loan January 2022 Maturing February 15, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.70%	2.70%
CLO Term Loan February 2022 Maturing November 10, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.4		0
CLO Term Loan February 2022 Maturing November 10, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	2.75%	2.75%
CLO Term Loan July 2022 Maturing Februray 15, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 15.5		0
CLO Term Loan July 2022 Maturing Februray 15, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	3.61%	3.61%
CLO Borrowings
Debt Instrument [Line Items]
Borrowing Outstanding	$ 384.4		$ 222.6
CLO Term Loan Various \| Average effective interest rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	0.50%

Borrowings - Senior Notes (Deta

Borrowings - Senior Notes (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
Borrowings - Senior Notes (Details) - USD ($)	Nov. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Sep. 30, 2019	Sep. 30, 2018	Mar. 31, 2014	Mar. 31, 2013	Jan. 31, 2013
Debt Instrument [Line Items]
Interest Expense		$ 17,200,000	$ 19,700,000	$ 51,700,000	$ 59,200,000
3.875% Senior Notes Due 2/01/2023
Debt Instrument [Line Items]
Interest rate (percent)	3.875%	3.875%		3.875%
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Interest rate (percent)		5.625%		5.625%
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Interest rate (percent)		5.65%		5.65%
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)		3.50%		3.50%
Senior Notes
Debt Instrument [Line Items]
Interest Expense	$ 10,100,000
Senior Notes \| 3.875% Senior Notes Due 2/01/2023
Debt Instrument [Line Items]
Interest rate (percent)		3.875%		3.875%
Aggregate Principal Amount	$ 250,000,000	$ 0		$ 0
Fair Value		0		0		$ 0
Interest Expense		0	2,500,000	0	7,500,000
Senior notes percentage of par value (percent)											99.966%
Senior Notes \| 5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Aggregate Principal Amount		600,000,000		600,000,000					$ 200,000,000	$ 400,000,000
Fair Value		515,500,000		515,500,000		795,500,000
Interest Expense		8,400,000	8,400,000	25,300,000	25,300,000
Senior notes percentage of par value (percent)									104.315%	99.583%
Senior Notes \| 5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Aggregate Principal Amount		350,000,000		350,000,000
Fair Value		312,600,000		312,600,000		484,700,000
Interest Expense		$ 5,000,000	5,000,000	$ 14,900,000	14,900,000
Senior notes percentage of par value (percent)								99.914%
Senior Notes \| 3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)		3.50%		3.50%
Aggregate Principal Amount		$ 425,000,000		$ 425,000,000
Fair Value		361,600,000		361,600,000		$ 457,400,000
Interest Expense		$ 3,800,000	$ 3,800,000	$ 11,500,000	$ 11,500,000
Senior notes percentage of par value (percent)							99.841%

Borrowings - Outstanding Loans

Borrowings - Outstanding Loans Payable of Consolidated Funds (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	$ 5,516.9	$ 5,890
Fair value of liabilities	5,333.2	5,811.7
Senior secured notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	160.5
Loans Payable of Consolidated Funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	5,613.5	5,903
Fair Value	5,303.7	5,811
Senior secured notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	5,466.6	5,585.4
Fair Value	$ 5,085.8	$ 5,561.1
Weighted Average Interest Rate	2.62%	1.68%
Weighted Average Remaining Maturity in Years	9 years 9 months 7 days	10 years 3 months
Subordinated notes, preferred shares and other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	$ 146.9	$ 317.6
Fair Value	$ 217.9	$ 249.9
Weighted Average Remaining Maturity in Years	9 years 11 months 19 days	10 years 4 months 28 days

Accrued Compensation and Bene_3

Accrued Compensation and Benefits - Components (Details) - USD ($) $ in Millions	Sep. 30, 2022	Aug. 01, 2022	Dec. 31, 2021	Dec. 31, 2018
Business Acquisition [Line Items]
Accrued performance allocations and incentive fee related compensation	$ 3,784.5		$ 4,087.8
Accrued bonuses	365.2		521.4
Employment-based contingent cash consideration	45.2		6.3
Accrued pension liability	34.1		27.4
Other	118.7		312.1
Total	4,347.7		4,955
Realized performance allocations and incentive fee-related compensation not yet paid	27.6		$ 207
Carlyle Aviation Partners/Apollo Aviation Group
Business Acquisition [Line Items]
Contingent consideration, estimated maximum range				$ 150
Abingworth
Business Acquisition [Line Items]
Contingent consideration, estimated maximum range	$ 130	$ 130

Accrued Compensation and Bene_4

Accrued Compensation and Benefits - Performance Allocations and Incentive Fee Related Compensation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Retirement Benefits [Abstract]
Realized	$ 377	$ 478.5	$ 776.7	$ 789.8
Unrealized	(213.5)	16.7	(35.5)	1,566
Total	$ 163.5	$ 495.2	$ 741.2	$ 2,355.8

Commitments and Contingencies -

Commitments and Contingencies - Unfunded Commitments (Details) - USD ($) $ in Millions	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022
Segment Reporting Information [Line Items]
Unfunded Commitments			$ 3,988.4
Unfunded commitment subscribed individually by senior Carlyle professionals, operating executives and other professionals			3,300
Unfunded commitment, fair market value of interest			12.7
Unfunded commitments related to origination and syndication of loans and securities			99.6
Subsequent event
Segment Reporting Information [Line Items]
Unfunded commitments, purchase agreement	$ 61
Unfunded commitments related to origination and syndication of loans Settled		$ 80
Global Private Equity
Segment Reporting Information [Line Items]
Unfunded Commitments			3,351.2
Global Credit
Segment Reporting Information [Line Items]
Unfunded Commitments			376.2
Global Investment Solutions
Segment Reporting Information [Line Items]
Unfunded Commitments			$ 261

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Details) R$ in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) employee	Dec. 31, 2021 USD ($)	Aug. 31, 2021 BRL (R$)
Guarantor Obligations [Line Items]
Liability for potential repayment of previously received performance fees	$ 40.9	$ 30.2
Unbilled receivable for giveback obligations from current and former employees	10.4	$ 0
Amount of accrued giveback obligation of various current and former senior Carlyle professionals and other limited partners of Carlyle Holdings partnerships	18.9
Amount of net accrued giveback obligation attributable to Carlyle Holdings	$ 22
Options to extend (up to)	5 years
Options to terminate (within)	1 year
Right-of-use asset impairment	$ 26.8
Number of employees serving on board of directors \| employee	2
Proceeds from sale of investment	$ 87.5
Loss contingency accrual	$ 40
Minimum
Guarantor Obligations [Line Items]
Term of lease	1 year
Maximum
Guarantor Obligations [Line Items]
Term of lease	14 years
Guaranteed Employee Credit Facility
Guarantor Obligations [Line Items]
Guarantor obligations, current carrying value	$ 0.4
Contingent Obligations (Giveback)
Guarantor Obligations [Line Items]
Cash withheld from carried interest distributions for potential giveback obligations	132.4
Amount of realized and distributed carried interest subject to potential giveback on after-tax basis	1,400
Contingent Obligations (Giveback) \| Current and Former Senior Carlyle Professionals
Guarantor Obligations [Line Items]
Amount of realized and distributed carried interest subject to potential giveback on after-tax basis	600
Indemnifications
Guarantor Obligations [Line Items]
Guaranteed loans, aggregate program limit	$ 18.5		R$ 100.0

Commitments and Contingencies_3

Commitments and Contingencies - Lease Cost, Cash Flows and Other Supplemental Information - Operating Leases (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Operating lease cost	$ 14	$ 14.1	$ 42	$ 41.6
Sublease income	(1.8)	(1)	(4.7)	(2.2)
Total operating lease cost	12.2	13.1	37.3	39.4
Cash paid for amounts included in the measurement of operating lease liabilities	$ 15.8	$ 12.4	$ 47.8	$ 35.1
Weighted-average remaining lease term	11 years 8 months 12 days	12 years 1 month 6 days	11 years 8 months 12 days	12 years 1 month 6 days
Weighted-average discount rate	4.40%	4.10%	4.40%	4.10%

Commitments and Contingencies_4

Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
2022 (excluding the nine months ended September 30, 2022)	$ 16
2023	65.8
2024	62.9
2025	58.9
2026	56.8
Thereafter	393.5
Total lease payments	653.9
Less payments for leases that have not yet commenced	(31.1)
Less imputed interest	(122.9)
Total lease liabilities	$ 499.9	$ 537.8

Related Party Transactions - Du

Related Party Transactions - Due from Affiliates and Other Receivables (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Accrued incentive fees	$ 14.5	$ 12.2
Unbilled receivable for giveback obligations from current and former employees	10.4	0
Notes receivable and accrued interest from affiliates	41.3	25.3
Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net	420.2	342.1
Total	$ 486.4	$ 379.6

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended		9 Months Ended
	May 05, 2020	Jan. 01, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Maximum percentage of interest on amounts due from affiliates (percent)					7.02%
Tax receivable agreement termination, cash payments per partnership unit exchanged (in dollars per share)		$ 1.50
Tax receivable agreement termination, term of annual installments		5 years
Tax receivable agreement termination, annual cash payments per partnership unit exchanged (in dollars per share)		$ 0.30
Conversion of units, deferred consideration obligation, discount		$ 11.3
Percentage of estimated realizable tax benefit to be paid by corporate taxpayers on exchange transactions					85%
Payment of aircraft related expenses			$ 0.4	$ 0.5	$ 0.9	$ 1.2
Fair value of assets			7,098.7		7,098.7		$ 7,003.8
Level III
Related Party Transaction [Line Items]
Fair value of assets			6,691.6		6,691.6		6,955.3
Level III \| BDC preferred shares \| Market Yield Analysis
Related Party Transaction [Line Items]
Fair value of assets			61.2		61.2		72.5
Affiliated Entity
Related Party Transaction [Line Items]
Interest-bearing loans			$ 22.3		$ 22.3		$ 18.2
Floor rate			3.50%		3.50%
Actual rate			0.0525		0.0525
Affiliated Entity \| WSJ Prime Rate
Related Party Transaction [Line Items]
Accrued interest percentage			1%		1%
Carlyle Secured Lending, Inc. \| Affiliated Entity
Related Party Transaction [Line Items]
Purchase of investment (in shares)	2,000,000
Purchase of investment (in dollars per share)	$ 25
Dividend rate, percentage	7%
Dividend rate, payable in shares, percentage	9%
Initial conversion price (in usd per share)	$ 9.50
Interest income			$ 0.9	$ 0.9	$ 2.6	$ 2.6

Related Party Transactions - _2

Related Party Transactions - Due to Affiliates (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Due to affiliates of Consolidated Funds	$ 15.6	$ 0
Due to non-consolidated affiliates	77.2	60.5
Deferred consideration for Carlyle Holdings units	133.7	200.5
Amounts owed under the tax receivable agreement	101.9	101.9
Other	23.2	25.2
Total	$ 351.6	$ 388.1

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 76.2	$ 153.9	$ 274.9	$ 733.5
Effective tax rate (percent)	21%	22%	20%	24%
Income taxes payable	$ 64.9		$ 64.9		$ 93.3

Non-controlling Interests in _3

Non-controlling Interests in Consolidated Entities - Non-Controlling Interests in Consolidated Entities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	$ 537.2	$ 427.2
Non-Carlyle interests in Consolidated Funds
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	346.8	180.1
Non-Carlyle interests in majority-owned subsidiaries
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	187.4	234.4
Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	$ 3	$ 12.7

Non-controlling Interests in _4

Non-controlling Interests in Consolidated Entities - Non-Controlling Interests in Income (Loss) of Consolidated Entities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Noncontrolling Interest [Line Items]
Non-controlling interests in income of consolidated entities	$ 1.6	$ 14.6	$ 28.3	$ 57.7
Non-Carlyle interests in Consolidated Funds
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	(15.7)	0.7	14	0.9
Non-Carlyle interests in majority-owned subsidiaries
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	16.3	13.2	11.9	46.6
Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	$ 1	$ 0.7	$ 2.4	$ 10.2

Earnings Per Common Share - Bas

Earnings Per Common Share - Basic and Diluted Net Income Per Common Unit (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Basic
Net income attributable to common shares	$ 280,800,000	$ 532,800,000	$ 1,097,800,000	$ 2,327,100,000
Weighted-average common shares outstanding (in shares)	362,895,064	355,954,734	360,657,999	354,903,371
Net income per common share (in dollars per share)	$ 0.77	$ 1.50	$ 3.04	$ 6.56
Diluted
Net loss attributable to common shares	$ 280,800,000	$ 532,800,000	$ 1,097,800,000	$ 2,327,100,000
Weighted-average common shares outstanding (in shares)	366,787,149	364,740,675	365,389,217	362,471,998
Net income per common share (in dollars per share)	$ 0.77	$ 1.46	$ 3	$ 6.42

Earnings Per Common Share - Wei

Earnings Per Common Share - Weighted-Average Common Units Outstanding, Basic and Diluted (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	362,895,064	355,954,734	360,657,999	354,903,371
Weighted-average common shares outstanding, diluted (in shares)	366,787,149	364,740,675	365,389,217	362,471,998
The Carlyle Group Inc. weighted-average common shares outstanding
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	362,895,064	355,954,734	360,657,999	354,903,371
Weighted-average common shares outstanding, diluted (in shares)	362,895,064	355,954,734	360,657,999	354,903,371
Unvested restricted stock units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	0	0	0	0
Weighted-average common shares outstanding, diluted (in shares)	1,698,568	6,716,547	2,845,204	5,582,360
Issuable common shares and performance-vesting restricted stock units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	0	0	0	0
Weighted-average common shares outstanding, diluted (in shares)	2,193,517	2,069,394	1,886,014	1,986,267

Equity - Additional Information

Equity - Additional Information (Details) - USD ($) $ in Millions		1 Months Ended			3 Months Ended	9 Months Ended
	Mar. 21, 2022	Aug. 31, 2022	Mar. 31, 2022	Oct. 31, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Equity, Class of Treasury Stock [Line Items]
Realized performance allocations and incentive fee related compensation, percentage				20%
Newly issued shares, fully vested in period (in shares)					78,953	850,110
Realized performance allocations and incentive fee related compensation					$ 2.4	$ 38.9
Amount authorized for repurchase				$ 400
Payments to repurchase units						$ 146.9	$ 84.5
Shares/units repurchased (in shares)						3,600,000	1,900,000
Remaining authorized amount					253.1	$ 253.1
Purchase price paid for issuance of shares						194.5
Abingworth
Equity, Class of Treasury Stock [Line Items]
Number of shares		600,000
Purchase price paid for issuance of shares		$ 25			$ 25	$ 25
Management Contracts
Equity, Class of Treasury Stock [Line Items]
Newly issued common shares (in shares)	4,200,000		4,200,000
Purchase price paid for acquisition of management contracts related portfolio of assets			$ 194.5

Equity - Quarterly Distribution

Equity - Quarterly Distributions on Common Units (Details) - USD ($) $ / shares in Units, $ in Millions								3 Months Ended	9 Months Ended
	Nov. 25, 2022	Aug. 16, 2022	May 17, 2022	Feb. 23, 2022	Nov. 17, 2021	Aug. 17, 2021	May 19, 2021	Aug. 16, 2022	Feb. 23, 2022
Subsequent Event [Line Items]
Dividend per Common Share (in dollars per share)		$ 0.325	$ 0.325	$ 0.250	$ 0.250	$ 0.250	$ 0.250	$ 0.975	$ 1
Dividend to Common Stockholders		$ 118.3	$ 117.6	$ 89.5	$ 89.1	$ 89.3	$ 88.7	$ 354.1	$ 356.6
Forecast
Subsequent Event [Line Items]
Dividend per Common Share (in dollars per share)	$ 0.325
Dividend to Common Stockholders	$ 118.2

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 01, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	12,994,991		12,994,991		16,000,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share based compensation expense	$ 54.2	$ 42.5	$ 139.3	$ 122
Tax benefits related to equity-based compensation expense	6.1	$ 8.4	23.5	$ 25.6
Unrecognized equity-based compensation expense	$ 271.9		$ 271.9
Weighted-average term for unrecognized compensation expense to be recognized			2 years

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary of Status of Non-Vested Equity-Based Awards (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Restricted Stock Units
Unvested Units
Beginning balance (in shares) \| shares	14,775,651
Granted (in shares) \| shares	3,616,132
Vested (in shares) \| shares	5,572,684
Forfeited (in shares) \| shares	1,585,664
Ending balance (in shares) \| shares	11,233,435
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) \| $ / shares	$ 30.70
Granted (in dollars per share) \| $ / shares	42.96
Vested (in dollars per share) \| $ / shares	27.74
Forfeited (in dollars per share) \| $ / shares	29.29
Ending balance (in dollars per share) \| $ / shares	$ 36.32
Unvested Common Shares
Unvested Units
Beginning balance (in shares) \| shares	635,430
Granted (in shares) \| shares	188,223
Vested (in shares) \| shares	370,773
Forfeited (in shares) \| shares	0
Ending balance (in shares) \| shares	452,880
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) \| $ / shares	$ 29.27
Granted (in dollars per share) \| $ / shares	49.06
Vested (in dollars per share) \| $ / shares	26.54
Forfeited (in dollars per share) \| $ / shares	0
Ending balance (in dollars per share) \| $ / shares	$ 39.73

Segment Reporting - Additional

Segment Reporting - Additional Information (Details) - segment	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting [Abstract]
Number of reportable segments	3	3	3	3

Segment Reporting - Reportable

Segment Reporting - Reportable Segments Financial Data (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fund level fee revenues
Investment income	$ 422.3	$ 1,134.9	$ 1,846.7	$ 5,318.5
Interest income	35.5	21.9	92.5	63.3
Total revenues	1,088.5	1,639.5	3,719.3	6,783
Compensation and benefits
Cash-based compensation and benefits	251.4	224.9	779.7	685.2
Realized performance revenues related compensation	163.5	495.2	741.2	2,355.8
Total compensation and benefits	469.1	762.5	1,660.2	3,163
General, administrative, and other indirect expenses	149.2	99.6	387.2	300.4
Interest expense	27.3	27.9	82	76.4
Total expenses	699.6	938.1	2,267.3	3,674.3
Realized net performance revenues	134.6	479.3	605	2,485.5
Consolidated VIEs, assets	21,092.4		21,092.4		$ 21,250.4
Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	569.7	440.1	1,678.1	1,277.4
Interest income	10.5	1.5	16.5	5.5
Total revenues	1,401.7	1,523.8	3,342.4	3,055.3
Compensation and benefits
Cash-based compensation and benefits	246.7	218	752.2	647.6
Realized performance revenues related compensation	373.7	477.4	741	786.4
Total compensation and benefits	620.4	695.4	1,493.2	1,434
General, administrative, and other indirect expenses	100.8	60	265	177.2
Depreciation and amortization expense	9.6	10.7	28.6	29
Interest expense	26.5	27.1	79.6	74.2
Total expenses	757.3	793.2	1,866.4	1,714.4
Distributable Earnings	644.4	730.6	1,476	1,340.9
Realized net performance revenues	391.1	533.5	780	846.9
Realized principal investment income	56.7	71.3	126.8	139.1
Net interest	16	25.6	63.1	68.7
Fee Related Earnings	212.6	151.4	632.3	423.6
Consolidated VIEs, assets	14,993.2		14,993.2
Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	343.9	272.4	1,051.6	812.8
Interest income	5.1	0.2	6.7	0.9
Total revenues	1,023.4	1,297.1	2,454.8	2,448.9
Compensation and benefits
Cash-based compensation and benefits	146.7	133.6	453.9	396.3
Realized performance revenues related compensation	283.5	434.5	588.7	688.3
Total compensation and benefits	430.2	568.1	1,042.6	1,084.6
General, administrative, and other indirect expenses	65.3	38.4	170.1	116.2
Depreciation and amortization expense	6.3	7.1	18.9	19.3
Interest expense	15.9	17.4	47.7	46.9
Total expenses	517.7	631	1,279.3	1,267
Distributable Earnings	505.7	666.1	1,175.5	1,181.9
Realized net performance revenues	344.9	528.4	713.4	837.6
Realized principal investment income	46	61.6	94.4	109.3
Net interest	10.8	17.2	41	46
Fee Related Earnings	125.6	93.3	408.7	281
Consolidated VIEs, assets	10,046.3		10,046.3
Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	170.2	108.4	459.1	292.7
Interest income	4.5	1.3	8.6	4.5
Total revenues	246.9	119.2	592.5	322.5
Compensation and benefits
Cash-based compensation and benefits	69.9	58.7	214.2	168
Realized performance revenues related compensation	28.9	1	45	1
Total compensation and benefits	98.8	59.7	259.2	169
General, administrative, and other indirect expenses	26.4	14.7	70.2	39.5
Depreciation and amortization expense	2.1	2.3	6	6.2
Interest expense	7.9	6.8	23.5	19.4
Total expenses	135.2	83.5	358.9	234.1
Distributable Earnings	111.7	35.7	233.6	88.4
Realized net performance revenues	34.1	1.1	51.6	1.2
Realized principal investment income	9.2	7.4	28.2	23.1
Net interest	3.4	5.5	14.9	14.9
Fee Related Earnings	71.8	32.7	168.7	79
Consolidated VIEs, assets	3,205.3		3,205.3
Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	55.6	59.3	167.4	171.9
Interest income	0.9	0	1.2	0.1
Total revenues	131.4	107.5	295.1	283.9
Compensation and benefits
Cash-based compensation and benefits	30.1	25.7	84.1	83.3
Realized performance revenues related compensation	61.3	41.9	107.3	97.1
Total compensation and benefits	91.4	67.6	191.4	180.4
General, administrative, and other indirect expenses	9.1	6.9	24.7	21.5
Depreciation and amortization expense	1.2	1.3	3.7	3.5
Interest expense	2.7	2.9	8.4	7.9
Total expenses	104.4	78.7	228.2	213.3
Distributable Earnings	27	28.8	66.9	70.6
Realized net performance revenues	12.1	4	15	8.1
Realized principal investment income	1.5	2.3	4.2	6.7
Net interest	1.8	2.9	7.2	7.8
Fee Related Earnings	15.2	25.4	54.9	63.6
Consolidated VIEs, assets	1,741.6		1,741.6
Fund management fees
Fund level fee revenues
Total fund level fee revenues	535.9	407.5	1,532.9	1,182.9
Fund management fees \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	514.1	405.7	1,484.5	1,187.9
Fund management fees \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	330.1	265.1	971.3	788.7
Fund management fees \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	128.4	81.3	345.8	227.6
Fund management fees \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	55.6	59.3	167.4	171.6
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	35	23.2	93.4	58.5
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	7.7	7.3	21.3	24.1
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	27.3	15.9	72.1	34.1
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	0	0	0	0.3
Fee related performance revenues \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	20.6	11.2	100.2	31
Fee related performance revenues \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	6.1	0	59	0
Fee related performance revenues \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	14.5	11.2	41.2	31
Fee related performance revenues \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	0	0	0	0
Performance allocations
Fund level fee revenues
Investment income	298.1	974.5	1,346.2	4,841.3
Performance allocations \| Total Reportable Segments
Fund level fee revenues
Investment income	764.8	1,010.9	1,521	1,633.3
Performance allocations \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Investment income	628.4	962.9	1,302.1	1,525.9
Performance allocations \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Investment income	63	2.1	96.6	2.2
Performance allocations \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Investment income	73.4	45.9	122.3	105.2
Principal investment income
Fund level fee revenues
Investment income	124.2	160.4	500.5	477.2
Principal investment income \| Total Reportable Segments
Fund level fee revenues
Investment income	56.7	71.3	126.8	139.1
Principal investment income \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Investment income	46	61.6	94.4	109.3
Principal investment income \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Investment income	9.2	7.4	28.2	23.1
Principal investment income \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Investment income	$ 1.5	$ 2.3	$ 4.2	$ 6.7

Segment Reporting - Total Segme

Segment Reporting - Total Segments to Partnership Income Before Provision for Taxes Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenues	$ 1,088.5	$ 1,639.5	$ 3,719.3	$ 6,783
Expenses	699.6	938.1	2,267.3	3,674.3
Other income (loss)	(30.3)	(0.1)	(51)	9.6
Distributable earnings	358.6	701.3	1,401	3,118.3
Total assets	21,092.4		21,092.4		$ 21,250.4
Total Reportable Segments
Segment Reporting Information [Line Items]
Revenues	1,401.7	1,523.8	3,342.4	3,055.3
Expenses	757.3	793.2	1,866.4	1,714.4
Other income (loss)	0	0	0	0
Distributable earnings	644.4	730.6	1,476	1,340.9
Total assets	14,993.2		14,993.2
Consolidated Funds
Segment Reporting Information [Line Items]
Revenues			204.6	185.3
Expenses			166	162.6
Other income (loss)			(51)	9.6
Distributable earnings	(12.6)	10.1	(12.4)	32.3
Total assets	6,695.8		6,695.8
Reconciling Items
Segment Reporting Information [Line Items]
Revenues	(392.9)	53.6	172.3	3,542.4
Expenses	(119.7)	93	234.9	1,797.3
Other income (loss)	0	0	0	0
Distributable earnings	(273.2)	$ (39.4)	(62.6)	$ 1,745.1
Total assets	$ (596.6)		$ (596.6)

Segment Reporting - Revenue Adj

Segment Reporting - Revenue Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Unrealized principal investment income (loss)			$ 483.8	$ 458.3
Revenues	$ 1,088.5	$ 1,639.5	3,719.3	6,783
Reconciling Items
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenues	(376.2)	(29.8)	334.8	3,212.7
Unrealized principal investment income (loss)	(29.9)	70.4	(33.3)	280.5
Adjustments related to expenses associated with investments in NGP Management and its affiliates	(3.8)	(3.6)	(9.9)	(10.2)
Tax expense associated with certain foreign performance revenues	0.1	0.1	0	0.3
Non-controlling interests and other adjustments to present certain costs on a net basis	28.4	33.2	60	119.6
Revenues	(392.9)	53.6	172.3	3,542.4
Reconciling Items \| Fortitude Re
Segment Reporting Information [Line Items]
Principal investment loss from dilution of indirect investment in Fortitude	0	0	(176.9)	0
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Revenues	$ (11.5)	$ (16.7)	$ (2.4)	$ (60.5)

Segment Reporting - Reconciliat

Segment Reporting - Reconciliation of Fund Level Fee Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total Reportable Segments
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	$ 569.7	$ 440.1	$ 1,678.1	$ 1,277.4
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Adjustments	(33.8)	(32.6)	(145.2)	(94.5)
Fund management fees
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	535.9	407.5	1,532.9	1,182.9
Fund management fees \| Total Reportable Segments
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	514.1	405.7	1,484.5	1,187.9
Fund management fees \| Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	$ (6.2)	$ (6.8)	$ (19.1)	$ (18.6)

Segment Reporting - Expense Adj

Segment Reporting - Expense Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenue compensation expense	$ (213.5)	$ 16.7	$ (35.5)	$ 1,566
Equity-based compensation	54.2	42.4	139.3	122
Right-of-use asset impairment			26.8
Expenses	699.6	938.1	2,267.3	3,674.3
Total Reportable Segments
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenue compensation expense	(224)	15	(50.4)	1,567.1
Expenses	757.3	793.2	1,866.4	1,714.4
Reconciling Items
Segment Reporting Information [Line Items]
Equity-based compensation	56	44.3	145	129.5
Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment	42.4	24.4	124.9	54.7
Tax expense associated with certain foreign performance revenues related compensation	3.7	(2.5)	3	(12.1)
Non-controlling interests and other adjustments to present certain costs on a net basis	7.5	15.9	35.8	53.2
Right-of-use asset impairment	0	0	0	26.8
Other adjustments including severance	3.1	3.2	5.4	7.2
Expenses	(119.7)	93	234.9	1,797.3
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Equity-based compensation	0	0	0	0
Expenses	$ (8.4)	$ (7.3)	$ (28.8)	$ (29.1)

Segment Reporting - Reconcili_2

Segment Reporting - Reconciliation of Income Before Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Income (loss) before provision for income taxes	$ 358.6	$ 701.3	$ 1,401	$ 3,118.3
Adjustments:
Unrealized principal investment (income) loss	(422.3)	(1,134.9)	(1,846.7)	(5,318.5)
Equity-based compensation	54.2	42.4	139.3	122
Net income attributable to non-controlling interests in consolidated entities	1.6	14.6	28.3	57.7
Right-of-use asset impairment			26.8
Realized performance revenues, net of related compensation	134.6	479.3	605	2,485.5
Total Reportable Segments
Adjustments:
Net unrealized performance and fee related performance revenues	152.2	44.8	(385.2)	(1,645.6)
Distributable Earnings	644.4	730.6	1,476	1,340.9
Realized performance revenues, net of related compensation	391.1	533.5	780	846.9
Realized principal investment income	56.7	71.3	126.8	139.1
Net interest	16	25.6	63.1	68.7
Fee Related Earnings	212.6	151.4	632.3	423.6
Reconciling Items
Adjustments:
Equity-based compensation	56	44.3	145	129.5
Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment	42.4	24.4	124.9	54.7
Tax expense associated with certain foreign performance revenues	3.8	(2.4)	3	(11.8)
Net income attributable to non-controlling interests in consolidated entities	(1.6)	(14.6)	(28.3)	(57.7)
Right-of-use asset impairment	0	0	0	26.8
Other adjustments including severance	3.1	3.2	5.4	7.2
Unrealized principal investment income (loss) \| Reconciling Items
Adjustments:
Unrealized principal investment (income) loss	29.9	(70.4)	33.3	(280.5)
Unrealized principal investment income (loss) \| Reconciling Items \| Fortitude Group Holdings, LLC
Adjustments:
Principal investment loss from dilution of indirect investment in Fortitude	$ 0	$ 0	$ 176.9	$ 0

Segment Reporting - Adjustments

Segment Reporting - Adjustments for Performance Fees, Performance Fee Related Compensation and Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Investment income	$ 422.3	$ 1,134.9	$ 1,846.7	$ 5,318.5
Performance revenues related compensation expense	163.5	495.2	741.2	2,355.8
Net performance revenues	134.6	479.3	605	2,485.5
Adjustments
Segment Reporting Information [Line Items]
Performance revenues related compensation expense	210.2	(17.8)	(0.2)	(1,569.4)
Net performance revenues	256.5	54.2	175	(1,638.6)
Total Reportable Segments
Segment Reporting Information [Line Items]
Performance revenues related compensation expense	373.7	477.4	741	786.4
Net performance revenues	391.1	533.5	780	846.9
Performance allocations
Segment Reporting Information [Line Items]
Investment income	298.1	974.5	1,346.2	4,841.3
Performance allocations \| Adjustments
Segment Reporting Information [Line Items]
Investment income	466.7	36.4	174.8	(3,208)
Performance allocations \| Total Reportable Segments
Segment Reporting Information [Line Items]
Investment income	764.8	1,010.9	1,521	1,633.3
Principal investment income
Segment Reporting Information [Line Items]
Investment income	124.2	160.4	500.5	477.2
Principal investment income \| Adjustments
Segment Reporting Information [Line Items]
Investment income	(67.5)	(89.1)	(373.7)	(338.1)
Principal investment income \| Total Reportable Segments
Segment Reporting Information [Line Items]
Investment income	$ 56.7	$ 71.3	$ 126.8	$ 139.1

Subsequent Events (Details)

Subsequent Events (Details)	Nov. 30, 2022 $ / shares
Subsequent event
Subsequent Event [Line Items]
Distribution payable (in dollars per share)	$ 0.325

Supplemental Financial Inform_3

Supplemental Financial Information - Financial Position (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Assets
Cash and cash equivalents	$ 1,361.9		$ 2,469.5	$ 2,399
Cash and cash equivalents held at Consolidated Funds	177.2		147.8	134.8
Restricted cash	0.6		5.6	6.9
Corporate treasury investments	69.5		0
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively	10,998.2		10,832
Investments of Consolidated Funds	6,409.7		6,661
Due from affiliates and other receivables, net	486.4		379.6
Due from affiliates and other receivables of Consolidated Funds, net	108.6		138.8
Fixed assets, net	134.4		143.9
Lease right-of-use assets, net	333.5		361.1
Deposits and other	69.4		61.7
Intangible assets, net	925.1		34.9
Deferred tax assets	17.9		14.5
Total assets	21,092.4		21,250.4
Liabilities and equity
Debt obligations	2,235		2,071.6
Loans payable of Consolidated Funds	5,516.9		5,890
Accounts payable, accrued expenses and other liabilities	379.4		379.7
Accrued compensation and benefits	4,347.7		4,955
Due to affiliates	351.6		388.1
Deferred revenue	394.2		120.8
Deferred tax liabilities	449.9		487.1
Other liabilities of Consolidated Funds	222		683.9
Lease liabilities	499.9		537.8
Accrued giveback obligations	40.9		30.2
Total liabilities	14,437.5		15,544.2
Common stock	3.6		3.6
Additional paid-in-capital	3,123		2,717.6
Retained earnings	3,430.8		2,805.3
Accumulated other comprehensive income (loss)	(439.7)		(247.5)
Non-controlling interests in consolidated entities	537.2		427.2
Total equity	6,654.9	$ 6,432.3	5,706.2	5,033	$ 4,622	$ 2,930.2
Total liabilities and equity	21,092.4		21,250.4
Accrued performance allocations	7,428.7		8,133
Consolidated Operating Entities
Assets
Cash and cash equivalents	1,361.9			2,399
Cash and cash equivalents held at Consolidated Funds	177.2			134.8
Restricted cash	0.6			$ 6.9
Consolidated Entities and Consolidated Funds
Assets
Total assets	6,695.8
Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Assets
Cash and cash equivalents	1,361.9		2,469.5
Cash and cash equivalents held at Consolidated Funds	0		0
Restricted cash	0.6		5.6
Corporate treasury investments	69.5
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively	11,130.8		11,022.5
Investments of Consolidated Funds	0		0
Due from affiliates and other receivables, net	950.4		384.9
Due from affiliates and other receivables of Consolidated Funds, net	0		0
Fixed assets, net	134.4		143.9
Lease right-of-use assets, net	333.5		361.1
Deposits and other	69.1		61.3
Intangible assets, net	925.1		34.9
Deferred tax assets	17.9		14.5
Total assets	14,993.2		14,498.2
Liabilities and equity
Debt obligations	2,235		2,071.6
Loans payable of Consolidated Funds	0		0
Accounts payable, accrued expenses and other liabilities	379.4		379.7
Accrued compensation and benefits	4,347.7		4,955
Due to affiliates	336		388.1
Deferred revenue	394.2		120.8
Deferred tax liabilities	449.9		487.1
Other liabilities of Consolidated Funds	0		0
Lease liabilities	499.9		537.8
Accrued giveback obligations	40.9		30.2
Total liabilities	8,683		8,970.3
Common stock	3.6		3.6
Additional paid-in-capital	3,123		2,717.6
Retained earnings	3,430.8		2,805.3
Accumulated other comprehensive income (loss)	(437.6)		(245.7)
Non-controlling interests in consolidated entities	190.4		247.1
Total equity	6,310.2		5,527.9
Total liabilities and equity	14,993.2		14,498.2
Consolidated Entities and Consolidated Funds \| Consolidated Funds
Assets
Cash and cash equivalents	0		0
Cash and cash equivalents held at Consolidated Funds	177.2		147.8
Restricted cash	0		0
Corporate treasury investments	0
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively	0		0
Investments of Consolidated Funds	6,409.7		6,661
Due from affiliates and other receivables, net	0		0
Due from affiliates and other receivables of Consolidated Funds, net	108.6		138.8
Fixed assets, net	0		0
Lease right-of-use assets, net	0		0
Deposits and other	0.3		0.4
Intangible assets, net	0		0
Deferred tax assets	0		0
Total assets	6,695.8		6,948
Liabilities and equity
Debt obligations	0		0
Loans payable of Consolidated Funds	5,975.3		5,890
Accounts payable, accrued expenses and other liabilities	0		0
Accrued compensation and benefits	0		0
Due to affiliates	15.7		0
Deferred revenue	0		0
Deferred tax liabilities	0		0
Other liabilities of Consolidated Funds	222.1		684
Lease liabilities	0		0
Accrued giveback obligations	0		0
Total liabilities	6,213.1		6,574
Common stock	0		0
Additional paid-in-capital	157.2		198.6
Retained earnings	0		0
Accumulated other comprehensive income (loss)	(21.3)		(4.7)
Non-controlling interests in consolidated entities	346.8		180.1
Total equity	482.7		374
Total liabilities and equity	6,695.8		6,948
Eliminations
Assets
Cash and cash equivalents	0		0
Cash and cash equivalents held at Consolidated Funds	0		0
Restricted cash	0		0
Corporate treasury investments	0
Investments, including accrued performance allocations of $7,428.7 million and $8,133.0 million as of September 30, 2022 and December 31, 2021, respectively	(132.6)		(190.5)
Investments of Consolidated Funds	0		0
Due from affiliates and other receivables, net	(464)		(5.3)
Due from affiliates and other receivables of Consolidated Funds, net	0		0
Fixed assets, net	0		0
Lease right-of-use assets, net	0		0
Deposits and other	0		0
Intangible assets, net	0		0
Deferred tax assets	0		0
Total assets	(596.6)		(195.8)
Liabilities and equity
Debt obligations	0		0
Loans payable of Consolidated Funds	(458.4)		0
Accounts payable, accrued expenses and other liabilities	0		0
Accrued compensation and benefits	0		0
Due to affiliates	(0.1)		0
Deferred revenue	0		0
Deferred tax liabilities	0		0
Other liabilities of Consolidated Funds	(0.1)		(0.1)
Lease liabilities	0		0
Accrued giveback obligations	0		0
Total liabilities	(458.6)		(0.1)
Common stock	0		0
Additional paid-in-capital	(157.2)		(198.6)
Retained earnings	0		0
Accumulated other comprehensive income (loss)	19.2		2.9
Non-controlling interests in consolidated entities	0		0
Total equity	(138)		(195.7)
Total liabilities and equity	$ (596.6)		$ (195.8)

Supplemental Financial Inform_4

Supplemental Financial Information - Results of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Condensed Income Statements, Captions [Line Items]
Investment income	$ 422.3	$ 1,134.9	$ 1,846.7	$ 5,318.5
Interest and other income	35.5	21.9	92.5	63.3
Interest and other income of Consolidated Funds	79.7	62.1	204.6	185.3
Total revenues	1,088.5	1,639.5	3,719.3	6,783
Compensation and benefits
Cash-based compensation and benefits	251.4	224.9	779.7	685.2
Equity-based compensation	54.2	42.4	139.3	122
Performance allocations and incentive fee related compensation	163.5	495.2	741.2	2,355.8
Total compensation and benefits	469.1	762.5	1,660.2	3,163
General, administrative and other expenses	149.2	99.6	387.2	300.4
Interest	27.3	27.9	82	76.4
Interest and other expenses of Consolidated Funds	53.7	44.6	137.1	133.5
Other non-operating income	0.3	3.5	0.8	1
Total expenses	699.6	938.1	2,267.3	3,674.3
Other income
Net investment income (loss) of Consolidated Funds	(30.3)	(0.1)	(51)	9.6
Income before provision for income taxes	358.6	701.3	1,401	3,118.3
Provision for income taxes	76.2	153.9	274.9	733.5
Net income	282.4	547.4	1,126.1	2,384.8
Net income attributable to non-controlling interests in consolidated entities	1.6	14.6	28.3	57.7
Net income attributable to The Carlyle Group Inc.	280.8	532.8	1,097.8	2,327.1
Consolidated Operating Entities
Compensation and benefits
Equity-based compensation			139.3	122
Other income
Net income			1,112.1	2,383.9
Consolidated Entities and Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Total revenues			204.6	185.3
Compensation and benefits
Total expenses			166	162.6
Other income
Net investment income (loss) of Consolidated Funds			(51)	9.6
Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	425.4	1,139.7	1,814.6	5,344.4
Interest and other income	37.6	27	107.8	79.3
Interest and other income of Consolidated Funds	0	0	0	0
Total revenues	1,020.3	1,594.1	3,517.1	6,658.2
Compensation and benefits
Cash-based compensation and benefits	251.4	224.9	779.7	685.2
Equity-based compensation	54.2	42.4	139.3	122
Performance allocations and incentive fee related compensation	163.5	495.2	741.2	2,355.8
Total compensation and benefits	469.1	762.5	1,660.2	3,163
General, administrative and other expenses	149.3	99.6	387.1	300.4
Interest	27.3	27.9	82	76.4
Interest and other expenses of Consolidated Funds	0	0	0	0
Other non-operating income	0.3	3.5	0.8	1
Total expenses	646	893.5	2,130.1	3,540.8
Other income
Net investment income (loss) of Consolidated Funds	0	0	0	0
Income before provision for income taxes	374.3	700.6	1,387	3,117.4
Provision for income taxes	76.2	153.9	274.9	733.5
Net income	298.1	546.7	1,112.1	2,383.9
Net income attributable to non-controlling interests in consolidated entities	17.3	13.9	14.3	56.8
Net income attributable to The Carlyle Group Inc.	280.8	532.8	1,097.8	2,327.1
Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0	0	0
Interest and other income	0	0	0	0
Interest and other income of Consolidated Funds	79.7	62.1	204.6	185.3
Total revenues	79.7	62.1	204.6	185.3
Compensation and benefits
Cash-based compensation and benefits	0	0	0	0
Equity-based compensation	0	0	0	0
Performance allocations and incentive fee related compensation	0	0	0	0
Total compensation and benefits	0	0	0	0
General, administrative and other expenses	0	0	0	0
Interest	0	0	0	0
Interest and other expenses of Consolidated Funds	62	51.9	166	162.6
Other non-operating income	0	0	0	0
Total expenses	62	51.9	166	162.6
Other income
Net investment income (loss) of Consolidated Funds	(30.3)	(0.1)	(51)	9.6
Income before provision for income taxes	(12.6)	10.1	(12.4)	32.3
Provision for income taxes	0	0	0	0
Net income	(12.6)	10.1	(12.4)	32.3
Net income attributable to non-controlling interests in consolidated entities	0	0	0	0
Net income attributable to The Carlyle Group Inc.	(12.6)	10.1	(12.4)	32.3
Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	(3.1)	(4.8)	32.1	(25.9)
Interest and other income	(2.1)	(5.1)	(15.3)	(16)
Interest and other income of Consolidated Funds	0	0	0	0
Total revenues	(11.5)	(16.7)	(2.4)	(60.5)
Compensation and benefits
Cash-based compensation and benefits	0	0	0	0
Equity-based compensation	0	0	0	0
Performance allocations and incentive fee related compensation	0	0	0	0
Total compensation and benefits	0	0	0	0
General, administrative and other expenses	(0.1)	0	0.1	0
Interest	0	0	0	0
Interest and other expenses of Consolidated Funds	(8.3)	(7.3)	(28.9)	(29.1)
Other non-operating income	0	0	0	0
Total expenses	(8.4)	(7.3)	(28.8)	(29.1)
Other income
Net investment income (loss) of Consolidated Funds	0	0	0	0
Income before provision for income taxes	(3.1)	(9.4)	26.4	(31.4)
Provision for income taxes	0	0	0	0
Net income	(3.1)	(9.4)	26.4	(31.4)
Net income attributable to non-controlling interests in consolidated entities	(15.7)	0.7	14	0.9
Net income attributable to The Carlyle Group Inc.	12.6	(10.1)	12.4	(32.3)
Fund management fees
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	535.9	407.5	1,532.9	1,182.9
Fund management fees \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	542.1	414.3	1,552	1,201.5
Fund management fees \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	0	0	0	0
Fund management fees \| Eliminations
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	(6.2)	(6.8)	(19.1)	(18.6)
Incentive fees
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	15.1	13.1	42.6	33
Incentive fees \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	15.2	13.1	42.7	33
Incentive fees \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	0	0	0	0
Incentive fees \| Eliminations
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	(0.1)	0	(0.1)	0
Performance allocations
Condensed Income Statements, Captions [Line Items]
Investment income	298.1	974.5	1,346.2	4,841.3
Performance allocations \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	297.8	974.5	1,350.7	4,841.3
Performance allocations \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0	0	0
Performance allocations \| Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	0.3	0	(4.5)	0
Principal investment income
Condensed Income Statements, Captions [Line Items]
Investment income	124.2	160.4	500.5	477.2
Principal investment income \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	127.6	165.2	463.9	503.1
Principal investment income \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0	0	0
Principal investment income \| Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	$ (3.4)	$ (4.8)	$ 36.6	$ (25.9)

Supplemental Financial Inform_5

Supplemental Financial Information - Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash flows from operating activities
Net income	$ 282.4	$ 547.4	$ 1,126.1	$ 2,384.8
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization			102.7	40.5
Right-of-use asset impairment, net of broker fees			0	24.8
Equity-based compensation	54.2	42.4	139.3	122
Non-cash performance allocations and incentive fees			184.1	(1,662.3)
Non-cash principal investment income			(483.8)	(458.3)
Other non-cash amounts			(27.4)	20.7
Purchases of investments			(559.6)	(178)
Proceeds from the sale of investments			388.3	533.8
Payments of contingent consideration			(5.7)	(50)
Changes in deferred taxes, net			(2.3)	449.1
Change in due from affiliates and other receivables			(62.6)	(21.4)
Change in deposits and other			(12.8)	(23.3)
Change in accounts payable, accrued expenses and other liabilities			(27.7)	90.9
Change in accrued compensation and benefits			(265.3)	17.3
Change in due to affiliates			2.4	1.4
Change in lease right-of-use assets and lease liabilities			(7)	5.9
Change in deferred revenue			274.9	247.6
Net cash provided by (used in) operating activities			(258.5)	1,302.4
Cash flows from investing activities
Purchases of corporate treasury investments, net			(69.6)	0
Purchases of fixed assets, net			(25)	(27)
Purchase of Abingworth, net of cash acquired			(150.2)	0
Purchase of CBAM intangibles and investments, net			(618.4)	0
Net cash used in investing activities			(863.2)	(17.8)
Cash flows from financing activities
Borrowings under credit facilities			0	70
Issuance of 4.625% subordinated notes due 2061, net of financing costs			0	484.1
Payments on CLO borrowings			(8.9)	(231.5)
Proceeds from CLO borrowings, net of financing costs			55.2	87.5
Payments of contingent consideration			0	0.1
Dividends to common stockholders			(325.4)	(266.7)
Payment of deferred consideration for Carlyle Holdings units			(68.8)	(68.8)
Contributions from non-controlling interest holders			282.1	57.2
Distributions to non-controlling interest holders			(173.5)	(76.3)
Common shares issued for performance allocations			38.9	0
Common shares repurchased			(146.9)	(84.5)
Change in due to/from affiliates financing activities			(13.2)	21.8
Net cash provided by financing activities			88.9	157.9
Effect of foreign exchange rate changes			(79.8)	(26.2)
Increase (decrease) in cash, cash equivalents and restricted cash			(1,112.6)	1,416.3
Cash, cash equivalents and restricted cash, beginning of period			2,475.1	989.6
Cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9	1,362.5	2,405.9
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,361.9	2,399	1,361.9	2,399	$ 2,469.5
Restricted cash	0.6	6.9	0.6	6.9	5.6
Total cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9	1,362.5	2,405.9	2,475.1
Cash and cash equivalents held at Consolidated Funds	177.2	134.8	177.2	134.8	147.8
MRE
Cash flows from investing activities
Proceeds from sale, net of cash sold			0	5.9
Brazil management entity
Cash flows from investing activities
Proceeds from sale, net of cash sold			0	3.3
Consolidated Operating Entities
Cash flows from operating activities
Net income			1,112.1	2,383.9
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization			102.7	40.5
Right-of-use asset impairment, net of broker fees			0	24.8
Equity-based compensation			139.3	122
Non-cash performance allocations and incentive fees			179.4	(1,662.3)
Non-cash principal investment income			(434.9)	(470.7)
Other non-cash amounts			(27.4)	20.7
Purchases of investments			(582.4)	(250.9)
Proceeds from the sale of investments			410.2	559.1
Payments of contingent consideration			(5.7)	(50)
Changes in deferred taxes, net			(2.3)	449.1
Change in due from affiliates and other receivables			(62)	(21.1)
Change in deposits and other			(12.8)	(23.3)
Change in accounts payable, accrued expenses and other liabilities			(27.7)	90.9
Change in accrued compensation and benefits			(265.3)	17.3
Change in due to affiliates			2.4	1.4
Change in lease right-of-use assets and lease liabilities			(7)	5.9
Change in deferred revenue			274.9	247.6
Net cash provided by (used in) operating activities			793.5	1,484.9
Cash flows from investing activities
Purchases of corporate treasury investments, net			(69.6)	0
Purchases of fixed assets, net			(25)	(27)
Purchase of Abingworth, net of cash acquired			(150.2)	0
Purchase of CBAM intangibles and investments, net			(618.4)	0
Net cash used in investing activities			(863.2)	(17.8)
Cash flows from financing activities
Borrowings under credit facilities			0	70
Issuance of 4.625% subordinated notes due 2061, net of financing costs			0	484.1
Payments on CLO borrowings			(8.9)	(231.5)
Proceeds from CLO borrowings, net of financing costs			55.2	87.5
Payments of contingent consideration			0	0.1
Dividends to common stockholders			(325.4)	(266.7)
Payment of deferred consideration for Carlyle Holdings units			(68.8)	(68.8)
Contributions from non-controlling interest holders			7.2	13.1
Distributions to non-controlling interest holders			(52.5)	(56.3)
Common shares issued for performance allocations			38.9	0
Common shares repurchased			(146.9)	(84.5)
Change in due to/from affiliates financing activities			(471.6)	21.8
Net cash provided by financing activities			(972.8)	(31.4)
Effect of foreign exchange rate changes			(70.1)	(19.4)
Increase (decrease) in cash, cash equivalents and restricted cash			(1,112.6)	1,416.3
Cash, cash equivalents and restricted cash, beginning of period			2,475.1	989.6
Cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9	1,362.5	2,405.9
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM and Abingworth			219.5	0
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,361.9	2,399	1,361.9	2,399
Restricted cash	0.6	6.9	0.6	6.9
Total cash, cash equivalents and restricted cash, end of period	1,362.5	2,405.9	1,362.5	2,405.9	$ 2,475.1
Cash and cash equivalents held at Consolidated Funds	$ 177.2	$ 134.8	177.2	134.8
Consolidated Operating Entities \| MRE
Cash flows from investing activities
Proceeds from sale, net of cash sold			0	5.9
Consolidated Operating Entities \| Brazil management entity
Cash flows from investing activities
Proceeds from sale, net of cash sold			$ 0	$ 3.3
Consolidated Operating Entities \| Subordinated Notes Due 2061
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Interest rate (percent)		4.625%		4.625%